Busca un médico

Val Lowe, M.D.

  1. Nuclear Medicine Specialist
Solicite una Consulta

Publicaciones

  1. Singh-Reilly N, Pham NTT, Graff-Radford J, Machulda MM, Spychalla AJ, Senjem ML, Petersen RC, Lowe VJ, Boeve BF, Jack CR Jr, Josephs KA, Kantarci K, Whitwell JL. White matter hyperintensities in dementia with lewy bodies and posterior cortical atrophy. Neurobiol Aging. 2025 Jun; 150:44-52 Epub 2025 Mar 03
    View PubMed
  2. Vassilaki M, Aakre JA, Lesnick TG, Kremers WK, Graff-Radford J, Knopman DS, Mosley TH, Windham BG, Griswold ME, Geda YE, Lowe VJ, Jack CR Jr, Petersen RC, Vemuri P. Patterns of Factors in the National Institute on Aging Health Disparities Research Framework Domains and Mild Cognitive Impairment Risk. AJPM Focus. 2025 Jun; 4 (3):100324 Epub 2025 Feb 17
    View PubMed
  3. Singh-Reilly N, Graff-Radford J, Li D, Mielke MM, Machulda MM, Schwarz CG, Senjem ML, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL. Abeta(42/40) and p-tau 181 as disease biomarkers in atypical Alzheimer's disease. J Alzheimers Dis. 2025 Apr 23; 13872877251333450 [Epub ahead of print]
    View PubMed
  4. Fu M, Gunter J, Satoh R, Gatto R, Ali F, Clark HM, Stierwalt J, Machulda M, Stephens YC, Youssef H, Pham NTT, Jack C, Lowe V, Josephs K, Whitwell J. Disproportionately Enlarged Subarachnoid-space Hydrocephalus and Progressive Supranuclear Palsy (P1-5.023). Neurology. 2025 Apr 8; 104 (7_Supplement_1):1786 Epub 2025 Apr 07
    View PubMed
  5. Medeiros MS, Ferreira PL, Bellaver B, Ruppert E, Zalzale H, Soares C, Bauer-Negrini G, Povala G, Amaral L, Lussier F, Tudorascu D, Masdeu J, Soleimani-Meigooni D, Fortea J, Lowe V, Oh H, Pascual B, Gordon B, Rosa-Neto P, Schilling LP, Baker S, Pascoal T. Comparison of MK-6240 and Flortaucipir Tau PET for the Biological Staging of Alzheimer Disease (P11-4.004). Neurology. 2025 Apr 8; 104 (7_Supplement_1):6044 Epub 2025 Apr 07
    View PubMed
  6. Jones KE, Aakre JA, Castillo AM, Ramanan VK, Kremers WK, Jack CR Jr, Vemuri P, Schwarz CG, Lowe VJ, Knopman DS, Petersen RC, Graff-Radford J, Vassilaki M. Eligibility for donanemab trial in a population-based study of cognitive aging. J Prev Alzheimers Dis. 2025 Apr; 12 (4):100088 Epub 2025 Feb 17
    View PubMed
  7. Valentino RR, Koga S, Soto-Beasley AI, Ono D, Wieczorek MA, Johnson PW, White LJ, Watkins MM, Murray ME, Kasanuki K, McLean PJ, Springer W, Uitti RJ, Fields JA, Botha H, Ramanan VK, Kantarci K, Lowe VJ, Jack CR Jr, Bras J, Guerreiro R, Ertekin-Taner N, Savica R, Graff-Radford J, Petersen RC, Parisi JE, Reichard RR, Graff-Radford NR, Ferman TJ, Boeve BF, Wszolek ZK, Dickson DW, Heckman MG, Ross OA. Genome-wide association study of neuropathological features in Lewy body disease. Brain. 2025 Mar 17 [Epub ahead of print]
    View PubMed
  8. Ghatamaneni S, Coleman C, Shin I, Bruinsma T, Scott N, Lee J, Fang P, Min HK, Moloney CM, Wood AC, Constantopoulos E, Reichard RR, Schwarz CG, Jones DT, Graff-Radford J, Knopman DS, Jack CR Jr, Petersen RC, Dickson DW, Murray ME, Lowe VJ. High resolution autoradiography of [(18)F]MK-6240 and [(18)F]Flortaucipir shows similar neurofibrillary tangle binding patterns preferentially recognizing middling neurofibrillary tangle maturity. Acta Neuropathol. 2025 Mar 14; 149 (1):26
    View PubMed
  9. Ghirelli A, Goodrich AW, Stephens YC, Graff-Radford J, Ali F, Machulda MM, Schwarz CG, Senjem ML, Agosta F, Filippi M, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL. Relationships between hypometabolism and both beta-amyloid and tau PET in corticobasal syndrome. Alzheimers Dement. 2025 Mar; 21 (3):e70018
    View PubMed
  10. Ferreira D, Przybelski SA, Lesnick TG, Diaz-Galvan P, Schwarz CG, Murray MM, Dickson DW, Nguyen A, Reichard RR, Senjem ML, Gunter JL, Jack CR Jr, Min PH, Jain MK, Miyagawa T, Forsberg LK, Fields JA, Savica R, Graff-Radford J, Ramanan VK, Jones DT, Botha H, St Louis EK, Knopman DS, Graff-Radford NR, Day GS, Ferman TJ, Kremers WK, Petersen RC, Boeve BF, Lowe VJ, Kantarci K. Longitudinal FDG-PET Metabolic Change Along the Lewy Body Continuum. JAMA Neurol. 2025 Mar 01; 82(3):285-294.
    View PubMed
  11. Mak E, Przybelski SA, Wiste HJ, Fought AJ, Schwarz CG, Senjem ML, Jack CR Jr, Lowe VJ, Petersen RC, Boeve BF, O'Brien JT, Kantarci K, Alzheimer's Disease Neuroimaging Initiative. Influence of alpha-synuclein on glucose metabolism in Alzheimer's disease continuum: Analyses of alpha-synuclein seed amplification assay and FDG-PET. Alzheimers Dement. 2025 Feb; 21 (2):e14571
    View PubMed
  12. Cogswell PM, Wiste HJ, Weigand SD, Therneau TM, Griswold ME, Braunstein JB, West T, Verghese PB, Graff-Radford J, Algeciras-Schimnich A, Lowe VJ, Schwarz CG, Senjem ML, Gunter JL, Knopman DS, Vemuri P, Petersen RC, Jack CR Jr. Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PET. Alzheimers Dement. 2025 Feb; 21 (2):e14629
    View PubMed
  13. Elasfar S, Hameed H, Boeve BF, Fields JA, Jack CR Jr, Kantarci K, St Louis EK, Lowe VJ, Petersen RC, Ali F, Ehgoetz Martens K. Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid deposition. Alzheimers Dement. 2025 Feb; 21 (2):e14351 Epub 2025 Jan 27
    View PubMed
  14. Kandimalla M, Lim S, Thakkar J, Dewan S, Kang D, In MH, Jo HJ, Jang DP, Nedelska Z, Lapid MI, Shu Y, Cheon-Pyung CheonPyung, Cogswell PM, Lowe VJ, Lee J, Min HK. Cardiorespiratory dynamics in the brain: Review on the significance of cardiovascular and respiratory correlates in functional MRI signal. Neuroimage. 2025 Feb 1; 306:121000 Epub 2025 Jan 01
    View PubMed
  15. Kara F, Tosakulwong N, Lesnick TG, Fought AJ, Kendell-Thomas J, Kapoor E, Faubion LL, Schwarz CG, Senjem ML, Fields JA, Min PH, Lowe VJ, Jack CR Jr, Bailey KR, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE, Kantarci K. Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy. Menopause. 2025 Jan 1; 32 (1):12-22
    View PubMed
  16. Kantarci K, Kapoor E, Geske JR, Castillo A, Fields JA, Kara F, Knyazhanskaya EE, Schwarz CG, Senjem ML, Bailey KR, Lowe V, LeBrasseur NK, Rocca WA, Mielke MM. Premenopausal bilateral oophorectomy and Alzheimer's disease imaging biomarkers later in life. Alzheimers Dement. 2024 Dec 23 [Epub ahead of print]
    View PubMed
  17. Lavrova A, Satoh R, Pham NTT, Nguyen A, Jack CR Jr, Petersen RC, Ross RR, Dickson DW, Lowe VJ, Whitwell JL, Josephs KA. Investigating the feasibility of (18)F-flortaucipir PET imaging in the antemortem diagnosis of primary age-related tauopathy (PART): An observational imaging-pathological study. Alzheimers Dement. 2024 Dec; 20 (12):8605-8614 Epub 2024 Oct 17
    View PubMed
  18. Teigen LM, McCarter SJ, Ziegert Z, Staley C, Grant KM, Gupta VK, Zhao X, St Louis EK, Kantarci K, Lowe VJ, Forsberg LK, Savica R, Ramanan VK, Jones DT, Petersen RC, Sung J, Khoruts A, Boeve BF, Ross OA. Taxonomic intestinal microbiota differences in Lewy body spectrum disease and cohabitant controls. Parkinsonism Relat Disord. 2024 Dec; 129:107176 Epub 2024 Oct 16
    View PubMed
  19. Gatto RG, Hossam Y, Reichard RR, Lowe VJ, Whitwell JL, Josephs KA. Microscopy assessment of a fluorescence [(18)F] flortaucipir analog (T726) shows neuropathological overlap with 3R and 4R tau lesions. Alzheimers Dement. 2024 Dec; 20 (12):8758-8768 Epub 2024 Oct 22
    View PubMed
  20. Zeydan B, Johnson DR, Schwarz CG, Przybelski SA, Lesnick TG, Senjem ML, Kantarci OH, Min PH, Kemp BJ, Jack CR Jr, Kantarci K, Lowe VJ. Visual assessments of 11 C-Pittsburgh compound-B PET vs. 18 F-flutemetamol PET across the age spectrum. Nucl Med Commun. 2024 Dec 1; 45 (12):1047-1054 Epub 2024 Sept 13
    View PubMed
  21. Armstrong MF, Burkett BJ, O'Byrne TJ, Gottlich HC, Yin LX, Tasche KK, Price DL, Moore EJ, Routman DM, Gamez M, Lester SC, Neben-Wittich MA, Ma DJ, Price KA, Lowe VJ, Van Abel KM. Cancer in Patients With Incidental Asymmetric Oropharynx Positron Emission Tomography Uptake. JAMA Otolaryngol Head Neck Surg 2024 Dec 1; 150 (12):1078-1086
    View PubMed
  22. Tissot C, Tsai HY, Therriault J, Tudorascu D, Rahmouni N, Servaes S, Stevenson J, Lussier FZ, Pezzoli S, Ziontz J, Gordon BA, Pascual B, Lowe VJ, Soleimani-Meigooni DN, Oh H, Klunk WE, Rosa-Neto P, Jagust WJ, Pascoal TA, Baker SL. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e094377
    View PubMed
  23. Povala G, Bauer-Negrini G, Bellaver B, Lussier FZ, Amaral L, Ferreira PCL, Zatt B, Tudorascu D, Lopresti BJ, Jagust WJ, Klunk WE, Lowe VJ, Soleimani-Meigooni DN, Oh H, Pascual B, Gordon BA, Rosa-Neto P, Pascoal TA. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e094383
    View PubMed
  24. Singh NA, Alnobani A, Graff-Radford J, Machulda MM, Mielke MM, Schwarz CG, Senjem ML, Jack CR Jr, Lowe VJ, Kanekiyo T, Josephs KA, Whitwell JL. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e094001
    View PubMed
  25. Soares C, Povala G, Bauer-Negrini G, Lussier FZ, Ferreira PCL, Bellaver B, Amaral L, Zalzale H, Madeiros MS, Cehula J, Bloomquist M, Oliveira M Jr, Felix C, Rodrigues MS, Ruppert EP, Abbas S, Zimmer ER, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Rosa-Neto P, Tudorascu D, Jagust WJ, Klunk WE, Baker SL, Pascoal TA. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e094006
    View PubMed
  26. Lussier FZ, Povala G, Bauer-Negrini G, Amaral L, Cehula J, Fine DJ, Lemaire P, Bloomquist M, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Rosa-Neto P, Tudorascu D, Jagust WJ, Klunk WE, Baker SL, Pascoal TA. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e094013
    View PubMed
  27. Bauer-Negrini G, Povala G, Bellaver B, Lussier FZ, Tissot C, Tsai HY, Amaral L, Ferreira PCL, Tudorascu D, Jagust WJ, Klunk WE, Lowe VJ, Soleimani-Meigooni DN, Oh H, Pascual B, Gordon BA, Rosa-Neto P, Baker SL, Pascoal TA. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e094084
    View PubMed
  28. Felix C, Ferreira PCL, Rodrigues MS, Snitz BE, Abbas S, Oliveira M Jr, Bauer-Negrini G, Povala G, Lemaire P, Kollasserry FJ, Medeiros MS, Soares C, Rebok G, Aguzzoli CS, Bellaver B, Lussier FZ, Amaral L, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Tudorascu D, Jagust WJ, Klunk WE, Rosa-Neto P, Baker SL, Pascoal TA. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e094075
    View PubMed
  29. Ruppert EP, Povala G, Bauer-Negrini G, Lussier FZ, Ferreira PCL, Bellaver B, Amaral L, Zalzale H, Oliveira M Jr, Saha P, Rodrigues MS, Abbas S, Soares C, Felix C, Madeiros MS, de Paula E, Resende F, Caramelli P, Klunk WE, Tudorascu D, Jagust WJ, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Rosa-Neto P, Baker SL, Pascoal TA. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e094086
    View PubMed
  30. Aguzzoli CS, Povala G, Ferreira PCL, Lussier FZ, Bauer-Negrini G, Amaral L, Soares C, Ferrari-Souza JP, Zalzale H, Bellaver B, Rohden F, Abbas S, Leffa DT, Schilling LP, Zimmer ER, Tudorascu D, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Rosa-Neto P, Baker SL, Pascoal TA. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e094042
    View PubMed
  31. Povala G, Bauer-Negrini G, Bellaver B, Lussier FZ, Amaral L, Ferreira PCL, Finn Q, Zatt B, Tudorascu D, Jagust WJ, Klunk WE, Lowe VJ, Soleimani-Meigooni DN, Oh H, Pascual B, Gordon BA, Rosa-Neto P, Baker SL, Pascoal TA. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e094123
    View PubMed
  32. Bellaver B, Povala G, Bauer-Negrini G, Lussier FZ, Amaral L, Ferreira PCL, Lowe VJ, Soleimani-Meigooni DN, Oh H, Tudorascu D, Jagust WJ, Klunk WE, Pascual B, Gordon BA, Rosa-Neto P, Baker SL, Pascoal TA. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e094093
    View PubMed
  33. Karim HT, Povala G, Bauer-Negrini G, Lussier FZ, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Rosa-Neto P, Jagust WJ, Klunk WE, Baker SL, Pascoal TA. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e094117
    View PubMed
  34. Macedo AC, Therriault J, Rahmouni N, Servaes S, Wang YT, Tissot C, Lussier FZ, Arias JF, Socualaya KMQ, Hosseini SA, Ferreira PCL, Bellaver B, Ferrari-Souza JP, Aguzzoli CS, Povala G, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Baker SL, Pascoal TA, Rosa-Neto P. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e093737
    View PubMed
  35. Tissot C, Tsai HY, Tudorascu D, Lussier FZ, Rahmouni N, Servaes S, Therriault J, Stevenson J, Gordon BA, Pascual B, Lowe VJ, Soleimani-Meigooni DN, Oh H, Klunk WE, Rosa-Neto P, Jagust WJ, Pascoal TA, Baker SL. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e093894
    View PubMed
  36. Bellaver B, Povala G, Bauer-Negrini G, Lussier FZ, Amaral L, Ferreira PCL, Lowe VJ, Soleimani-Meigooni DN, Oh H, Tudorascu D, Jagust WJ, Klunk WE, Pascual B, Gordon BA, Rosa-Neto P, Baker SL, Pascoal TA. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e092862
    View PubMed
  37. Felix C, Ferreira PCL, Kollasserry FJ, Snitz BE, Rebok G, Tudorascu D, Rodrigues MS, Oliveira M Jr, Povala G, Lemaire P, Bauer-Negrini G, Medeiros MS, Abbas S, Soares C, Aguzzoli CS, Bellaver B, Lussier FZ, Amaral L, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Klunk WE, Rosa-Neto P, Jagust WJ, Baker SL, Pascoal TA. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e092683
    View PubMed
  38. Singh NA, Alnobani A, Graff-Radford J, Machulda MM, Mielke MM, Schwarz CG, Senjem ML, Jack CR Jr, Lowe VJ, Kanekiyo T, Josephs KA, Whitwell JL. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e091767
    View PubMed
  39. Singh NA, Graff-Radford J, Li D, Mielke MM, Machulda MM, Schwarz CG, Senjem ML, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e091571
    View PubMed
  40. Povala G, Bauer-Negrini G, Bellaver B, Lussier FZ, Amaral L, Ferreira PCL, Finn Q, Zatt B, Tudorascu D, Jagust WJ, Klunk WE, Lowe VJ, Soleimani-Meigooni DN, Oh H, Pascual B, Gordon BA, Rosa-Neto P, Baker SL, Pascoal TA. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e093141
    View PubMed
  41. Ruppert EP, Povala G, Bauer-Negrini G, Lussier FZ, Ferreira PCL, Bellaver B, Amaral L, Zalzale H, Oliveira M Jr, Saha P, Rodrigues MS, Abbas S, Soares C, Felix C, Madeiros MS, de Paula E, Resende F, Caramelli P, Klunk WE, Tudorascu D, Jagust WJ, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Rosa-Neto P, Baker SL, Pascoal TA. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e092793
    View PubMed
  42. Soares C, Povala G, Bauer-Negrini G, Lussier FZ, Ferreira PCL, Bellaver B, Amaral L, Zalzale H, Madeiros MS, Cehula J, Bloomquist M, Oliveira M Jr, Felix C, Rodrigues MS, Ruppert EP, Abbas S, Zimmer ER, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Rosa-Neto P, Tudorascu D, Jagust WJ, Klunk WE, Baker SL, Pascoal TA. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e091820
    View PubMed
  43. Amaral L, Povala G, Bellaver B, Bauer-Negrini G, Lussier FZ, Ferreira PCL, Cehula J, Tudorascu D, Jagust WJ, Klunk WE, Lowe VJ, Oh H, Soleimani-Meigooni DN, Pascual B, Gordon BA, Rosa-Neto P, Baker SL, Pascoal TA. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e091693
    View PubMed
  44. Machado VH, Povala G, Bellaver B, Ferreira PCL, Amaral L, Bauer-Negrini G, Lussier FZ, Tudorascu D, Jagust WJ, Klunk WE, Lowe VJ, Soleimani-Meigooni DN, Oh H, Pascual B, Gordon BA, Rosa-Neto P, Baker SL, Pascoal TA. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e091694
    View PubMed
  45. Povala G, Bauer-Negrini G, Bellaver B, Lussier FZ, Amaral L, Ferreira PCL, Zatt B, Tudorascu D, Lopresti BJ, Jagust WJ, Klunk WE, Lowe VJ, Soleimani-Meigooni DN, Oh H, Pascual B, Gordon BA, Rosa-Neto P, Pascoal TA. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e089555
    View PubMed
  46. Finn Q, Povala G, Bauer-Negrini G, Franco A, Vo T, Lussier FZ, Amaral L, Gordon BA, Klunk WE, Lowe VJ, Oh H, Rosa-Neto P, Soleimani-Meigooni DN, Baker SL, Masdeu JC, Pascoal T, Pascual B. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e089551
    View PubMed
  47. Lussier FZ, Povala G, Bauer-Negrini G, Amaral L, Cehula J, Fine DJ, Lemaire P, Bloomquist M, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Rosa-Neto P, Tudorascu D, Jagust WJ, Klunk WE, Baker SL, Pascoal TA. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e091910
    View PubMed
  48. Bauer-Negrini G, Povala G, Bellaver B, Lussier FZ, Tissot C, Tsai HY, Amaral L, Ferreira PCL, Tudorascu D, Jagust WJ, Klunk WE, Lowe VJ, Soleimani-Meigooni DN, Oh H, Pascual B, Gordon BA, Rosa-Neto P, Baker SL, Pascoal TA. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e092768
    View PubMed
  49. Karim HT, Povala G, Bauer-Negrini G, Lussier FZ, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Rosa-Neto P, Jagust WJ, Klunk WE, Baker SL, Pascoal TA. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e093082
    View PubMed
  50. Tissot C, Tsai HY, Tudorascu D, Lussier FZ, Rahmouni N, Servaes S, Therriault J, Stevenson J, Gordon BA, Pascual B, Lowe VJ, Soleimani-Meigooni DN, Oh H, Klunk WE, Rosa-Neto P, Jagust WJ, Pascoal TA, Baker SL. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e090568
    View PubMed
  51. Macedo AC, Therriault J, Rahmouni N, Servaes S, Wang YT, Tissot C, Lussier FZ, Arias JF, Socualaya KMQ, Hosseini SA, Ferreira PCL, Bellaver B, Ferrari-Souza JP, Aguzzoli CS, Povala G, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Baker SL, Pascoal TA, Rosa-Neto P. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e087615
    View PubMed
  52. Tissot C, Tsai HY, Therriault J, Tudorascu D, Rahmouni N, Servaes S, Stevenson J, Lussier FZ, Pezzoli S, Ziontz J, Gordon BA, Pascual B, Lowe VJ, Soleimani-Meigooni DN, Oh H, Klunk WE, Rosa-Neto P, Jagust WJ, Pascoal TA, Baker SL. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e087641
    View PubMed
  53. Corriveau-Lecavalier N, Botha H, Graff-Radford J, Switzer A, Przybelski SA, Wiste HJ, Murray ME, Reichard RR, Dickson DW, Nguyen AT, Ramanan VK, McCarter SJ, Boeve B, Machulda MM, Fields JA, Stricker NH, Nelson PT, Grothe MJ, Knopman DS, Lowe VJ, Petersen RC, Jack CR Jr, Jones DT. Clinical Manifestations. Alzheimers Dement. 2024 Dec; 20 Suppl 3:e084087
    View PubMed
  54. Gebre RK, Moscoso A, Raghavan S, Wiste HJ, Heeman F, Costoya-Sanchez A, Schwarz CG, Spychalla AJ, Lowe VJ, Graff-Radford J, Knopman DS, Petersen RC, Scholl M, Murray ME, Jack CR Jr, Vemuri P. Basic Science and Pathogenesis. Alzheimers Dement. 2024 Dec; 20 Suppl 1:e091770
    View PubMed
  55. Zalzale H, Madeiros MS, Soares C, Bauer-Negrini G, Povala G, Ferreira PCL, Amaral L, Lussier FZ, Bellaver B, Abbas S, Rodrigues MS, Tudorascu D, Oliveira M Jr, Felix C, Leffa DT, Tissot C, Aguzzoli CS, Ruppert EP, Saha P, Rahmouni N, Zetterberg H, Blennow K, Ashton NJ, Pascual B, Gordon BA, Jagust WJ, Lowe VJ, Karikari TK, Oh H, Klunk WE, Soleimani-Meigooni DN, Rosa-Neto P, Baker SL, Pascoal TA. Clinical Manifestations. Alzheimers Dement. 2024 Dec; 20 Suppl 3:e093241
    View PubMed
  56. Aguzzoli CS, Povala G, Ferreira PCL, Lussier FZ, Bauer-Negrini G, Amaral L, Soares C, Ferrari-Souza JP, Zalzale H, Bellaver B, Rohden F, Abbas S, Leffa DT, Schilling LP, Zimmer ER, Tudorascu D, Pascual B, Gordon BA, Lowe VJ, Oh H, Soleimani-Meigooni DN, Rosa-Neto P, Baker SL, Pascoal TA. Clinical Manifestations. Alzheimers Dement. 2024 Dec; 20 Suppl 3:e092310
    View PubMed
  57. Tian J, Raghavan S, Cogswell PM, Reid RI, Przybelski SA, Schwarz CG, Graff-Radford J, Lowe VJ, Kantarci K, Knopman DS, Petersen RC, Jack CR Jr, Vemuri P. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e093924
    View PubMed
  58. Raghavan S, Reid RI, Przybelski SA, Kamykowski MG, Lesnick TG, Graff-Radford J, Lowe VJ, Knopman DS, Jack CR Jr, Petersen RC, Vemuri P. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e093870
    View PubMed
  59. Schwarz CG, Kremers WK, Prakaashana CM, Przybelski SA, Christenson LR, Wiliams JM, Gunter JL, Senjem ML, Arani A, Reid RI, Machulda MM, Fields JA, Lowe VJ, Kantarci K, Graff-Radford J, Vemuri P, Petersen RC, Knopman DS, Jack CR Jr. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e093966
    View PubMed
  60. Wakefield WC, Barnard LR, Botha H, Graff-Radford J, Kantarci K, Boeve BF, Petersen RC, Jack CR Jr, Lowe VJ, Jones DT. Alzheimer's Imaging Consortium. Alzheimers Dement. 2024 Dec; 20 Suppl 9:e093646
    View PubMed
  61. Ramanan VK, Graff-Radford J, Bornhorst JA, Johnson DR, Cogswell PM, Burkett BJ, Lowe VJ, Stricker NH, Botha H, Jones DT, McCarter SJ, Neth BJ, Jack CR Jr, Knopman DS, Petersen RC, Algeciras-Schimnich A. Developing Topics. Alzheimers Dement. 2024 Dec; 20 Suppl 8:e095777
    View PubMed
  62. Vassilaki M, Aakre JA, Castillo AM, Lesnick TG, Kremers WK, Algeciras-Schimnich A, Graff-Radford J, Knopman DS, Mosley TH, Windham BG, Griswold ME, Lowe VJ, Jack CR Jr, Petersen RC, Vemuri P. Developing Topics. Alzheimers Dement. 2024 Dec; 20 Suppl 8:e095372
    View PubMed
  63. Schwarz CG, Kremers WK, Prakaashana CM, Przybelski SA, Christenson LR, Wiliams JM, Gunter JL, Senjem ML, Arani A, Reid RI, Machulda MM, Fields JA, Lowe VJ, Kantarci K, Graff-Radford J, Vemuri P, Petersen RC, Knopman DS, Jack CR Jr. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e091346
    View PubMed
  64. Tian J, Raghavan S, Cogswell PM, Reid RI, Przybelski SA, Schwarz CG, Graff-Radford J, Lowe VJ, Kantarci K, Knopman DS, Petersen RC, Jack CR Jr, Vemuri P. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e090927
    View PubMed
  65. Miyagawa T, Vernon C, Przybelski SA, Min HK, Fields JA, Forsberg LK, St Louis EK, Kantarci K, Lowe VJ, Boeve BF. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e091810
    View PubMed
  66. Lowe VJ, Mester CT, Lundt ES, Lee J, Ghatamaneni S, Algeciras-Schimnich A, Campbell MR, Graff-Radford J, Nguyen AT, Min HK, Murray ME, Senjem ML, Schwarz CG, Kantarci K, Boeve BF, Vemuri P, Jones DT, Knopman DS, Jack CR Jr, Petersen RC, Mielke MM. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e092471
    View PubMed
  67. Lee J, Lim S, Kandimalla M, Ghatamaneni S, Thakkar J, Dewan S, Cogswell PM, Gunter JL, Botha H, Graff-Radford J, Yook S, Kim H, McCarter SJ, Park JG, St Louis EK, Mantilla C, Huston J 3rd, Lowe VJ, Min HK. Public Health. Alzheimers Dement. 2024 Dec; 20 Suppl 7:e093200
    View PubMed
  68. Raghavan S, Hofrenning EI, Fought AJ, Algeciras-Schimnich A, Knopman DS, Jack CR Jr, Petersen RC, Lowe VJ, Graff-Radford J, Vemuri P. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e090142
    View PubMed
  69. Mak E, Reid RI, Przybelski SA, Lesnick TG, Schwarz CG, Senjem ML, Raghavan S, Vemuri P, Jack CR Jr, Min HK, Jain MK, Miyagawa T, Forsberg LK, Fields JA, Savica R, Graff-Radford J, Jones DT, Botha H, St Louis EK, Knopman DS, Ramanan VK, Dickson DW, Graff-Radford NR, Ferman TJ, Petersen RC, Lowe VJ, Boeve B, O'Brien JT, Kantarci K. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e089309
    View PubMed
  70. Cogswell PM, Lundt ES, Therneau TM, Griswold ME, Graff-Radford J, Algeciras-Schimnich A, Lowe VJ, Schwarz CG, Senjem ML, Gunter JL, Knopman DS, Vemuri P, Petersen RC, Jack CR Jr. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e090361
    View PubMed
  71. Raghavan S, Reid RI, Przybelski SA, Kamykowski MG, Lesnick TG, Graff-Radford J, Lowe VJ, Knopman DS, Jack CR Jr, Petersen RC, Vemuri P. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e090097
    View PubMed
  72. Wakefield WC, Barnard LR, Botha H, Graff-Radford J, Kantarci K, Boeve BF, Petersen RC, Jack CR Jr, Lowe VJ, Jones DT. Biomarkers. Alzheimers Dement. 2024 Dec; 20 Suppl 2:e085469
    View PubMed
  73. Salian VS, Tang X, Thompson KJ, Curan GL, Lowe VJ, Li L, Kalari KR, Kandimalla KK. Molecular Mechanisms Underlying Amyloid Beta Peptide Mediated Upregulation of Vascular Cell Adhesion Molecule-1 in Alzheimer Disease. J Pharmacol Exp Ther. 2024 Nov 19; 391 (3):430-440
    View PubMed
  74. Essa H, Ali HM, Min PH, Ali DN, Lowe V, Petersen RC, Knopman DS, Lundt ES, Mester CT, Bormann NL, Choi DS. Impact of alcohol use disorder on cognition in correlation with aging: a community-based retrospective cohort study. Alcohol Alcohol. 2024 Nov 18; 60 (1)
    View PubMed
  75. Watanabe H, Duffy JR, Clark H, Machulda MM, Graff-Radford J, Thu Pham NT, Dickson DW, Lowe VJ, Whitwell JL, Josephs KA. Primary Progressive Aphasia Lacking Core Features of Nonfluent and Semantic Variants: Clinical, Neuroimaging, and Neuropathologic Features. Neurology. 2024 Nov 12; 103 (9):e209924 Epub 2024 Oct 08
    View PubMed
  76. Wang Z, Zhong R, Curran GL, Min P, Lowe VJ, Li L, Kandimalla KK. High-Density Lipoprotein Mimetic Peptide 4F Reduces Toxic Amyloid-Beta Exposure to the Blood-Brain Barrier Endothelium in Alzheimer's Disease Transgenic Mice. Mol Pharm. 2024 Nov 4; 21 (11):5661-5671 Epub 2024 Oct 11
    View PubMed
  77. Coburn RP, Graff-Radford J, Machulda MM, Schwarz CG, Lowe VJ, Jones DT, Jack CR Jr, Josephs KA, Whitwell JL, Botha H. Baseline multimodal imaging to predict longitudinal clinical decline in atypical Alzheimer's disease. Cortex. 2024 Nov; 180:18-34 Epub 2024 Sept 11
    View PubMed
  78. Miyagawa T, Vernon C, Przybelski SA, Min PH, Fields JA, Dickerson BC, Dickson DW, Kantarci K, Lowe VJ, Wszolek ZK, Boeve BF. Prominent loss of striatal dopamine transporter binding in frontotemporal lobar degeneration with the MAPT N279K mutation present as early as at prodromal stage without parkinsonism. Parkinsonism Relat Disord 2024 Nov; 128:107144 Epub 2024 Sept 08
    View PubMed
  79. Lowe VJ, Mester CT, Lundt ES, Lee J, Ghatamaneni S, Algeciras-Schimnich A, Campbell MR, Graff-Radford J, Nguyen A, Min HK, Senjem ML, Machulda MM, Schwarz CG, Dickson DW, Murray ME, Kandimalla KK, Kantarci K, Boeve B, Vemuri P, Jones DT, Knopman D, Jack CR Jr, Petersen RC, Mielke MM. Amyloid PET detects the deposition of brain Abeta earlier than CSF fluid biomarkers. Alzheimers Dement. 2024 Nov; 20 (11):8097-8112 Epub 2024 Oct 11
    View PubMed
  80. Therriault J, Janelidze S, Benedet AL, Ashton NJ, Arranz Martinez J, Gonzalez-Escalante A, Bellaver B, Alcolea D, Vrillon A, Karim H, Mielke MM, Hyung Hong C, Roh HW, Contador J, Puig Pijoan A, Algeciras-Schimnich A, Vemuri P, Graff-Radford J, Lowe VJ, Karikari TK, Jonaitis E, Brum W, Tissot C, Servaes S, Rahmouni N, Macedo AC, Stevenson J, Fernandez-Arias J, Wang YT, Woo MS, Friese MA, Jia WL, Dumurgier J, Hourregue C, Cognat E, Ferreira PL, Vitali P, Johnson S, Pascoal TA, Gauthier S, Lleo A, Paquet C, Petersen RC, Salmon D, Mattsson-Carlgren N, Palmqvist S, Stomrud E, Galasko D, Son SJ, Zetterberg H, Fortea J, Suarez-Calvet M, Jack CR Jr, Blennow K, Hansson O, Rosa-Neto P. Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability. Nat Aging. 2024 Nov; 4 (11):1529-1537 Epub 2024 Nov 12
    View PubMed
  81. Gebre RK, Rial AM, Raghavan S, Wiste HJ, Heeman F, Costoya-Sanchez A, Schwarz CG, Spychalla AJ, Lowe VJ, Graff-Radford J, Knopman DS, Petersen RC, Scholl M, Murray ME, Jack CR Jr, Vemuri P, Alzheimer's Disease Neuroimaging Initiative. Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure. J Nucl Med. 2024 Sep 3; 65 (9):1473-1480 Epub 2024 Sept 03
    View PubMed
  82. Figdore DJ, Griswold M, Bornhorst JA, Graff-Radford J, Ramanan VK, Vemuri P, Lowe VJ, Knopman DS, Jack CR Jr, Petersen RC, Algeciras-Schimnich A. Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays. Alzheimers Dement. 2024 Sep; 20 (9):6506-6516 Epub 2024 July 19
    View PubMed
  83. Garcia-Guaqueta DP, Ghayal NB, Lowe VJ, Dickson DW, Whitwell JL, Josephs KA. Patterns of glucose hypometabolism can help differentiate FTLD-FET from other types of FTLD. J Neurol. 2024 Sep; 271 (9):6264-6273 Epub 2024 Aug 01
    View PubMed
  84. Hollenbeak CS, Duan F, Subramaniam RM, Taurone A, Sicks J, Lowe VJ, Stack BC Jr. Quality of life following surgery for head and neck cancer: Evidence from ACRIN 6685. Head Neck. 2024 Aug; 46 (8):1988-1998 Epub 2024 Feb 14
    View PubMed
  85. Garcia-Guaqueta DP, Stephens YC, Ali F, Utianski RL, Duffy JR, Clark HM, Thu Pham NT, Machulda MM, Lowe VJ, Dickson DW, Whitwell JL, Josephs KA. Comparing classic-onset corticobasal syndrome to speech/language-onset corticobasal syndrome. Parkinsonism Relat Disord. 2024 Aug; 125:107025 Epub 2024 June 03
    View PubMed
  86. Meade G, Thu Pham NT, Schwarz CG, Clark HM, Duffy JR, Senjem ML, Lowe V, Botha H, Whitwell JL, Josephs KA, Utianski RL. The yes-no reversal phenomenon in patients with primary progressive apraxia of speech. Cortex. 2024 Aug; 177:28-36 Epub 2024 May 04
    View PubMed
  87. Josephs KA, Tosakulwong N, Weigand SD, Graff-Radford J, Schwarz CG, Senjem ML, Machulda MM, Kantarci K, Knopman DS, Nguyen A, Reichard RR, Dickson DW, Petersen RC, Lowe VJ, Jack CR Jr, Whitwell JL. Flortaucipir PET uncovers relationships between tau and amyloid-beta in primary age-related tauopathy and Alzheimer's disease. Sci Transl Med. 2024 Jul 24; 16 (757):eado8076 Epub 2024 July 24
    View PubMed
  88. Gundam SR, Bansal A, Kethamreddy M, Ghatamaneni S, Lowe VJ, Murray ME, Pandey MK. Synthesis and preliminary evaluation of novel PET probes for GSK-3 imaging. Sci Rep. 2024 Jul 10; 14 (1):15960 Epub 2024 July 10
    View PubMed
  89. Pradeep A, Raghavan S, Przybelski SA, Preboske GM, Schwarz CG, Lowe VJ, Knopman DS, Petersen RC, Jack CR Jr, Graff-Radford J, Cogswell PM, Vemuri P. Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population? Alzheimers Res Ther. 2024 Jul 10; 16(1):157.
    View PubMed
  90. Song C, Jung D, Kendi AT, Rho JK, Kim EJ, Horn I, Curran GL, Ghattamaneni S, Shim JY, Kang PS, Kang D, Thakkar JB, Dewan S, Lowe VJ, Lee SB. Metformin Prevents Tumor Cell Growth and Invasion of Human Hormone Receptor-Positive Breast Cancer (HR+ BC) Cells via FOXA1 Inhibition. Int J Mol Sci. 2024 Jul 8; 25 (13) Epub 2024 July 08
    View PubMed
  91. Lavrova A, Pham NTT, Vernon CJ, Carlos AF, Petersen RC, Dickson DW, Lowe VJ, Jack CR Jr, Whitwell JL, Josephs KA. A multimodal clinical diagnostic approach using MRI and (18)F-FDG-PET for antemortem diagnosis of TDP-43 in cases with low-intermediate Alzheimer's disease neuropathologic changes and primary age-related tauopathy. J Neurol. 2024 Jul; 271 (7):4105-4118 Epub 2024 Apr 05
    View PubMed
  92. Black JA, Pham NTT, Ali F, Machulda MM, Lowe VJ, Josephs KA, Whitwell JL. Frontal hypometabolism in the diagnosis of progressive supranuclear palsy clinical variants. J Neurol. 2024 Jul; 271 (7):4267-4280 Epub 2024 Apr 17
    View PubMed
  93. Singh NA, Alnobani A, Graff-Radford J, Machulda MM, Mielke MM, Schwarz CG, Senjem ML, Jack CR Jr, Lowe VJ, Kanekiyo T, Josephs KA, Whitwell JL. Relationships between PET and blood plasma biomarkers in corticobasal syndrome. Alzheimers Dement. 2024 Jul; 20(7):4765-4774. Epub 2024 Jun 17.
    View PubMed
  94. Yu X, Przybelski SA, Reid RI, Lesnick TG, Raghavan S, Graff-Radford J, Lowe VJ, Kantarci K, Knopman DS, Petersen RC, Jack CR Jr, Vemuri P. NODDI in gray matter is a sensitive marker of aging and early AD changes. Alzheimers Dement (Amst). 2024 Jul-Sep; 16 (3):e12627 Epub 2024 July 29
    View PubMed
  95. Lecy EE, Min HK, Apgar CJ, Maltais DD, Lundt ES, Albertson SM, Senjem ML, Schwarz CG, Botha H, Graff-Radford J, Jones DT, Vemuri P, Kantarci K, Knopman DS, Petersen RC, Jack CR Jr, Lee J, Lowe VJ. Patterns of Early Neocortical Amyloid-beta Accumulation: A PET Population-Based Study. J Nucl Med. 2024 Jul 1; 65 (7):1122-1128 Epub 2024 July 01
    View PubMed
  96. Burkett BJ, Johnson DR, Lowe VJ. Evaluation of Neurodegenerative Disorders with Amyloid-beta, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls. J Nucl Med. 2024 Jun 3; 65 (6):829-837 Epub 2024 June 03
    View PubMed
  97. Arnaldi D, Mattioli P, Raffa S, Pardini M, Massa F, Iranzo A, Perissinotti A, Ninerola-Baizan A, Gaig C, Serradell M, Munoz-Lopetegi A, Maya G, Liguori C, Fernandes M, Placidi F, Chiaravalloti A, Sonka K, Dusek P, Zogala D, Trnka J, Boeve BF, Miyagawa T, Lowe VJ, Miyamoto T, Miyamoto M, Puligheddu M, Figorilli M, Serra A, Hu MT, Klein JC, Bes F, Kunz D, Cochen De Cock V, de Verbizier D, Plazzi G, Antelmi E, Terzaghi M, Bossert I, Kulcsarova K, Martino A, Giuliani A, Pagani M, Nobili F, Morbelli S, International REM Sleep Behavior Disorder Study Group. Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy. Ann Neurol. 2024 Jun; 95 (6):1178-1192 Epub 2024 Mar 11
    View PubMed
  98. Kouri N, Frankenhauser I, Peng Z, Labuzan SA, Boon BDC, Moloney CM, Pottier C, Wickland DP, Caetano-Anolles K, Corriveau-Lecavalier N, Tranovich JF, Wood AC, Hinkle KM, Lincoln SJ, Spychalla AJ, Senjem ML, Przybelski SA, Engelberg-Cook E, Schwarz CG, Kwan RS, Lesser ER, Crook JE, Carter RE, Ross OA, Lachner C, Ertekin-Taner N, Ferman TJ, Fields JA, Machulda MM, Ramanan VK, Nguyen AT, Reichard RR, Jones DT, Graff-Radford J, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K, Day GS, Duara R, Graff-Radford NR, Dickson DW, Lowe VJ, Vemuri P, Murray ME. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease. JAMA Neurol. 2024 Jun 1; 81 (6):619-629
    View PubMed
  99. Singh NA, Graff-Radford J, Machulda MM, Carlos AF, Schwarz CG, Senjem ML, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL. Atypical Alzheimer's disease: new insights into an overlapping spectrum between the language and visual variants. J Neurol. 2024 Jun; 271 (6):3571-3585 Epub 2024 Mar 29
    View PubMed
  100. Gatto RG, Pham NTT, Duffy JR, Clark HM, Utianski RL, Botha H, Machulda MM, Lowe VJ, Schwarz CG, Jack CR Jr, Josephs KA, Whitwell JL. Multimodal cross-examination of progressive apraxia of speech by diffusion tensor imaging-based tractography and Tau-PET scans. Hum Brain Mapp. 2024 Jun 1; 45 (8):e26704
    View PubMed
  101. Zhou AL, Swaminathan SK, Salian VS, Wang L, Curran GL, Min HK, Lowe VJ, Kandimalla KK. Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood-Brain Barrier. Mol Pharm. 2024 May 6; 21 (5):2176-2186 Epub 2024 Apr 16
    View PubMed
  102. Tetzloff KA, Martin PR, Duffy JR, Utianski RL, Clark HM, Botha H, Machulda MM, Thu Pham NT, Schwarz CG, Senjem ML, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL. Longitudinal flortaucipir, metabolism and volume differ between phonetic and prosodic speech apraxia. Brain. 2024 May 3; 147 (5):1696-1709
    View PubMed
  103. Sintini I, Singh NA, Li D, Mielke MM, Machulda MM, Schwarz CG, Senjem ML, Jack CR Jr, Lowe VJ, Graff-Radford J, Josephs KA, Whitwell JL. Plasma glial fibrillary acidic protein in the visual and language variants of Alzheimer's disease. Alzheimers Dement. 2024 May; 20 (5):3679-3686 Epub 2024 Mar 25
    View PubMed
  104. Maalouf E, Khasawneh H, Karbhari A, AlAsfoor S, Breen-Lyles M, Bernard C, Rajan E, Farrugia G, Lowe V, Goenka A, Grover M. Preliminary study on the dynamic positron emission tomography imaging with (11)C-ER176 to delineate macrophage activation in diabetic gastroparesis. Neurogastroenterol Motil. 2024 May; 36 (5):e14762 Epub 2024 Feb 20
    View PubMed
  105. Singh NA, Goodrich AW, Graff-Radford J, Machulda MM, Sintini I, Carlos AF, Robinson CG, Reid RI, Lowe VJ, Jack CR Jr, Petersen RC, Boeve BF, Josephs KA, Kantarci K, Whitwell JL. Altered structural and functional connectivity in Posterior Cortical Atrophy and Dementia with Lewy bodies. Neuroimage. 2024 Apr 15; 290:120564 Epub 2024 Mar 03
    View PubMed
  106. Habich A, Oltra J, Schwarz CG, Przybelski SA, Oppedal K, Inguanzo A, Blanc F, Lemstra AW, Hort J, Westman E, Segura B, Junque C, Lowe VJ, Boeve BF, Aarsland D, Dierks T, Kantarci K, Ferreira D. Grey matter networks in women and men with dementia with Lewy bodies. NPJ Parkinsons Dis. 2024 Apr 13; 10 (1):84
    View PubMed
  107. Corriveau-Lecavalier N, Barnard LR, Botha H, Graff-Radford J, Ramanan VK, Lee J, Dicks E, Rademakers R, Boeve BF, Machulda MM, Fields JA, Dickson DW, Graff-Radford N, Knopman DS, Lowe VJ, Petersen RC, Jack CR Jr, Jones DT. Uncovering the distinct macro-scale anatomy of dysexecutive and behavioural degenerative diseases. Brain. 2024 Apr 4; 147 (4):1483-1496
    View PubMed
  108. Mak E, Reid RI, Przybelski SA, Lesnick TG, Schwarz CG, Senjem ML, Raghavan S, Vemuri P, Jack CR Jr, Min HK, Jain MK, Miyagawa T, Forsberg LK, Fields JA, Savica R, Graff-Radford J, Jones DT, Botha H, St Louis EK, Knopman DS, Ramanan VK, Dickson DW, Graff-Radford NR, Ferman TJ, Petersen RC, Lowe VJ, Boeve BF, O'Brien JT, Kantarci K. Influences of amyloid-ß and tau on white matter neurite alterations in dementia with Lewy bodies. NPJ Parkinsons Dis. 2024 Apr 03; 10(1):76.
    View PubMed
  109. Diaz-Galvan P, Przybelski SA, Algeciras-Schimnich A, Figdore DJ, Lesnick TG, Schwarz CG, Senjem ML, Gunter JL, Jack CR Jr, Min PH, Jain MK, Miyagawa T, Forsberg LK, Fields JA, Savica R, Graff-Radford J, Ramanan VK, Jones DT, Botha H, St Louis EK, Knopman DS, Graff-Radford NR, Ferman TJ, Petersen RC, Lowe VJ, Boeve BF, Kantarci K. Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies. Alzheimers Dement. 2024 Apr; 20(4):2485-2496. Epub 2024 Feb 08.
    View PubMed
  110. Walton RL, Koga S, Beasley AI, White LJ, Griesacker T, Murray ME, Kasanuki K, Hou X, Fiesel FC, Springer W, Uitti RJ, Fields JA, Botha H, Ramanan VK, Kantarci K, Lowe VJ, Jack CR, Ertekin-Taner N, Savica R, Graff-Radford J, Petersen RC, Parisi JE, Reichard RR, Graff-Radford NR, Ferman TJ, Boeve BF, Wszolek ZK, Dickson DW, Ross OA, Heckman MG. Role of GBA variants in Lewy body disease neuropathology. Acta Neuropathol. 2024 Mar 12; 147 (1):54
    View PubMed
  111. Oltra J, Habich A, Schwarz CG, Nedelska Z, Przybelski SA, Inguanzo A, Diaz-Galvan P, Lowe VJ, Oppedal K, Gonzalez MC, Philippi N, Blanc F, Barkhof F, Lemstra AW, Hort J, Padovani A, Rektorova I, Bonanni L, Massa F, Kramberger MG, Taylor JP, Snaedal JG, Walker Z, Antonini A, Dierks T, Segura B, Junque C, Westman E, Boeve BF, Aarsland D, Kantarci K, Ferreira D. Sex differences in brain atrophy in dementia with Lewy bodies. Alzheimers Dement. 2024 Mar; 20 (3):1815-1826 Epub 2023 Dec 22
    View PubMed
  112. Lee J, Burkett BJ, Min HK, Senjem ML, Dicks E, Corriveau-Lecavalier N, Mester CT, Wiste HJ, Lundt ES, Murray ME, Nguyen AT, Reichard RR, Botha H, Graff-Radford J, Barnard LR, Gunter JL, Schwarz CG, Kantarci K, Knopman DS, Boeve BF, Lowe VJ, Petersen RC, Jack CR Jr, Jones DT. Synthesizing images of tau pathology from cross-modal neuroimaging using deep learning. Brain. 2024 Mar 1; 147 (3):980-995
    View PubMed
  113. Robinson CG, Lee J, Min PH, Przybelski SA, Josephs KA, Jones DT, Graff-Radford J, Boeve BF, Knopman DS, Jack CR Jr, Petersen RC, Machulda MM, Fields JA, Lowe VJ. Significance of a positive tau PET scan with a negative amyloid PET scan. Alzheimers Dement. 2024 Mar; 20 (3):1923-1932 Epub 2023 Dec 30
    View PubMed
  114. Jack CR Jr, Wiste HJ, Algeciras-Schimnich A, Weigand SD, Figdore DJ, Lowe VJ, Vemuri P, Graff-Radford J, Ramanan VK, Knopman DS, Mielke MM, Machulda MM, Fields J, Schwarz CG, Cogswell PM, Senjem ML, Therneau TM, Petersen RC. Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals. Alzheimers Dement. 2024 Mar; 20(3):2143-2154. Epub 2024 Jan 24.
    View PubMed
  115. Cogswell PM, Lundt ES, Therneau TM, Wiste HJ, Graff-Radford J, Algeciras-Schimnich A, Lowe VJ, Mielke MM, Schwarz CG, Senjem ML, Gunter JL, Knopman DS, Vemuri P, Petersen RC, Jack CR Jr. Modeling the temporal evolution of plasma p-tau in relation to amyloid beta and tau PET. Alzheimers Dement. 2024 Feb; 20 (2):1225-1238 Epub 2023 Nov 14
    View PubMed
  116. Badihian N, Ali F, Botha H, Savica R, Machulda MM, Clark HM, Stierwalt JAG, Pham NTT, Baker MC, Rademakers R, Lowe V, Whitwell JL, Josephs KA. The MAPT p.E342K and p.R406W mutations are associated with progressive supranuclear palsy with atypical features. Parkinsonism Relat Disord. 2024 Feb; 119:105962 Epub 2023 Dec 17
    View PubMed
  117. Satoh R, Ali F, Botha H, Lowe VJ, Josephs KA, Whitwell JL. Direct comparison between (18)F-Flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy. Neuroimage. 2024 Feb 1; 286:120509 Epub 2024 Jan 04
    View PubMed
  118. Gunter NB, Gebre RK, Graff-Radford J, Heckman MG, Jack CR Jr, Lowe VJ, Knopman DS, Petersen RC, Ross OA, Vemuri P, Ramanan VK, Alzheimer's Disease Neuroimaging Initiative. Machine Learning Models of Polygenic Risk for Enhanced Prediction of Alzheimer Disease Endophenotypes. Neurol Genet. 2024 Feb; 10 (1):e200120 Epub 2024 Jan 10
    View PubMed
  119. Miyagawa T, Vernon C, Przybelski SA, Min HK, Fields JA, Kantarci K, Lowe V, Boeve BF. Marked Decreased Tracer Binding in 123I-FP-CIT SPECT Scans From Lisdexafetamine Dismesylate Interaction: A Case Report. Clin Neuropharmacol. 2024 Jan 2 Epub 2024 Jan 02
    View PubMed
  120. Corriveau-Lecavalier N, Barnard LR, Przybelski SA, Gogineni V, Botha H, Graff-Radford J, Ramanan VK, Forsberg LK, Fields JA, Machulda MM, Rademakers R, Gavrilova RH, Lapid MI, Boeve BF, Knopman DS, Lowe VJ, Petersen RC, Jack CR, Kantarci K, Jones DT. Assessing network degeneration and phenotypic heterogeneity in genetic frontotemporal lobar degeneration by decoding FDG-PET. Neuroimage Clin. 2024; 41:103559 Epub 2023 Dec 22
    View PubMed
  121. Sintini I, Corriveau-Lecavalier N, Jones DT, Machulda MM, Gunter JL, Schwarz CG, Botha H, Carlos AF, Kamykowski MG, Singh NA, Petersen RC, Jack CR Jr, Lowe VJ, Graff-Radford J, Josephs KA, Whitwell JL. Longitudinal default mode sub-networks in the language and visual variants of Alzheimer's disease. Brain Commun. 2024; 6 (2):fcae005 Epub 2024 Jan 08
    View PubMed
  122. Carlos AF, Weigand SD, Duffy JR, Clark HM, Utianski RL, Machulda MM, Botha H, Thu Pham NT, Lowe VJ, Schwarz CG, Whitwell JL, Josephs KA. Volumetric analysis of hippocampal subregions and subfields in left and right semantic dementia. Brain Commun. 2024; 6 (2):fcae097 Epub 2024 Mar 25
    View PubMed
  123. Figdore DJ, Wiste HJ, Bornhorst JA, Bateman RJ, Li Y, Graff-Radford J, Knopman DS, Vemuri P, Lowe VJ, Jr CRJ, Petersen RC, Algeciras-Schimnich A. Performance of the Lumipulse plasma Abeta42/40 and pTau181 immunoassays in the detection of amyloid pathology. Alzheimers Dement (Amst). 2024 Jan-Mar; 16 (1):e12545 Epub 2024 Jan 31
    View PubMed
  124. Corriveau-Lecavalier N, Botha H, Graff-Radford J, Switzer AR, Przybelski SA, Wiste HJ, Murray ME, Reichard RR, Dickson DW, Nguyen AT, Ramanan VK, McCarter SJ, Boeve BF, Machulda MM, Fields JA, Stricker NH, Nelson PT, Grothe MJ, Knopman DS, Lowe VJ, Petersen RC, Jack CR Jr, Jones DT. Clinical criteria for a limbic-predominant amnestic neurodegenerative syndrome. Brain Commun. 2024; 6 (4):fcae183 Epub 2024 July 17
    View PubMed
  125. Singh-Reilly N, Botha H, Duffy JR, Clark HM, Utianski RL, Machulda MM, Graff-Radford J, Schwarz CG, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell JL. Speech-language within and between network disruptions in primary progressive aphasia variants. Neuroimage Clin. 2024; 43:103639. Epub 2024 Jul 04.
    View PubMed
  126. Carvalho DZ, Kremen V, Mivalt F, St Louis EK, McCarter SJ, Bukartyk J, Przybelski SA, Kamykowski MG, Spychalla AJ, Machulda MM, Boeve BF, Petersen RC, Jack CR Jr, Lowe VJ, Graff-Radford J, Worrell GA, Somers VK, Varga AW, Vemuri P. Non-rapid eye movement sleep slow-wave activity features are associated with amyloid accumulation in older adults with obstructive sleep apnoea. Brain Commun. 2024; 6 (5):fcae354 Epub 2024 Oct 07
    View PubMed
  127. Ali F, Clark H, Machulda M, Senjem ML, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell J, Botha H. Patterns of brain volume and metabolism predict clinical features in the progressive supranuclear palsy spectrum. Brain Commun. 2024; 6 (4):fcae233 Epub 2024 July 16
    View PubMed
  128. Shir D, Graff-Radford J, Fought AJ, Lesnick TG, Przybelski SA, Vassilaki M, Lowe VJ, Knopman DS, Machulda MM, Petersen RC, Jack CR Jr, Mielke MM, Vemuri P. Complex relationships of socioeconomic status with vascular and Alzheimer's pathways on cognition. Neuroimage Clin. 2024; 43:103634 Epub 2024 June 15
    View PubMed
  129. Gebre RK, Graff-Radford J, Ramanan VK, Raghavan S, Hofrenning EI, Przybelski SA, Nguyen AT, Lesnick TG, Gunter JL, Algeciras-Schimnich A, Knopman DS, Machulda MM, Vassilaki M, Lowe VJ, Jack CR Jr, Petersen RC, Vemuri P. Can integration of Alzheimer's plasma biomarkers with MRI, cardiovascular, genetics, and lifestyle measures improve cognition prediction? Brain Commun. 2024; 6(5):fcae300. Epub 2024 Sep 04.
    View PubMed
  130. Carlos AF, Sekiya H, Koga S, Gatto RG, Casey MC, Pham NTT, Sintini I, Machulda MM, Jack CR, Lowe VJ, Whitwell JL, Petrucelli L, Reichard RR, Petersen RC, Dickson DW, Josephs KA. Clinicopathologic features of a novel star-shaped transactive response DNA-binding protein 43 (TDP-43) pathology in the oldest old. J Neuropathol Exp Neurol. 2023 Dec 22; 83 (1):36-52
    View PubMed
  131. Pittock RR, Aakre JA, Castillo AM, Ramanan VK, Kremers WK, Jack CR Jr, Vemuri P, Lowe VJ, Knopman DS, Petersen RC, Graff-Radford J, Vassilaki M. Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging. Neurology. 2023 Nov 7; 101 (19):e1837-e1849 Epub 2023 Aug 16
    View PubMed
  132. Ramanan VK, Gebre RK, Graff-Radford J, Hofrenning E, Algeciras-Schimnich A, Figdore DJ, Lowe VJ, Mielke MM, Knopman DS, Ross OA, Jack CR Jr, Petersen RC, Vemuri P. Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis. Brain. 2023 Nov 2; 146 (11):4508-4519
    View PubMed
  133. Mielke MM, Dage JL, Frank RD, Algeciras-Schimnich A, Knopman DS, Lowe VJ, Bu G, Vemuri P, Graff-Radford J, Jack CR Jr, Petersen RC. Author Correction: Performance of plasma phosphorylated tau 181 and 217 in the community. Nat Med. 2023 Nov; 29 (11):2954
    View PubMed
  134. Krell-Roesch J, Rakusa M, Syrjanen JA, van Harten AC, Lowe VJ, Jack CR Jr, Kremers WK, Knopman DS, Stokin GB, Petersen RC, Vassilaki M, Geda YE. Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging. Alzheimers Dement. 2023 Oct; 19 (10):4498-4506 Epub 2022 Feb 09
    View PubMed
  135. Sintini I, Graff-Radford J, Schwarz CG, Machulda MM, Singh NA, Carlos AF, Senjem ML, Jr CRJ, Lowe VJ, Josephs KA, Whitwell JL. Longitudinal rates of atrophy and tau accumulation differ between the visual and language variants of atypical Alzheimer's disease. Alzheimers Dement. 2023 Oct; 19 (10):4396-4406 Epub 2023 July 23
    View PubMed
  136. Liu T, Benarroch E, Hogan W, McKeon A, Lowe VJ, Savica R. Frontotemporal Hypometabolism in Medication-Induced Tardive Dyskinesia. Neurology. 2023 Sep 26; 101 (13):585-587 Epub 2023 May 18
    View PubMed
  137. Diaz-Galvan P, Przybelski SA, Lesnick TG, Schwarz CG, Senjem ML, Gunter JL, Jack CR, Min HP, Jain M, Miyagawa T, Forsberg LK, Fields JA, Savica R, Graff-Radford J, Jones DT, Botha H, St Louis EK, Knopman DS, Ramanan VK, Ross O, Graff-Radford N, Day GS, Dickson DW, Ferman TJ, Petersen RC, Lowe VJ, Boeve BF, Kantarci K. beta-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies. Neurology. 2023 Jul 11; 101 (2):e178-e188 Epub 2023 May 18
    View PubMed
  138. Wang Z, Wang L, Ebbini M, Curran GL, Min PH, Siegel RA, Lowe VJ, Kandimalla KK. Deconvolution of Plasma Pharmacokinetics from Dynamic Heart Imaging Data Obtained by Single Positron Emission Computed Tomography/Computed Tomography Imaging. J Pharmacol Exp Ther. 2023 Jul; 386 (1):102-110 Epub 2023 May 23
    View PubMed
  139. Carlos AF, Tosakulwong N, Weigand SD, Senjem ML, Schwarz CG, Knopman DS, Boeve BF, Petersen RC, Nguyen AT, Reichard RR, Dickson DW, Jack CR Jr, Lowe V, Whitwell JL, Josephs KA. TDP-43 pathology effect on volume and flortaucipir uptake in Alzheimer's disease. Alzheimers Dement. 2023 Jun; 19 (6):2343-2354 Epub 2022 Dec 04
    View PubMed
  140. Tian J, Raghavan S, Reid RI, Przybelski SA, Lesnick TG, Gebre RK, Graff-Radford J, Schwarz CG, Lowe VJ, Kantarci K, Knopman DS, Petersen RC, Jack CR Jr, Vemuri P. White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease. Neurology. 2023 May 30; 100 (22):e2269-e2278 Epub 2023 Apr 17
    View PubMed
  141. Corriveau-Lecavalier N, Barnard LR, Lee J, Dicks E, Botha H, Graff-Radford J, Machulda MM, Boeve BF, Knopman DS, Lowe VJ, Petersen RC, Jack CR Jr, Jones DT. Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer's disease. Cereb Cortex. 2023 May 24; 33 (11):7026-7043
    View PubMed
  142. Jack CR, Wiste HJ, Algeciras-Schimnich A, Figdore DJ, Schwarz CG, Lowe VJ, Ramanan VK, Vemuri P, Mielke MM, Knopman DS, Graff-Radford J, Boeve BF, Kantarci K, Cogswell PM, Senjem ML, Gunter JL, Therneau TM, Petersen RC. Predicting amyloid PET and tau PET stages with plasma biomarkers. Brain. 2023 May 2; 146 (5):2029-2044
    View PubMed
  143. Josephs KA, Duffy JR, Martin PR, Stephens YC, Singh NA, Clark HM, Botha H, Lowe VJ, Whitwell JL, Utianski RL. Acoustic Analysis and Neuroimaging Correlates of Diadochokinetic Rates in Mild-Moderate Primary Progressive Apraxia of Speech. Brain Lang. 2023 May; 240 Epub 2023 Apr 06
    View PubMed
  144. Song C, Kendi AT, Shim JY, Jung D, Kang PS, Lowe VJ, Lee S. ER-/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor. Breast Cancer. 2023 May; 30 (3):436-452 Epub 2023 Mar 01
    View PubMed
  145. Robinson CG, Duffy JR, Clark HA, Utianski RL, Machulda MM, Botha H, Singh NA, Pham NTT, Ertekin-Taner N, Dickson DW, Lowe VJ, Whitwell JL, Josephs KA. Clinicopathological associations of hemispheric dominance in primary progressive apraxia of speech. Eur J Neurol. 2023 May; 30 (5):1209-1219 Epub 2023 Mar 15
    View PubMed
  146. Chandregowda A, Clark HM, Machulda MM, Pham NTT, Lowe VJ, Josephs KA, Whitwell JL. A Case of Atypical Alzheimer's Disease With Clinical Manifestation That Straddled the Boundary Between Primary Progressive Aphasia and Posterior Cortical Atrophy. Neurologist. 2023 May 1; 28 (3):195-197 Epub 2023 May 01
    View PubMed
  147. Patricia Diaz-Galvan, Scott A. Przybelski, Timothy G. Lesnick, Christopher G. Schwarz, Matthew L. Senjem, Jeffrey Gunter, Clifford R. Jack Jr, Paul H. Min , Manoj K. Jain , Toji Miyagawa , Leah K. Forsberg, Julie A. Fields , Rodolfo Savica , Jonathan Graff-Radford , David T. Jones , Hugo Botha , Erik K. St. Louis , David S. Knopman , Owen A. Ross , Neill Graff-Radford, Dennis W. Dickson , Tanis J. Ferman , Ronald C. Petersen , Val Lowe , Brad Boeve , Kejal Kantarci . Amyloid-ß PET in the continuum of dementia of Lewy Bodies Neurology. 2023.
  148. Vassilaki M, Aakre JA, Castillo A, Chamberlain AM, Wilson PM, Kremers WK, Mielke MM, Geda YE, Machulda MM, Alhurani RE, Graff-Radford J, Vemuri P, Lowe VJ, Jack CR Jr, Knopman DS, Petersen RC. Association of neighborhood socioeconomic disadvantage and cognitive impairment. Alzheimers Dement. 2023 Mar; 19 (3):761-770 Epub 2022 June 06
    View PubMed
  149. Singh NA, Tosakulwong N, Graff-Radford J, Machulda MM, Pham NTT, Sintini I, Weigand SD, Schwarz CG, Senjem ML, Carrasquillo MM, Ertekin-Taner N, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL. APOE epsilon4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease. Alzheimers Dement. 2023 Mar; 19 (3):784-796 Epub 2022 June 12
    View PubMed
  150. Pink A, Krell-Roesch J, Syrjanen JA, Christenson LR, Lowe VJ, Vemuri P, Fields JA, Stokin GB, Kremers WK, Scharf EL, Jack CR Jr, Knopman DS, Petersen RC, Vassilaki M, Geda YE. Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline. Psychiatr Res Clin Pract. 2023 Spring; 5 (1):4-15 Epub 2023 Jan 20
    View PubMed
  151. Ferreira D, Przybelski SA, Lesnick TG, Schwarz CG, Diaz-Galvan P, Graff-Radford J, Senjem ML, Fields JA, Knopman DS, Jones DT, Savica R, Ferman TJ, Lowe VJ, Jack CR, Petersen RC, Westman E, Boeve BF, Kantarci K. Cross-sectional Associations of beta-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies. Neurology. 2023 Feb 21; 100 (8):e846-e859 Epub 2022 Nov 28
    View PubMed
  152. Stack BC Jr, Duan F, Romanoff J, Sicks JD, Subramaniam RM, Lowe VJ. Impact of Neck PET/CT Positivity on Survival Outcomes-Visual and Quantitative Assessment: Results From ACRIN 6685. Clin Nucl Med. 2023 Feb 1; 48 (2):126-131 Epub 2022 Dec 07
    View PubMed
  153. Pavone C, Weigand SW, Ali F, Clark HM, Botha H, Machulda MM, Savica R, Pham NTT, Grijalva RM, Schwarz CG, Senjem ML, Agosta F, Filippi M, Jack CR, Lowe VJ, Josephs KA, Whitwell JL. Longitudinal clinical decline and baseline predictors in progressive supranuclear palsy. Parkinsonism Relat Disord. 2023 Feb; 107:105290 Epub 2023 Jan 16
    View PubMed
  154. Buciuc M, Koga S, Pham NTT, Duffy JR, Knopman DS, Ali F, Boeve BF, Graff-Radford J, Botha H, Lowe VJ, Nguyen A, Reichard RR, Dickson DW, Petersen RC, Whitwell JL, Josephs KA. The many faces of globular glial tauopathy: A clinical and imaging study. Eur J Neurol. 2023 Feb; 30(2):321-333. Epub 2022 Nov 01.
    View PubMed
  155. Inguanzo A, Poulakis K, Mohanty R, Schwarz CG, Przybelski SA, Diaz-Galvan P, Lowe VJ, Boeve BF, Lemstra AW, van de Beek M, van der Flier W, Barkhof F, Blanc F, Loureiro de Sousa P, Philippi N, Cretin B, Demuynck C, Nedelska Z, Hort J, Segura B, Junque C, Oppedal K, Aarsland D, Westman E, Kantarci K, Ferreira D. MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies. NPJ Parkinsons Dis. 2023 Jan 20; 9 (1):5
    View PubMed
  156. Tetzloff KA, Duffy JR, Clark HM, Pham NTT, Machulda MM, Botha H, Jack CR, Dickson DW, Lowe VJ, Josephs KA, Whitwell JL, Utianski RL. Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech. J Alzheimers Dis. 2023; 96 (4):1759-1765
    View PubMed
  157. Vassilaki M, Syrjanen JA, Krell-Roesch J, Graff-Radford J, Vemuri P, Scharf EL, Machulda MM, Fields JA, Kremers WK, Lowe VJ, Jack CR Jr, Knopman DS, Petersen RC, Geda YE. Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment. J Alzheimers Dis Rep. 2023; 7 (1):1237-1246 Epub 2023 Nov 03
    View PubMed
  158. Huls SJ, Burkett B, Ehman E, Lowe VJ, Subramaniam RM, Kendi AT. Clinical practice in prostate PET imaging. Ther Adv Med Oncol. 2023; 15:17588359231213618 Epub 2023 Nov 22
    View PubMed
  159. Wang Z, Wang L, Ebbini M, Curran GL, Min PH, Siegel RA, Lowe VJ, Kandimalla KK. Deconvolution of plasma pharmacokinetics from dynamic heart imaging data obtained by single positron emission computed tomography/computed tomography imaging. The Journal of Pharmacology and Experimental Therapeutics. 2023; 386 (1):102-10
  160. Singh NA, Martin PR, Graff-Radford J, Sintini I, Machulda MM, Duffy JR, Gunter JL, Botha H, Jones DT, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell JL. Altered within- and between-network functional connectivity in atypical Alzheimer's disease. Brain Commun. 2023; 5 (4):fcad184 Epub 2023 June 14
    View PubMed
  161. Schwarz CG, Kremers WK, Weigand SD, Prakaashana CM, Senjem ML, Przybelski SA, Lowe VJ, Gunter JL, Kantarci K, Vemuri P, Graff-Radford J, Petersen RC, Knopman DS, Jack CR Jr. Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer's disease research. Neuroimage Clin. 2023; 40:103507 Epub 2023 Sept 09
    View PubMed
  162. Diaz-Galvan P, Miyagawa T, Przybelski SA, Lesnick TG, Senjem ML, Jack CR Jr, Forsberg LK, Min HK, St Louis EK, Savica R, Fields JA, Benarroch EE, Lowe V, Petersen RC, Boeve BF, Kantarci K. Brain glucose metabolism and nigrostriatal degeneration in isolated rapid eye movement sleep behaviour disorder. Brain Commun. 2023; 5 (1):fcad021 Epub 2023 Feb 02
    View PubMed
  163. Singh NA, Graff-Radford J, Machulda MM, Pham NTT, Schwarz CG, Reid RI, Lowe VJ, Petersen RC, Jack CR, Josephs KA, Whitwell JL. Diffusivity Changes in Posterior Cortical Atrophy and Logopenic Progressive Aphasia: A Longitudinal Diffusion Tensor Imaging Study. J Alzheimers Dis. 2023; 94 (2):709-725
    View PubMed
  164. Utianski RL, Trang Thu Pham N, Botha H, Ali F, Duffy JR, Clark HM, Lowe VJ, Whitwell JL, Josephs KA. Longitudinal changes in dopamine transporter uptake scans in progressive apraxia of speech. Clin Park Relat Disord. 2023; 9:100207 Epub 2023 June 16
    View PubMed
  165. Gatto RG, Carlos AF, Reichard RR, Lowe VJ, Whitwell JL, Josephs KA. Comparative assessment of regional tau distribution by Tau-PET and Post-mortem neuropathology in a representative set of Alzheimer's & frontotemporal lobar degeneration patients. PLoS One. 2023; 18 (5):e0284182 Epub 2023 May 11
    View PubMed
  166. Shim JY, Chung JO, Jung D, Kang PS, Park SY, Kendi AT, Lowe VJ, Lee S. Parkin-mediated mitophagy is negatively regulated by FOXO3A, which inhibits Plk3-mediated mitochondrial ROS generation in STZ diabetic stress-treated pancreatic beta cells. PLoS One. 2023; 18 (5):e0281496 Epub 2023 May 03
    View PubMed
  167. Murray ME, Moloney CM, Kouri N, Syrjanen JA, Matchett BJ, Rothberg DM, Tranovich JF, Sirmans TNH, Wiste HJ, Boon BDC, Nguyen AT, Reichard RR, Dickson DW, Lowe VJ, Dage JL, Petersen RC, Jack CR Jr, Knopman DS, Vemuri P, Graff-Radford J, Mielke MM. Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels. Mol Neurodegener. 2022 Dec 27; 17 (1):85
    View PubMed
  168. Subramaniam RM, Duan FM, Romanoff J, Yu JQ, Bartel T, Dehdashti F, Intenzo CM, Solnes L, Sicks J, Stack BC Jr, Lowe VJ. (18)F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy-Results from Multicenter ACRIN 6685 Clinical Trial. J Nucl Med. 2022 Dec; 63 (12):1887-1890 Epub 2022 May 12
    View PubMed
  169. Singh NA, Graff-Radford J, Machulda MM, Schwarz CG, Baker MC, Rademakers R, Ertekin-Taner N, Lowe VJ, Josephs KA, Whitwell JL. Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles. J Neurol. 2022 Dec; 269(12):6613-6626. Epub 2022 Aug 24.
    View PubMed
  170. Sintini I, Duffy JR, Clark HM, Utianski RL, Botha H, Machulda MM, Senjem ML, Strand EA, Schwarz CG, Lowe VJ, Jack CR, Josephs KA, Whitwell JL. Functional connectivity to the premotor cortex maps onto longitudinal brain neurodegeneration in progressive apraxia of speech. Neurobiol Aging. 2022 Dec; 120:105-116 Epub 2022 Sept 02
    View PubMed
  171. Josephs KA, Tosakulwong N, Gatto RG, Weigand SD, Ali F, Botha H, Graff-Radford J, Machulda MM, Savica R, Schwarz CG, Senjem ML, Boeve BF, Kantarci K, Jones DT, Ramanan VK, Fields JA, Reichard RR, Dickson DW, Petersen RC, Jack CR Jr, Lowe VJ, Whitwell JL. Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross-Sectional Tau Positron Emission Tomography. Ann Neurol. 2022 Dec; 92 (6):1016-1029 Epub 2022 Aug 29
    View PubMed
  172. Alamiri J, Britton CJ, Ahmed ME, Andrews JR, Higa JL, Dundar A, Karnes RJ, Kwon E, Lowe VJ, Kendi AT, Bold MS, Pagliaro LC. Radiographic paradoxical response in metastatic castrate-resistant prostate cancer (mCRPC) managed with new generation anti-androgens: a retrospective analysis. Prostate. 2022 Dec; 82(16):1483-1490. Epub 2022 Sep 11.
    View PubMed
  173. Lucien F, Kim Y, Qian J, Orme JJ, Zhang H, Arafa A, Abraha F, Thapa I, Tryggestad EJ, Harmsen WS, Kosti J, Ali H, Lowe VJ, Johnson GB, Kwon ED, Dong H, Park SS. Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity. Int J Radiat Oncol Biol Phys. 2022 Nov 15; 114 (4):725-737 Epub 2022 June 04
    View PubMed
  174. Lee J, Burkett BJ, Min HK, Lundt ES, Albertson SM, Botha H, Senjem ML, Gunter JL, Schwarz CG, Jones DT, Knopman DS, Jack CR Jr, Petersen RC, Lowe VJ. The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability. J Nucl Med. 2022 Nov; 63 (11):1748-1753 Epub 2022 Mar 17
    View PubMed
  175. Pham NTT, Graff-Radford J, Machulda MM, Spychalla AJ, Schwarz CG, Senjem ML, Lowe VJ, Vemuri P, Kantarci K, Knopman DS, Petersen RC, Jack CR, Josephs KA, Whitwell JL. Regional white matter hyperintensities in posterior cortical atrophy and logopenic progressive aphasia. Neurobiol Aging. 2022 Nov; 119:46-55 Epub 2022 July 28
    View PubMed
  176. Pink A, Krell-Roesch J, Syrjanen JA, Vassilaki M, Lowe VJ, Vemuri P, Stokin GB, Christianson TJ, Kremers WK, Jack CR, Knopman DS, Petersen RC, Geda YE. A longitudinal investigation of Abeta, anxiety, depression, and mild cognitive impairment. Alzheimers Dement. 2022 Oct; 18 (10):1824-1831 Epub 2021 Dec 08
    View PubMed
  177. Burkett BJ, Babcock JC, Lowe VJ, Graff-Radford J, Subramaniam RM, Johnson DR. PET Imaging of Dementia: Update 2022. Clin Nucl Med. 2022 Sep 1; 47 (9):763-773 Epub 2022 May 12
    View PubMed
  178. Schwarz CG, Kremers WK, Lowe VJ, Savvides M, Gunter JL, Senjem ML, Vemuri P, Kantarci K, Knopman DS, Petersen RC, Jack CR Jr, Alzheimer's Disease Neuroimaging Initiative. Face recognition from research brain PET: An unexpected PET problem. Neuroimage. 2022 Sep; 258:119357 Epub 2022 June 03
    View PubMed
  179. Cogswell PM, Wiste HJ, Mielke MM, Schwarz CG, Weigand SD, Lowe VJ, Therneau TM, Knopman DS, Graff-Radford J, Vemuri P, Senjem ML, Gunter JL, Algeciras-Schimnich A, Petersen RC, Jack CR Jr. CSF phosphorylated tau as an indicator of subsequent tau accumulation. Neurobiol Aging. 2022 Sep; 117:189-200 Epub 2022 May 26
    View PubMed
  180. Chandregowda A, Duffy JR, Machulda MM, Lowe VJ, Whitwell JL, Josephs KA. Dynamic aphasia with emerging agrammatism, anomia, and aberrant frontal behaviors in a case of atypical parkinsonism. Neurol Clin Neurosci. 2022 Sep; 10 (5):262-265 Epub 2022 July 20
    View PubMed
  181. Corriveau-Lecavalier N, Machulda MM, Botha H, Graff-Radford J, Knopman DS, Lowe VJ, Fields JA, Stricker NH, Boeve BF, Jack CR Jr, Petersen RC, Jones DT. Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer's disease: a series of clinical cases. J Neurol. 2022 Aug; 269 (8):4110-4128 Epub 2022 Feb 25
    View PubMed
  182. McCarter SJ, Jones DT, Jack CR, Lowe V, Botha H. Posterior Cingulate Involvement Does Not Argue Against LATE. J Nucl Med 2022 Aug; 63 (8):1282-1283 Epub 2022 Mar 24
    View PubMed
  183. Zeydan B, Schwarz CG, Przybelski SA, Lesnick TG, Kremers WK, Senjem ML, Kantarci OH, Min PH, Kemp BJ, Jack CR Jr, Kantarci K, Lowe VJ. Comparison of (11)C-Pittsburgh Compound B and (18)F-Flutemetamol White Matter Binding in PET. J Nucl Med. 2022 Aug; 63 (8):1239-1244 Epub 2021 Dec 16
    View PubMed
  184. Carlos AF, Sekiya H, Koga S, Pham NTT, Ali F, Botha H, Clark HM, Coon EA, Lowe V, Ahlskog JE, Trejo-Lopez JA, Dickson DW, Whitwell JL, Josephs KA. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy. Parkinsonism Relat Disord. 2022 Aug; 101:9-14 Epub 2022 June 16
    View PubMed
  185. Valentino RR, Ramnarine C, Heckman MG, Johnson PW, Soto-Beasley AI, Walton RL, Koga S, Kasanuki K, Murray ME, Uitti RJ, Fields JA, Botha H, Ramanan VK, Kantarci K, Lowe VJ, Jack CR, Ertekin-Taner N, Savica R, Graff-Radford J, Petersen RC, Parisi JE, Reichard RR, Graff-Radford NR, Ferman TJ, Boeve BF, Wszolek ZK, Dickson DW, Ross OA. Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures. Acta Neuropathol Commun. 2022 Jul 14; 10 (1):103 Epub 2022 July 14
    View PubMed
  186. Shir D, Graff-Radford J, Machulda MM, Pham NTT, Jack CR Jr, Lowe VJ, Whitwell JL, Josephs KA. Posterior cortical atrophy: Primary occipital variant. Eur J Neurol. 2022 Jul; 29 (7):2138-2143 Epub 2022 Mar 30
    View PubMed
  187. Lee J, Chung JO, Park SY, Rajamohan N, Singh A, Kim J, Lowe VJ, Lee S. Natural COA water inhibits mitochondrial ROS-mediated apoptosis through Plk3 downregulation under STZ diabetic stress in pancreatic beta-cell lines. Biochem Biophys Rep. 2022 Jul; 30:101247 Epub 2022 Mar 11
    View PubMed
  188. Mielke MM, Dage JL, Frank RD, Algeciras-Schimnich A, Knopman DS, Lowe VJ, Bu G, Vemuri P, Graff-Radford J, Jack CR Jr, Petersen RC. Performance of plasma phosphorylated tau 181 and 217 in the community. Nat Med. 2022 Jul; 28 (7):1398-1405 Epub 2022 May 26
    View PubMed
  189. Whitwell JL, Martin PR, Graff-Radford J, Machulda MM, Sintini I, Buciuc M, Senjem ML, Schwarz CG, Botha H, Carrasquillo MM, Ertekin-Taner N, Lowe VJ, Jack CR, Josephs KA. Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease. Neurology. 2022 Jun 13; 98 (24):e2436-e2445 Epub 2022 June 13
    View PubMed
  190. Chen Q, Przybelski SA, Senjem ML, Schwarz CG, Lesnick TG, Botha H, Knopman DS, Graff-Radford J, Savica R, Jones DT, Fields JA, Jain MK, Graff-Radford NR, Ferman TJ, Kremers WK, Jack CR Jr, Petersen RC, Boeve BF, Lowe VJ, Kantarci K. Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies. Mov Disord. 2022 Jun; 37 (6):1256-1264 Epub 2022 Mar 08
    View PubMed
  191. Josephs KA, Tosakulwong N, Weigand SD, Buciuc M, Lowe VJ, Dickson DW, Whitwell JL. Relationship Between (18)F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies. J Nucl Med. 2022 Jun; 63 (6):931-935 Epub 2021 Sept 23
    View PubMed
  192. Taubel JC, Nelson NR, Bansal A, Curran GL, Wang L, Wang Z, Berg HM, Vernon CJ, Min HK, Larson NB, DeGrado TR, Kandimalla KK, Lowe VJ, Pandey MK. Design, Synthesis, and Preliminary Evaluation of [(68)Ga]Ga-NOTA-Insulin as a PET Probe in an Alzheimer's Disease Mouse Model. Bioconjug Chem. 2022 May 18; 33 (5):892-906 Epub 2022 Apr 14
    View PubMed
  193. Ramanan VK, Heckman MG, Lesnick TG, Przybelski SA, Cahn EJ, Kosel ML, Murray ME, Mielke MM, Botha H, Graff-Radford J, Jones DT, Lowe VJ, Machulda MM, Jack CR Jr, Knopman DS, Petersen RC, Ross OA, Vemuri P. Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer's disease. Acta Neuropathol. 2022 May; 143 (5):571-583 Epub 2022 Apr 12
    View PubMed
  194. Polsinelli AJ, Machulda MM, Martin PR, Duffy JR, Clark HM, Butts AM, Botha H, Lowe VJ, Whitwell JL, Josephs KA, Utianski RL. Neuropsychological Profiles of Patients with Progressive Apraxia of Speech and Aphasia. J Int Neuropsychol Soc. 2022 May; 28 (5):441-451 Epub 2021 July 22
    View PubMed
  195. Lee J, Burkett BJ, Min HK, Senjem ML, Lundt ES, Botha H, Graff-Radford J, Barnard LR, Gunter JL, Schwarz CG, Kantarci K, Knopman DS, Boeve BF, Lowe VJ, Petersen RC, Jack CR Jr, Jones DT. Deep learning-based brain age prediction in normal aging and dementia. Nat Aging. 2022 May; 2 (5):412-424 Epub 2022 May 09
    View PubMed
  196. Kara F, Joers JM, Deelchand DK, Park YW, Przybelski SA, Lesnick TG, Senjem ML, Zeydan B, Knopman DS, Lowe VJ, Vemuri P, Mielke MM, Machulda MM, Jack CR, Petersen RC, Oz G, Kantarci K. (1)H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults. Neurobiol Aging. 2022 Apr; 112:16-26 Epub 2022 Jan 05
    View PubMed
  197. Vassilaki M, Aakre JA, Kremers WK, Mielke MM, Geda YE, Machulda MM, Knopman DS, Vemuri P, Lowe VJ, Jack CR Jr, Roberson ED, Gerstenecker A, Martin RC, Kennedy RE, Marson DC, Petersen RC. Association of Performance on the Financial Capacity Instrument-Short Form With Brain Amyloid Load and Cortical Thickness in Older Adults. Neurol Clin Pract. 2022 Apr; 12 (2):113-124
    View PubMed
  198. Raghavan S, Przybelski SA, Reid RI, Lesnick TG, Ramanan VK, Botha H, Matchett BJ, Murray ME, Reichard RR, Knopman DS, Graff-Radford J, Jones DT, Lowe VJ, Mielke MM, Machulda MM, Petersen RC, Kantarci K, Whitwell JL, Josephs KA, Jack CR Jr, Vemuri P. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition. Acta Neuropathol Commun. 2022 Feb 5; 10 (1):16 Epub 2022 Feb 05
    View PubMed
  199. Song C, Kendi AT, Lowe VJ, Lee S. The A20/TNFAIP3-CDC20-CASP1 Axis Promotes Inflammation-mediated Metastatic Disease in Triple-negative Breast Cancer. Anticancer Res. 2022 Feb; 42(2):681-695.
    View PubMed
  200. Graff-Radford J, Jones DT, Wiste HJ, Cogswell PM, Weigand SD, Lowe V, Elder BD, Vemuri P, Van Harten A, Mielke MM, Knopman DS, Graff-Radford NR, Petersen RC, Jack CR Jr, Gunter JL. Cerebrospinal fluid dynamics and discordant amyloid biomarkers. Neurobiol Aging. 2022 Feb; 110:27-36 Epub 2021 Nov 01
    View PubMed
  201. Josephs KA, Pham NTT, Graff-Radford J, Machulda MM, Lowe VJ, Whitwell JL. Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign. J Alzheimers Dis. 2022; 86 (1):491-498
    View PubMed
  202. Zhou AL, Sharda N, Sarma VV, Ahlschwede KM, Curran GL, Tang X, Poduslo JF, Kalari KR, Lowe VJ, Kandimalla KK. Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-beta Peptides and Insulin. J Alzheimers Dis. 2022; 85 (3):1031-1044
    View PubMed
  203. Jack CR Jr, Therneau TM, Lundt ES, Wiste HJ, Mielke MM, Knopman DS, Graff-Radford J, Lowe VJ, Vemuri P, Schwarz CG, Senjem ML, Gunter JL, Petersen RC. Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk. Brain Commun. 2022; 4 (2):fcac017 Epub 2022 Feb 02
    View PubMed
  204. Shir D, Graff-Radford J, Hofrenning EI, Lesnick TG, Przybelski SA, Lowe VJ, Knopman DS, Petersen RC, Jack CR Jr, Vemuri P, Algeciras-Schimnich A, Campbell MR, Stricker NH, Mielke MM. Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology. Alzheimers Dement (Amst). 2022; 14 (1):e12291 Epub 2022 Feb 28
    View PubMed
  205. McCarter SJ, Lesnick TG, Lowe VJ, Rabinstein AA, Przybelski SA, Algeciras-Schimnich A, Ramanan VK, Jack CR, Petersen RC, Knopman DS, Boeve BF, Kantarci K, Vemuri P, Mielke MM, Graff-Radford J. Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds. J Alzheimers Dis. 2022; 87 (4):1537-1547
    View PubMed
  206. Kantarci K, Nedelska Z, Chen Q, Senjem ML, Schwarz CG, Gunter JL, Przybelski SA, Lesnick TG, Kremers WK, Fields JA, Graff-Radford J, Savica R, Jones D, Botha H, Knopman DS, Lowe V, Graff-Radford NR, Murray MM, Dickson DW, Reichard RR, Jack CR Jr, Petersen RC, Ferman TJ, Boeve BF. Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration. Brain Commun. 2022; 4(2):fcac013. Epub 2022 Feb 07.
    View PubMed
  207. Ramanan VK, Heckman MG, Przybelski SA, Lesnick TG, Lowe VJ, Graff-Radford J, Mielke M, Jack CR, Knopman DS, Petersen RC, Ross OA, Vemuri P, Alzheimer's Disease Neuroimaging Initiative. Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden. J Alzheimers Dis. 2022; 88 (4):1615-1625
    View PubMed
  208. Schwarz CG, Knopman DS, Ramanan VK, Lowe VJ, Wiste HJ, Cogswell PM, Utianski RL, Senjem ML, Gunter JR, Vemuri P, Petersen RC, Jack CR. Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual. J Alzheimers Dis 2022; 85 (1):59-64
    View PubMed
  209. Jimbo M, Andrews JR, Ahmed ME, Dundar A, Karnes RJ, Bryce AH, Kendi AT, Kwon ED, Lowe VJ, Bold MS. Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy. Prostate. 2022 Jan; 82(1):41-48. Epub 2021 Oct 11.
    View PubMed
  210. Butts AM, Machulda MM, Martin P, Przybelski SA, Duffy JR, Graff-Radford J, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL. Temporal Cortical Thickness and Cognitive Associations among Typical and Atypical Phenotypes of Alzheimer's Disease. J Alzheimers Dis Rep. 2022; 6 (1):479-491 Epub 2022 Aug 05
    View PubMed
  211. Singh NA, Arani A, Graff-Radford J, Senjem ML, Martin PR, Machulda MM, Schwarz CG, Shu Y, Cogswell PM, Knopman DS, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell JL. Distinct brain iron profiles associated with logopenic progressive aphasia and posterior cortical atrophy. Neuroimage Clin. 2022; 36:103161. Epub 2022 Aug 22.
    View PubMed
  212. Marks JD, Syrjanen JA, Graff-Radford J, Petersen RC, Machulda MM, Campbell MR, Algeciras-Schimnich A, Lowe V, Knopman DS, Jack CR Jr, Vemuri P, Mielke MM, Alzheimer's Disease Neuroimaging Initiative. Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes. Alzheimers Res Ther. 2021 Dec 14; 13 (1):199
    View PubMed
  213. Chandregowda A, Clark HM, Duffy JR, Machulda MM, Lowe VJ, Whitwell JL, Josephs KA. Dynamic Aphasia as a Variant of Frontotemporal Dementia. Cogn Behav Neurol. 2021 Dec 2; 34 (4):303-318 Epub 2021 Dec 02
    View PubMed
  214. Zhang H, Orme JJ, Abraha F, Stish BJ, Lowe VJ, Lucien F, Tryggestad EJ, Bold MS, Pagliaro LC, Choo CR, Brinkmann DH, Iott MJ, Davis BJ, Quevedo JF, Harmsen WS, Costello BA, Johnson GB, Nathan MA, Olivier KR, Pisansky TM, Kwon ED, Dong H, Park SS. Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in (11)C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2021 Dec 1; 27 (23):6376-6383 Epub 2021 Sept 30
    View PubMed
  215. Whitwell JL, Tosakulwong N, Weigand SD, Graff-Radford J, Ertekin-Taner N, Machulda MM, Duffy JR, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Josephs KA, Alzheimer's Disease Neuroimaging Initiative. Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease. Neurobiol Aging. 2021 Dec; 108:90-98 Epub 2021 Aug 25
    View PubMed
  216. Krell-Roesch J, Syrjanen JA, Rakusa M, Vemuri P, Machulda MM, Kremers WK, Mielke MM, Lowe VJ, Jack CR Jr, Knopman DS, Stokin GB, Petersen RC, Vassilaki M, Geda YE. Association of Cortical and Subcortical beta-Amyloid With Standardized Measures of Depressive and Anxiety Symptoms in Adults Without Dementia. J Neuropsychiatry Clin Neurosci. 2021 Winter; 33 (1):64-71 Epub 2020 Oct 22
    View PubMed
  217. Schumacher J, Gunter JL, Przybelski SA, Jones DT, Graff-Radford J, Savica R, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Knopman DS, Fields JA, Kremers WK, Petersen RC, Graff-Radford NR, Ferman TJ, Boeve BF, Thomas AJ, Taylor JP, Kantarci K. Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks. Brain. 2021 Nov 29; 144 (10):3212-3225
    View PubMed
  218. Therneau TM, Knopman DS, Lowe VJ, Botha H, Graff-Radford J, Jones DT, Vemuri P, Mielke MM, Schwarz CG, Senjem ML, Gunter JL, Petersen RC, Jack CR Jr. Relationships between beta-amyloid and tau in an elderly population: An accelerated failure time model. Neuroimage. 2021 Nov 15; 242:118440 Epub 2021 July 29
    View PubMed
  219. McCarter SJ, Lesnick TG, Lowe V, Mielke MM, Constantopoulos E, Rabinstein AA, Przybelski SA, Botha H, Jones DT, Ramanan VK, Jack CR, Petersen RC, Knopman D, Boeve BF, Murray ME, Dickson DW, Vemuri P, Kantarci K, Reichard RR, Graff-Radford J. Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-beta PET Signal. Neurology. 2021 Nov 2; 97 (18):e1799-e1808 Epub 2021 Sept 09
    View PubMed
  220. Wang Z, Sharda N, Curran GL, Li L, Lowe VJ, Kandimalla KK. Semimechanistic Population Pharmacokinetic Modeling to Investigate Amyloid Beta Trafficking and Accumulation at the BBB Endothelium. Mol Pharm. 2021 Nov 1; 18 (11):4148-4161 Epub 2021 Oct 19
    View PubMed
  221. Clark HM, Tosakulwong N, Weigand SD, Ali F, Botha H, Pham NTT, Schwarz CG, Reid RI, Senjem ML, Jack CR Jr, Lowe VJ, Ahlskog JE, Josephs KA, Whitwell JL. Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy. Mov Disord. 2021 Nov; 36 (11):2669-2675 Epub 2021 Aug 23
    View PubMed
  222. Liu CC, Murray ME, Li X, Zhao N, Wang N, Heckman MG, Shue F, Martens Y, Li Y, Raulin AC, Rosenberg CL, Doss SV, Zhao J, Wren MC, Jia L, Ren Y, Ikezu TC, Lu W, Fu Y, Caulfield T, Trottier ZA, Knight J, Chen Y, Linares C, Wang X, Kurti A, Asmann YW, Wszolek ZK, Smith GE, Vemuri P, Kantarci K, Knopman DS, Lowe VJ, Jack CR Jr, Parisi JE, Ferman TJ, Boeve BF, Graff-Radford NR, Petersen RC, Younkin SG, Fryer JD, Wang H, Han X, Frieden C, Dickson DW, Ross OA, Bu G. APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. Sci Transl Med. 2021 Sep 29; 13(613):eabc9375.
    View PubMed
  223. Mielke MM, Frank RD, Dage JL, Jeromin A, Ashton NJ, Blennow K, Karikari TK, Vanmechelen E, Zetterberg H, Algeciras-Schimnich A, Knopman DS, Lowe V, Bu G, Vemuri P, Graff-Radford J, Jack CR Jr, Petersen RC. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes. JAMA Neurol. 2021 Sep 1; 78 (9):1108-1117
    View PubMed
  224. Schwarz CG, Therneau TM, Weigand SD, Gunter JL, Lowe VJ, Przybelski SA, Senjem ML, Botha H, Vemuri P, Kantarci K, Boeve BF, Whitwell JL, Josephs KA, Petersen RC, Knopman DS, Jack CR Jr. Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation. Neuroimage. 2021 Sep; 238:118259 Epub 2021 June 09
    View PubMed
  225. Ferreira D, Nedelska Z, Graff-Radford J, Przybelski SA, Lesnick TG, Schwarz CG, Botha H, Senjem ML, Fields JA, Knopman DS, Savica R, Ferman TJ, Graff-Radford NR, Lowe VJ, Jack CR, Petersen RC, Lemstra AW, van de Beek M, Barkhof F, Blanc F, Loureiro de Sousa P, Philippi N, Cretin B, Demuynck C, Hort J, Oppedal K, Boeve BF, Aarsland D, Westman E, Kantarci K. Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies. Neurobiol Aging. 2021 Sep; 105:252-261 Epub 2021 May 14
    View PubMed
  226. Moloney CM, Lowe VJ, Murray ME. Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research. Alzheimers Dement. 2021 Sep; 17 (9):1554-1574 Epub 2021 Apr 02
    View PubMed
  227. Song C, Lowe VJ, Lee S. Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC). Breast Cancer. 2021 Sep; 28 (5):1073-1086 Epub 2021 Apr 03
    View PubMed
  228. Buciuc M, Duffy JR, Machulda MM, Graff-Radford J, Pham NTT, Martin PR, Senjem ML, Jack CR Jr, Ertekin-Taner N, Dickson DW, Lowe VJ, Whitwell JL, Josephs KA. Clinical, Imaging, and Pathologic Characteristics of Patients With Right vs Left Hemisphere-Predominant Logopenic Progressive Aphasia. Neurology. 2021 Aug 3; 97 (5):e523-e534 Epub 2021 June 04
    View PubMed
  229. Laack NN, Pafundi D, Anderson SK, Kaufmann T, Lowe V, Hunt C, Vogen D, Yan E, Sarkaria J, Brown P, Kizilbash S, Uhm J, Ruff M, Zakhary M, Zhang Y, Seaberg M, Wan Chan Tseung HS, Kabat B, Kemp B, Brinkmann D. Initial Results of a Phase 2 Trial of (18)F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma. Int J Radiat Oncol Biol Phys. 2021 Aug 1; 110 (5):1383-1395 Epub 2021 Mar 23
    View PubMed
  230. Chandregowda A, Duffy JR, Machulda MM, Lowe VJ, Whitwell JL, Josephs KA. Neurodegeneration of the visual word form area in a patient with word form alexia. Neurol Clin Neurosci. 2021 Jul; 9 (4):359-360 Epub 2021 May 24
    View PubMed
  231. Graff-Radford J, Lesnick T, Rabinstein AA, Gunter JL, Przybelski SA, Noseworthy PA, Preboske GM, Mielke MM, Lowe VJ, Knopman DS, Petersen RC, Kremers WK, Jack CR Jr, Vemuri P, Kantarci K. Cerebral Microbleeds: Relationship to Antithrombotic Medications. Stroke. 2021 Jul; 52 (7):2347-2355 Epub 2021 May 10
    View PubMed
  232. Josephs KA, Duffy JR, Clark HM, Utianski RL, Strand EA, Machulda MM, Botha H, Martin PR, Pham NTT, Stierwalt J, Ali F, Buciuc M, Baker M, Fernandez De Castro CH, Spychalla AJ, Schwarz CG, Reid RI, Senjem ML, Jack CR Jr, Lowe VJ, Bigio EH, Reichard RR, Polley EJ, Ertekin-Taner N, Rademakers R, DeTure MA, Ross OA, Dickson DW, Whitwell JL. A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech. Nat Commun. 2021 Jun 8; 12 (1):3452 Epub 2021 June 08
    View PubMed
  233. Stack BC Jr, Duan F, Subramaniam RM, Romanoff J, Sicks JD, Bartel T, Chen C, Lowe VJ. FDG-PET/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG-PET/CT cN0. Otolaryngol Head Neck Surg. 2021 Jun; 164 (6):1230-1239 Epub 2020 Nov 24
    View PubMed
  234. Ahmed ME, Joshi VB, Badawy M, Pagliaro LC, Karnes RJ, Lowe V, Thorpe MP, Kwon ED, Kendi AT. Radium-223 in the Third-Line Setting in Metastatic Castration-Resistant Prostate Cancer: Impact of Concomitant Use of Enzalutamide on Overall Survival (OS) and Predictors of Improved OS. Clin Genitourin Cancer. 2021 Jun; 19 (3):223-229 Epub 2021 Jan 07
    View PubMed
  235. Petersen RC, Wiste HJ, Weigand SD, Fields JA, Geda YE, Graff-Radford J, Knopman DS, Kremers WK, Lowe V, Machulda MM, Mielke MM, Stricker NH, Therneau TM, Vemuri P, Jack CR Jr. NIA-AA Alzheimer's Disease Framework: Clinical Characterization of Stages. Ann Neurol. 2021 Jun; 89 (6):1145-1156 Epub 2021 Apr 06
    View PubMed
  236. Hokelekli FO, Whitwell JL, Machulda MM, Jones DT, Uitti RJ, Pham NTT, Giannini C, Baker M, Lowe VJ, Dickson DW, Josephs KA. Underlying pathology identified after 20 years of disease course in two cases of slowly progressive frontotemporal dementia syndromes. Neurocase. 2021 Apr; 27 (2):212-222 Epub 2021 Apr 27
    View PubMed
  237. Garg I, Nathan MA, Packard AT, Kwon ED, Larson NB, Lowe V, Davis BJ, Haloi R, Mahon ML, Goenka AH. (11)C-choline positron emission tomography/computed tomography for detection of disease relapse in patients with history of biochemically recurrent prostate cancer and prostate-specific antigen View PubMed
  238. Ramanan VK, Lesnick TG, Przybelski SA, Heckman MG, Knopman DS, Graff-Radford J, Lowe VJ, Machulda MM, Mielke MM, Jack CR Jr, Petersen RC, Ross OA, Vemuri P, Alzheimer's Disease Neuroimaging Initiative (ADNI). Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer's pathophysiology. Acta Neuropathol Commun. 2021 Mar 23; 9 (1):48
    View PubMed
  239. Zeydan B, Lowe VJ, Tosakulwong N, Lesnick TG, Senjem ML, Jack CR Jr, Fields JA, James TT, Gleason CE, Dowling NM, Miller VM, Kantarci K. Sleep quality and cortical amyloid-beta deposition in postmenopausal women of the Kronos early estrogen prevention study. Neuroreport. 2021 Mar 3; 32 (4):326-331
    View PubMed
  240. Miyagawa T, Przybelski SA, Maltais D, Min HK, Jordan L, Lesnick TG, Chen Q, Graff-Radford J, Jones D, Savica R, Knopman D, Petersen R, Kremers WK, Forsberg LK, Fields JA, Ferman TJ, Allen L, Parisi J, Reichard RR, Murray M, Dickson D, Boeve BF, Kantarci K, Lowe VJ. The value of multimodal imaging with (123)I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer's disease dementia. Neurobiol Aging. 2021 Mar; 99:11-18 Epub 2020 Dec 15
    View PubMed
  241. Sharda N, Ahlschwede KM, Curran GL, Lowe VJ, Kandimalla KK. Distinct Uptake Kinetics of Alzheimer Disease Amyloid-beta 40 and 42 at the Blood-Brain Barrier Endothelium. J Pharmacol Exp Ther. 2021 Mar; 376 (3):482-490 Epub 2020 Dec 10
    View PubMed
  242. Buciuc M, Whitwell JL, Kasanuki K, Graff-Radford J, Machulda MM, Duffy JR, Strand EA, Lowe VJ, Graff-Radford NR, Rush BK, Franczak MB, Flanagan ME, Baker MC, Rademakers R, Ross OA, Ghetti BF, Parisi JE, Raghunathan A, Reichard RR, Bigio EH, Dickson DW, Josephs KA. Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype. Ann Neurol. 2021 Mar; 89 (3):520-533 Epub 2020 Dec 17
    View PubMed
  243. Chen Q, Lowe VJ, Boeve BF, Przybelski SA, Miyagawa T, Senjem ML, Jack CR Jr, Lesnick TG, Kremers WK, Fields JA, Min HK, Schwarz CG, Gunter JL, Graff-Radford J, Savica R, Knopman DS, Jones D, Ferman TJ, Graff-Radford NR, Petersen RC, Kantarci K. Beta-amyloid pet and 123i-fp-cit spect in mild cognitive impairment at risk for Lewy body dementia Neurology. 2021 Feb 23; 96 (8):E1180-9
  244. Chen Q, Lowe VJ, Boeve BF, Przybelski SA, Miyagawa T, Senjem ML, Jack CR Jr, Lesnick TG, Kremers WK, Fields JA, Min HK, Schwarz CG, Gunter JL, Graff-Radford J, Savica R, Knopman DS, Jones D, Ferman TJ, Graff-Radford NR, Petersen RC, Kantarci K. beta-Amyloid PET and (123)I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia. Neurology. 2021 Feb 22; 96 (8):e1180-e1189
    View PubMed
  245. Arnaldi D, Chincarini A, Hu MT, Sonka K, Boeve B, Miyamoto T, Puligheddu M, De Cock VC, Terzaghi M, Plazzi G, Tachibana N, Morbelli S, Rolinski M, Dusek P, Lowe V, Miyamoto M, Figorilli M, Verbizier D, Bossert I, Antelmi E, Meli R, Barber TR, Trnka J, Miyagawa T, Serra A, Pizza F, Bauckneht M, Bradley KM, Zogala D, McGowan DR, Jordan L, Manni R, Nobili F. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder. Brain. 2021 Feb 12; 144 (1):278-287
    View PubMed
  246. Sintini I, Graff-Radford J, Jones DT, Botha H, Martin PR, Machulda MM, Schwarz CG, Senjem ML, Gunter JL, Jack CR, Lowe VJ, Josephs KA, Whitwell JL. Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer's Disease. Cereb Cortex. 2021 Feb 5; 31 (3):1693-1706
    View PubMed
  247. Krell-Roesch J, Syrjanen JA, Vassilaki M, Lowe VJ, Vemuri P, Mielke MM, Machulda MM, Stokin GB, Christianson TJ, Kremers WK, Jack CR Jr, Knopman DS, Petersen RC, Geda YE. Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging. Am J Geriatr Psychiatry. 2021 Feb; 29 (2):179-191 Epub 2020 June 17
    View PubMed
  248. Utianski RL, Schwarz CG, Murray ME, Tranovich JF, Scott NE, Lowe VJ, Whitwell JL, Josephs KA. In Vivo Imaging and Autoradiography in a Case of Autopsy-Confirmed Pick Disease. Neurol Clin Pract. 2021 Feb; 11 (1):e11-e14
    View PubMed
  249. Knopman DS, Lundt ES, Therneau TM, Albertson SM, Gunter JL, Senjem ML, Schwarz CG, Mielke MM, Machulda MM, Boeve BF, Jones DT, Graff-Radford J, Vemuri P, Kantarci K, Lowe VJ, Petersen RC, Jack CR Jr, Alzheimer's Disease Neuroimaging Initiative. Association of Initial beta-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment. JAMA Neurol. 2021 Feb 1; 78 (2):217-228
    View PubMed
  250. Townley RA, Botha H, Graff-Radford J, Whitwell J, Boeve BF, Machulda MM, Fields JA, Drubach DA, Savica R, Petersen RC, Senjem ML, Knopman DS, Lowe VJ, Jack CR Jr, Josephs KA, Jones DT. Posterior cortical atrophy phenotypic heterogeneity revealed by decoding (18)F-FDG-PET. Brain Commun. 2021; 3 (4):fcab182 Epub 2021 Aug 19
    View PubMed
  251. Poulakis K, Reid RI, Przybelski SA, Knopman DS, Graff-Radford J, Lowe VJ, Mielke MM, Machulda MM, Jack CR Jr, Petersen RC, Westman E, Vemuri P. Longitudinal deterioration of white-matter integrity: heterogeneity in the ageing population. Brain Commun. 2021; 3 (1):fcaa238 Epub 2021 Jan 22
    View PubMed
  252. Sintini I, Kaufman K, Botha H, Martin PR, Loushin SR, Senjem ML, Reid RI, Schwarz CG, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL, Ali F. Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy. Neuroimage Clin. 2021; 32:102850 Epub 2021 Oct 12
    View PubMed
  253. Kantarci K, Boeve BF, Przybelski SA, Lesnick TG, Chen Q, Fields J, Schwarz CG, Senjem ML, Gunte JL, Jack CR, Min P, Jain M, Miyagawa T, Savica R, Graff-Radford J, Botha H, Jones DT, Knopman DS, Graff-Radford N, Ferman TJ, Petersen RC, Lowe VJ. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD. Neuroimage Clin. 2021; 31:102754 Epub 2021 July 04
    View PubMed
  254. Campbell MR, Ashrafzadeh-Kian S, Petersen RC, Mielke MM, Syrjanen JA, van Harten AC, Lowe VJ, Jack CR Jr, Bornhorst JA, Algeciras-Schimnich A. P-tau/Abeta42 and Abeta42/40 ratios in CSF are equally predictive of amyloid PET status. Alzheimers Dement (Amst). 2021; 13 (1):e12190 Epub 2021 May 18
    View PubMed
  255. Curet Burleson AX, Pham NTT, Buciuc M, Botha H, Duffy JR, Clark HM, Utianski RL, Machulda MM, Baker MC, Rademakers R, Lowe VJ, Whitwell JL, Josephs KA. Neurobehavioral Characteristics of FDG-PET Defined Right-Dominant Semantic Dementia: A Longitudinal Study. Dement Geriatr Cogn Disord. 2021; 50 (1):17-28 Epub 2021 Mar 23
    View PubMed
  256. Vemuri P, Graff-Radford J, Lesnick TG, Przybelski SA, Reid RI, Reddy AL, Lowe VJ, Mielke MM, Machulda MM, Petersen RC, Knopman DS, Jack CR Jr. White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline. Brain Commun. 2021; 3 (2):fcab076 Epub 2021 Apr 12
    View PubMed
  257. Jayachandran M, Miller VM, Lahr BD, Bailey KR, Lowe VJ, Fields JA, Mielke MM, Kantarci K. Peripheral Markers of Neurovascular Unit Integrity and Amyloid-beta in the Brains of Menopausal Women. J Alzheimers Dis. 2021; 80 (1):397-405
    View PubMed
  258. Cogswell PM, Wiste HJ, Senjem ML, Gunter JL, Weigand SD, Schwarz CG, Arani A, Therneau TM, Lowe VJ, Knopman DS, Botha H, Graff-Radford J, Jones DT, Kantarci K, Vemuri P, Boeve BF, Mielke MM, Petersen RC, Jack CR Jr. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers. Neuroimage. 2021 Jan 1; 224:117433 Epub 2020 Oct 06
    View PubMed
  259. Barath AS, Rusheen AE, Min HK, Lee J, Ross E, Shin S, Loudermilk A, Wessel B, Lowe VJ, Lee KH, Blaha CD. Brain Metabolic Changes with Longitudinal Transcutaneous Afferent Patterned Stimulation in Essential Tremor Subjects. Tremor Other Hyperkinet Mov (N Y). 2020 Dec 16; 10:52.
    View PubMed
  260. Ferreira D, Przybelski SA, Lesnick TG, Lemstra AW, Londos E, Blanc F, Nedelska Z, Schwarz CG, Graff-Radford J, Senjem ML, Fields JA, Knopman DS, Savica R, Ferman TJ, Graff-Radford NR, Lowe VJ, Jack CR Jr, Petersen RC, Mollenhauer B, Garcia-Ptacek S, Abdelnour C, Hort J, Bonanni L, Oppedal K, Kramberger MG, Boeve BF, Aarsland D, Westman E, Kantarci K. beta-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies. Neurology. 2020 Dec 15; 95 (24):e3257-e3268 Epub 2020 Sept 28
    View PubMed
  261. Whitwell JL, Tosakulwong N, Schwarz CC, Senjem ML, Spychalla AJ, Duffy JR, Graff-Radford J, Machulda MM, Boeve BF, Knopman DS, Petersen RC, Lowe VJ, Jack CR Jr, Dickson DW, Parisi JE, Josephs KA. Longitudinal anatomic, functional, and molecular characterization of Pick disease phenotypes. Neurology. 2020 Dec 15; 95(24):e3190-e3202. Epub 2020 Sep 28.
    View PubMed
  262. Qian J, Herman MG, Brinkmann DH, Laack NN, Kemp BJ, Hunt CH, Lowe V, Pafundi DH. Prediction of MGMT Status for Glioblastoma Patients Using Radiomics Feature Extraction From (18)F-DOPA-PET Imaging. Int J Radiat Oncol Biol Phys. 2020 Dec 1; 108 (5):1339-1346 Epub 2020 July 04
    View PubMed
  263. Seckin ZI, Duffy JR, Strand EA, Clark HM, Utianski RL, Machulda MM, Botha H, Ali F, Thu Pham NT, Lowe VJ, Whitwell JL, Josephs KA. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study. Parkinsonism Relat Disord. 2020 Dec; 81:34-40. Epub 2020 Oct 07.
    View PubMed
  264. Maltais DD, Jordan LG, Min HK, Miyagawa T, Przybelski SA, Lesnick TG, Reichard RR, Dickson DW, Murray ME, Kantarci K, Boeve BF, Lowe VJ. Confirmation of (123)I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders. J Nucl Med. 2020 Nov; 61 (11):1628-1635 Epub 2020 Mar 20
    View PubMed
  265. Ghirelli A, Tosakulwong N, Weigand SD, Clark HM, Ali F, Botha H, Duffy JR, Utianski RL, Buciuc M, Murray ME, Labuzan SA, Spychalla AJ, Pham NTT, Schwarz CG, Senjem ML, Machulda MM, Baker M, Rademakers R, Filippi M, Jack CR Jr, Lowe VJ, Parisi JE, Dickson DW, Josephs KA, Whitwell JL. Sensitivity-Specificity of Tau and Amyloid beta Positron Emission Tomography in Frontotemporal Lobar Degeneration. Ann Neurol. 2020 Nov; 88 (5):1009-1022 Epub 2020 Sept 12
    View PubMed
  266. Swaminathan SK, Zhou AL, Ahlschwede KM, Curran GL, Lowe VJ, Li L, Kandimalla KK. High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-beta Distribution between Brain and Plasma. J Pharmacol Exp Ther. 2020 Nov; 375 (2):308-316 Epub 2020 Aug 10
    View PubMed
  267. Boes S, Botha H, Machulda M, Lowe V, Graff-Radford J, Whitwell JL, Utianski RL, Duffy JR, Josephs KA. Dementia with Lewy bodies presenting as Logopenic variant primary progressive Aphasia. Neurocase. 2020 Oct; 26 (5):259-263 Epub 2020 July 16
    View PubMed
  268. Jack CR, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Botha H, Graff-Radford J, Jones DT, Ferman TJ, Boeve BF, Kantarci K, Vemuri P, Mielke MM, Whitwell J, Josephs K, Schwarz CG, Senjem ML, Gunter JL, Petersen RC. Predicting future rates of tau accumulation on PET. Brain. 2020 Oct 1; 143 (10):3136-3150
    View PubMed
  269. Nicolas CT, Kaiser RA, Hickey RD, Allen KL, Du Z, VanLith CJ, Guthman RM, Amiot B, Suksanpaisan L, Han B, Francipane MG, Cheikhi A, Jiang H, Bansal A, Pandey MK, Garg I, Lowe V, Bhagwate A, O'Brien D, Kocher JA, DeGrado TR, Nyberg SL, Lagasse E, Lillegard JB. Ex Vivo Cell Therapy by Ectopic Hepatocyte Transplantation Treats the Porcine Tyrosinemia Model of Acute Liver Failure. Mol Ther Methods Clin Dev. 2020 Sep 11; 18:738-750 Epub 2020 July 10
    View PubMed
  270. Seckin ZI, Whitwell JL, Utianski RL, Botha H, Ali F, Duffy JR, Clark HM, Machulda MM, Jordan LG, Min HK, Lowe VJ, Josephs KA. Ioflupane 123I (DAT scan) SPECT identifies dopamine receptor dysfunction early in the disease course in progressive apraxia of speech. J Neurol. 2020 Sep; 267(9):2603-2611. Epub 2020 May 09.
    View PubMed
  271. Carr RM, Duma N, McCleary-Wheeler AL, Almada LL, Marks DL, Graham RP, Smyrk TC, Lowe V, Borad MJ, Kim G, Johnson GB, Allred JB, Yin J, Lim VS, Bekaii-Saab T, Ma WW, Erlichman C, Adjei AA, Fernandez-Zapico ME. Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination. Pancreatology. 2020 Sep; 20 (6):1115-1122 Epub 2020 July 14
    View PubMed
  272. Utianski RL, Botha H, Whitwell JL, Martin PR, Schwarz CG, Duffy JR, Clark HM, Spychalla AJ, Senjem ML, Petersen RC, Knopman DS, Jack CR Jr, Lowe VJ, Josephs KA. Longitudinal flortaucipir ([(18)F]AV-1451) PET uptake in semantic dementia. Neurobiol Aging. 2020 Aug; 92:135-140 Epub 2020 Apr 18
    View PubMed
  273. Townley RA, Polsinelli AJ, Fields JA, Machulda MM, Jones DT, Graff-Radford J, Kantarci KM, Lowe VJ, Rademakers RV, Baker MC, Kumar N, Boeve BF. Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation. Neurocase. 2020 Aug; 26 (4):211-219 Epub 2020 June 30
    View PubMed
  274. Buciuc M, Botha H, Murray ME, Schwarz CG, Senjem ML, Jones DT, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr, Petrucelli L, Parisi JE, Dickson DW, Lowe V, Whitwell JL, Josephs KA. Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy. Neurology. 2020 Jul 7; 95 (1):e23-e34 Epub 2020 June 09
    View PubMed
  275. Sintini I, Graff-Radford J, Senjem ML, Schwarz CG, Machulda MM, Martin PR, Jones DT, Boeve BF, Knopman DS, Kantarci K, Petersen RC, Jack CR, Lowe VJ, Josephs KA, Whitwell JL. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes. Brain. 2020 Jul 1; 143 (7):2281-2294
    View PubMed
  276. Fleisher AS, Pontecorvo MJ, Devous MD Sr, Lu M, Arora AK, Truocchio SP, Aldea P, Flitter M, Locascio T, Devine M, Siderowf A, Beach TG, Montine TJ, Serrano GE, Curtis C, Perrin A, Salloway S, Daniel M, Wellman C, Joshi AD, Irwin DJ, Lowe VJ, Seeley WW, Ikonomovic MD, Masdeu JC, Kennedy I, Harris T, Navitsky M, Southekal S, Mintun MA, A16 Study Investigators. Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. JAMA Neurol. 2020 Jul 1; 77 (7):829-839
    View PubMed
  277. Utianski RL, Duffy JR, Clark HM, Strand EA, Botha H, Schwarz CG, Machulda MM, Senjem ML, Spychalla AJ, Jack CR Jr, Petersen RC, Lowe VJ, Whitwell JL, Josephs KA. Corrigendum to "Prosodic and phonetic subtypes of primary progressive apraxia of speech" [Brain Lang. 184 (2018) 54-65]. Brain Lang. 2020 Jun; 205:104792 Epub 2020 Apr 02
    View PubMed
  278. Sprung J, Warner DO, Knopman DS, Petersen RC, Mielke MM, Jack CR Jr, Lowe VJ, Martin DP, Hanson AC, Schroeder DR, Przybelski SA, Schulte PJ, Weingarten TN, Vemuri P. Exposure to surgery with general anaesthesia during adult life is not associated with increased brain amyloid deposition in older adults. Br J Anaesth. 2020 May; 124 (5):594-602 Epub 2020 Mar 12
    View PubMed
  279. Josephs KA, Tosakulwong N, Graff-Radford J, Weigand SD, Buciuc M, Machulda MM, Jones DT, Schwarz CG, Senjem ML, Ertekin-Taner N, Kantarci K, Boeve BF, Knopman DS, Jack CR Jr, Petersen RC, Lowe VJ, Whitwell JL. MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous. Ann Clin Transl Neurol. 2020 May; 7 (5):707-721 Epub 2020 Apr 15
    View PubMed
  280. Carvalho DZ, St Louis EK, Schwarz CG, Lowe VJ, Boeve BF, Przybelski SA, Reddy A, Mielke MM, Knopman DS, Petersen RC, Jack CR Jr, Vemuri P. Witnessed apneas are associated with elevated tau-PET levels in cognitively unimpaired elderly. Neurology. 2020 Apr 28; 94 (17):e1793-e1802 Epub 2020 Mar 26
    View PubMed
  281. Arenaza-Urquijo EM, Przybelski SA, Machulda MM, Knopman DS, Lowe VJ, Mielke MM, Reddy AL, Geda YE, Jack CR Jr, Petersen RC, Vemuri P. Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults. Neurology. 2020 Apr 14; 94 (15):e1571-e1579 Epub 2020 Jan 21
    View PubMed
  282. Zeydan B, Lowe VJ, Reichard RR, Przybelski SA, Lesnick TG, Schwarz CG, Senjem ML, Gunter JL, Parisi JE, Machulda MM, Vemuri P, Mielke MM, Knopman DS, Petersen RC, Jack CR Jr, Kantarci OH, Kantarci K. Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis. Ann Neurol. 2020 Apr; 87 (4):556-567 Epub 2020 Feb 08
    View PubMed
  283. Ghisays V, Goradia DD, Protas H, Bauer RJ 3rd, Devadas V, Tariot PN, Lowe VJ, Knopman DS, Petersen RC, Jack CR Jr, Caselli RJ, Su Y, Chen K, Reiman EM. Brain imaging measurements of fibrillar amyloid-beta burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE epsilon4 allele. Alzheimers Dement. 2020 Apr; 16 (4):598-609 Epub 2020 Jan 16
    View PubMed
  284. Vassilaki M, Aakre JA, Kremers WK, Lesnick TG, Mielke MM, Geda YE, Machulda MM, Knopman DS, Butler L, Traber M, Vemuri P, Lowe VJ, Jack CR Jr, Roberts RO, Petersen RC. Brain amyloid, cortical thickness, and changes in activities of daily living. Ann Clin Transl Neurol. 2020 Apr; 7 (4):474-485 Epub 2020 Apr 21
    View PubMed
  285. Lowe VJ, Lundt ES, Albertson SM, Min HK, Fang P, Przybelski SA, Senjem ML, Schwarz CG, Kantarci K, Boeve B, Jones DT, Reichard RR, Tranovich JF, Hanna Al-Shaikh FS, Knopman DS, Jack CR Jr, Dickson DW, Petersen RC, Murray ME. Tau-positron emission tomography correlates with neuropathology findings. Alzheimers Dement. 2020 Mar; 16 (3):561-571 Epub 2020 Jan 04
    View PubMed
  286. Utianski RL, Martin PR, Botha H, Schwarz CG, Duffy JR, Petersen RC, Knopman DS, Clark HM, Butts AM, Machulda MM, Jack CR Jr, Lowe VJ, Whitwell JL, Josephs KA. Longitudinal flortaucipir ([(18)F]AV-1451) PET imaging in primary progressive apraxia of speech. Cortex. 2020 Mar; 124:33-43 Epub 2019 Nov 19
    View PubMed
  287. Kantarci K, Lowe VJ, Chen Q, Przybelski SA, Lesnick TG, Schwarz CG, Senjem ML, Gunter JL, Jack CR Jr, Graff-Radford J, Jones DT, Knopman DS, Graff-Radford N, Ferman TJ, Parisi JE, Dickson DW, Petersen RC, Boeve BF, Murray ME. beta-Amyloid PET and neuropathology in dementia with Lewy bodies. Neurology. 2020 Jan 21; 94 (3):e282-e291 Epub 2019 Dec 20
    View PubMed
  288. Graff-Radford J, Lesnick T, Rabinstein AA, Gunter J, Aakre J, Przybelski SA, Spychalla AJ, Huston J 3rd, Brown RD Jr, Mielke MM, Lowe VJ, Knopman DS, Petersen RC, Jack CR Jr, Vemuri P, Kremers W, Kantarci K. Cerebral microbleed incidence, relationship to amyloid burden: The Mayo Clinic Study of Aging. Neurology. 2020 Jan 14; 94 (2):e190-e199 Epub 2019 Dec 04
    View PubMed
  289. Graff-Radford J, Lesnick TG, Savica R, Chen Q, Ferman TJ, Przybelski SA, Jones DT, Senjem ML, Gunter JL, Kremers WK, Jack CR Jr, Lowe VJ, Petersen RC, Knopman DS, Boeve BF, Murray ME, Dickson DW, Kantarci K. (18)F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies. Brain Commun. 2020; 2 (1):fcaa040 Epub 2020 Apr 08
    View PubMed
  290. Townley RA, Graff-Radford J, Mantyh WG, Botha H, Polsinelli AJ, Przybelski SA, Machulda MM, Makhlouf AT, Senjem ML, Murray ME, Reichard RR, Savica R, Boeve BF, Drubach DA, Josephs KA, Knopman DS, Lowe VJ, Jack CR Jr, Petersen RC, Jones DT. Progressive dysexecutive syndrome due to Alzheimer's disease: a description of 55 cases and comparison to other phenotypes. Brain Commun. 2020; 2 (1):fcaa068 Epub 2020 May 27
    View PubMed
  291. Whitwell JL, Tosakulwong N, Botha H, Ali F, Clark HM, Duffy JR, Utianski RL, Stevens CA, Weigand SD, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Ahlskog JE, Dickson DW, Josephs KA. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants. Neuroimage Clin. 2020; 25:102152 Epub 2019 Dec 28
    View PubMed
  292. Pandey MK, Jacobson MS, Groth EK, Tran NG, Lowe VJ, DeGrado TR. Radiation induced oxidation of [(18)F]fluorothia fatty acids under cGMP manufacturing conditions. Nucl Med Biol. 2020 Jan - Feb; 80-81:13-23 Epub 2019 Nov 09
    View PubMed
  293. McCleary-Wheeler AL, Carr RM, Palmer SR, Smyrk TC, Allred JB, Almada LL, Tolosa EJ, Lamberti MJ, Marks DL, Borad MJ, Molina JR, Qi Y, Lingle WL, Grothey A, Pitot HC, Jatoi A, Northfelt DW, Bryce AH, McWilliams RR, Okuno SH, Haluska P, Kim GP, Colon-Otero G, Lowe VJ, Callstrom MR, Ma WW, Bekaii-Saab T, Hung MC, Erlichman C, Fernandez-Zapico ME. Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer. Pancreatology. 2020 Jan; 20 (1):101-109 Epub 2019 Nov 21
    View PubMed
  294. Whitwell JL, Tosakulwong N, Weigand SD, Graff-Radford J, Duffy JR, Clark HM, Machulda MM, Botha H, Utianski RL, Schwarz CG, Senjem ML, Strand EA, Ertekin-Taner N, Jack CR, Lowe VJ, Josephs KA. Longitudinal Amyloid-beta PET in Atypical Alzheimer's Disease and Frontotemporal Lobar Degeneration. J Alzheimers Dis. 2020; 74 (1):377-389
    View PubMed
  295. Ramanan VK, Wang X, Przybelski SA, Raghavan S, Heckman MG, Batzler A, Kosel ML, Hohman TJ, Knopman DS, Graff-Radford J, Lowe VJ, Mielke MM, Jack CR Jr, Petersen RC, Ross OA, Vemuri P. Variants in PPP2R2B and IGF2BP3 are associated with higher tau deposition. Brain Commun. 2020; 2 (2):fcaa159 Epub 2020 Sept 26
    View PubMed
  296. Graff-Radford J, Gunter JL, Jones DT, Przybelski SA, Schwarz CG, Huston J 3rd, Lowe V, Elder BD, Machulda MM, Gunter NB, Petersen RC, Kantarci K, Vemuri P, Mielke MM, Knopman DS, Graff-Radford NR, Jack CR Jr. Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition. Neurology. 2019 Dec 10; 93 (24):e2237-e2246 Epub 2019 Nov 12
    View PubMed
  297. Nedelska Z, Schwarz CG, Lesnick TG, Boeve BF, Przybelski SA, Lowe VJ, Kremers WK, Gunter JL, Senjem ML, Graff-Radford J, Ferman TJ, Fields JA, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K. Association of Longitudinal beta-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia. JAMA Netw Open. 2019 Dec 2; 2 (12):e1916439 Epub 2019 Dec 02
    View PubMed
  298. Vemuri P, Lesnick TG, Knopman DS, Przybelski SA, Reid RI, Mielke MM, Graff-Radford J, Lowe VJ, Machulda MM, Petersen RC, Jack CR Jr. Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging. Ann Neurol. 2019 Dec; 86 (6):866-877 Epub 2019 Oct 17
    View PubMed
  299. Yost M, Fiebelkorn CA, Fiebelkorn CA, Rabinstein AA, Klaas J, Aakre JA, Brown RD Jr, Mielke MM, Knopman DS, Lowe V, Petersen RC, Jack CR Jr, Vemuri P, Graff-Radford J. Incidence of Convexal Subarachnoid Hemorrhage in the Elderly: The Mayo Clinic Study of Aging. J Stroke Cerebrovasc Dis. 2019 Dec; 28 (12):104451 Epub 2019 Oct 24
    View PubMed
  300. Ramanan VK, Castillo AM, Knopman DS, Graff-Radford J, Lowe VJ, Petersen RC, Jack CR Jr, Mielke MM, Vemuri P. Association of Apolipoprotein E varepsilon4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults. JAMA Netw Open. 2019 Oct 2; 2 (10):e1913909 Epub 2019 Oct 02
    View PubMed
  301. Utianski RL, Botha H, Martin PR, Schwarz CG, Duffy JR, Clark HM, Machulda MM, Butts AM, Lowe VJ, Jack CR Jr, Senjem ML, Spychalla AJ, Whitwell JL, Josephs KA. Clinical and neuroimaging characteristics of clinically unclassifiable primary progressive aphasia. Brain Lang. 2019 Oct; 197:104676 Epub 2019 Aug 13
    View PubMed
  302. Jack CR, Wiste HJ, Botha H, Weigand SD, Therneau TM, Knopman DS, Graff-Radford J, Jones DT, Ferman TJ, Boeve BF, Kantarci K, Lowe VJ, Vemuri P, Mielke MM, Fields JA, Machulda MM, Schwarz CG, Senjem ML, Gunter JL, Petersen RC. The bivariate distribution of amyloid-beta and tau: relationship with established neurocognitive clinical syndromes. Brain. 2019 Oct 1; 142 (10):3230-3242
    View PubMed
  303. Jethwa KR, Hellekson CD, Evans JD, Harmsen WS, Wilhite TJ, Whitaker TJ, Park SS, Choo CR, Stish BJ, Olivier KR, Haloi R, Lowe VJ, Welch BT, Quevedo JF, Mynderse LA, Karnes RJ, Kwon ED, Davis BJ. (11)C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities. Adv Radiat Oncol. 2019 Oct-Dec; 4 (4):659-667 Epub 2019 July 04
    View PubMed
  304. Jack CR Jr, Therneau TM, Weigand SD, Wiste HJ, Knopman DS, Vemuri P, Lowe VJ, Mielke MM, Roberts RO, Machulda MM, Graff-Radford J, Jones DT, Schwarz CG, Gunter JL, Senjem ML, Rocca WA, Petersen RC. Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework. JAMA Neurol 2019 Oct 1; 76 (10):1174-1183
    View PubMed
  305. Sintini I, Schwarz CG, Senjem ML, Reid RI, Botha H, Ali F, Ahlskog JE, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL. Multimodal neuroimaging relationships in progressive supranuclear palsy. Parkinsonism Relat Disord. 2019 Sep; 66:56-61. Epub 2019 Jul 02.
    View PubMed
  306. Tetzloff KA, Duffy JR, Clark HM, Utianski RL, Strand EA, Machulda MM, Botha H, Martin PR, Schwarz CG, Senjem ML, Reid RI, Gunter JL, Spychalla AJ, Knopman DS, Petersen RC, Jack CR, Lowe VJ, Josephs KA, Whitwell JL. Progressive agrammatic aphasia without apraxia of speech as a distinct syndrome. Brain. 2019 Aug 01; 142(8):2466-2482.
    View PubMed
  307. Graff-Radford J, Arenaza-Urquijo EM, Knopman DS, Schwarz CG, Brown RD, Rabinstein AA, Gunter JL, Senjem ML, Przybelski SA, Lesnick T, Ward C, Mielke MM, Lowe VJ, Petersen RC, Kremers WK, Kantarci K, Jack CR, Vemuri P. White matter hyperintensities: relationship to amyloid and tau burden. Brain. 2019 Aug 1; 142 (8):2483-2491
    View PubMed
  308. Lowe VJ, Duan F, Subramaniam RM, Sicks JD, Romanoff J, Bartel T, Yu JQM, Nussenbaum B, Richmon J, Arnold CD, Cognetti D, Stack BC Jr. Multicenter Trial of [(18)F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685. J Clin Oncol. 2019 Jul 10; 37 (20):1704-1712 Epub 2019 Feb 15
    View PubMed
  309. Lowe VJ, Bruinsma TJ, Wiste HJ, Min HK, Weigand SD, Fang P, Senjem ML, Therneau TM, Boeve BF, Josephs KA, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, Machulda MM, Mielke MM, Roberts RO, Knopman DS, Petersen RC, Jack CR Jr. Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults. Neurology. 2019 Jul 2; 93 (1):e29-e39 Epub 2019 May 30
    View PubMed
  310. Lowe VJ, Lundt ES, Albertson SM, Przybelski SA, Senjem ML, Parisi JE, Kantarci K, Boeve B, Jones DT, Knopman D, Jack CR Jr, Dickson DW, Petersen RC, Murray ME. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease. Alzheimers Dement. 2019 Jul; 15 (7):927-939 Epub 2019 June 04
    View PubMed
  311. Jack CR Jr, Wiste HJ, Therneau TM, Weigand SD, Knopman DS, Mielke MM, Lowe VJ, Vemuri P, Machulda MM, Schwarz CG, Gunter JL, Senjem ML, Graff-Radford J, Jones DT, Roberts RO, Rocca WA, Petersen RC. Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia. JAMA. 2019 Jun 18; 321 (23):2316-2325
    View PubMed
  312. Zhou AL, Swaminathan SK, Curran GL, Poduslo JF, Lowe VJ, Li L, Kandimalla KK. Apolipoprotein A-I Crosses the Blood-Brain Barrier through Clathrin-Independent and Cholesterol-Mediated Endocytosis. J Pharmacol Exp Ther. 2019 Jun; 369 (3):481-488 Epub 2019 Apr 10
    View PubMed
  313. Zattoni F, Incerti E, Dal Moro F, Moschini M, Castellucci P, Panareo S, Picchio M, Fallanca F, Briganti A, Gallina A, Fanti S, Schiavina R, Brunocilla E, Rambaldi I, Lowe V, Karnes JR, Evangelista L. (18)F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study. Cancers (Basel). 2019 May 20; 11 (5)
    View PubMed
  314. Vassilaki M, Aakre JA, Kremers WK, Mielke MM, Geda YE, Alhurani RE, Dutt T, Machulda MM, Knopman DS, Vemuri P, Coloma PM, Schauble B, Lowe VJ, Jack CR, Petersen RC, Roberts RO. The Association of Multimorbidity With Preclinical AD Stages and SNAP in Cognitively Unimpaired Persons. J Gerontol A Biol Sci Med Sci. 2019 May 16; 74 (6):877-883
    View PubMed
  315. Whitwell JL, Martin P, Graff-Radford J, Machulda MM, Senjem ML, Schwarz CG, Weigand SD, Spychalla AJ, Drubach DA, Jack CR Jr, Lowe VJ, Josephs KA. The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease. Alzheimers Dement. 2019 May; 15 (5):675-685 Epub 2019 Mar 08
    View PubMed
  316. Arenaza-Urquijo EM, Przybelski SA, Lesnick TL, Graff-Radford J, Machulda MM, Knopman DS, Schwarz CG, Lowe VJ, Mielke MM, Petersen RC, Jack CR, Vemuri P. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies. Brain. 2019 Apr 1; 142 (4):1134-1147
    View PubMed
  317. Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Boeve BF, Jones DT, Graff-Radford J, Albertson SM, Schwarz CG, Petersen RC, Jack CR. Entorhinal cortex tau, amyloid-beta, cortical thickness and memory performance in non-demented subjects. Brain. 2019 Apr 1; 142 (4):1148-1160
    View PubMed
  318. Sintini I, Schwarz CG, Martin PR, Graff-Radford J, Machulda MM, Senjem ML, Reid RI, Spychalla AJ, Drubach DA, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell JL. Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease. Hum Brain Mapp. 2019 Apr 1; 40 (5):1618-1631 Epub 2018 Dec 13
    View PubMed
  319. Zeydan B, Schwarz CG, Lowe VJ, Reid RI, Przybelski SA, Lesnick TG, Kremers WK, Senjem ML, Gunter JL, Min HK, Vemuri P, Knopman DS, Petersen RC, Jack CR Jr, Kantarci OH, Kantarci K. Investigation of white matter PiB uptake as a marker of white matter integrity. Ann Clin Transl Neurol. 2019 Apr; 6 (4):678-688 Epub 2019 Mar 03
    View PubMed
  320. Krell-Roesch J, Vassilaki M, Mielke MM, Kremers WK, Lowe VJ, Vemuri P, Machulda MM, Christianson TJ, Syrjanen JA, Stokin GB, Butler LM, Traber M, Jack CR Jr, Knopman DS, Roberts RO, Petersen RC, Geda YE. Cortical beta-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging. Transl Psychiatry. 2019 Mar 28; 9 (1):123
    View PubMed
  321. Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, la Fougere C, Langen KJ, Lopci E, Lowe V, McConathy J, Quick HH, Sattler B, Schuster DM, Tonn JC, Weller M. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 2019 Mar; 46 (3):540-557 Epub 2018 Dec 05
    View PubMed
  322. Nedelska Z, Josephs KA, Graff-Radford J, Przybelski SA, Lesnick TG, Boeve BF, Drubach DA, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Whitwell JL, Kantarci K. (18) F-AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy. Mov Disord. 2019 Mar; 34 (3):344-352 Epub 2019 Jan 07
    View PubMed
  323. Whitwell JL, Martin PR, Duffy JR, Clark HM, Machulda MM, Schwarz CG, Weigand SD, Sintini I, Senjem ML, Ertekin-Taner N, Botha H, Utianski RL, Graff-Radford J, Jones DT, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA. The influence of beta-amyloid on [(18)F]AV-1451 in semantic variant of primary progressive aphasia. Neurology. 2019 Feb 12; 92 (7):e710-e722 Epub 2019 Jan 11
    View PubMed
  324. La Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, Dore V, Grinberg LT, Huang E, Hwang JH, Ikonomovic MD, Jack C Jr, Jagust WJ, Jin LW, Klunk WE, Kofler J, Lesman-Segev OH, Lockhart SN, Lowe VJ, Masters CL, Mathis CA, McLean CL, Miller BL, Mungas D, O'Neil JP, Olichney JM, Parisi JE, Petersen RC, Rosen HJ, Rowe CC, Spina S, Vemuri P, Villemagne VL, Murray ME, Rabinovici GD. Multisite study of the relationships between antemortem [(11)C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimers Dement. 2019 Feb; 15 (2):205-216 Epub 2018 Oct 19
    View PubMed
  325. Graff-Radford J, Botha H, Rabinstein AA, Gunter JL, Przybelski SA, Lesnick T, Huston J 3rd, Flemming KD, Preboske GM, Senjem ML, Brown RD Jr, Mielke MM, Roberts RO, Lowe VJ, Knopman DS, Petersen RC, Kremers W, Vemuri P, Jack CR Jr, Kantarci K. Cerebral microbleeds: Prevalence and relationship to amyloid burden. Neurology. 2019 Jan 15; 92 (3):e253-e262 Epub 2018 Dec 19
    View PubMed
  326. Welch BT, Packard AT, Atwell TD, Johnson GB, Lowe VJ, Karnes RJ, Mynderse LA, Gunderson TM, Park SS, Stish BJ, Evans JD, Kwon ED, Davis BJ, Nathan MA. Percutaneous Image-Guided Nodal Biopsy After 11C-Choline PET/CT for Biochemically Recurrent Prostate Cancer: Imaging Predictors of Disease and Clinical Implications. Adv Radiat Oncol. 2019 Jan-Mar; 4 (1):79-89 Epub 2018 Sept 05
    View PubMed
  327. Schwarz CG, Gunter JL, Lowe VJ, Weigand S, Vemuri P, Senjem ML, Petersen RC, Knopman DS, Jack CR. A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR. J Alzheimers Dis. 2019; 67 (1):181-195
    View PubMed
  328. Zeydan B, Tosakulwong N, Schwarz CG, Senjem ML, Gunter JL, Reid RI, Gazzuola Rocca L, Lesnick TG, Smith CY, Bailey KR, Lowe VJ, Roberts RO, Jack CR Jr, Petersen RC, Miller VM, Mielke MM, Rocca WA, Kantarci K. Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration. JAMA Neurol. 2019 Jan 1; 76 (1):95-100
    View PubMed
  329. Barroeta-Espar I, Weinstock LD, Perez-Nievas BG, Meltzer AC, Siao Tick Chong M, Amaral AC, Murray ME, Moulder KL, Morris JC, Cairns NJ, Parisi JE, Lowe VJ, Petersen RC, Kofler J, Ikonomovic MD, Lopez O, Klunk WE, Mayeux RP, Frosch MP, Wood LB, Gomez-Isla T. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology. Neurobiol Dis. 2019 Jan; 121:327-337 Epub 2018 Oct 15
    View PubMed
  330. Petersen RC, Lundt ES, Therneau TM, Weigand SD, Knopman DS, Mielke MM, Roberts RO, Lowe VJ, Machulda MM, Kremers WK, Geda YE, Jack CR Jr. Predicting Progression to Mild Cognitive Impairment. Ann Neurol. 2019 Jan; 85 (1):155-160 Epub 2019 Jan 07
    View PubMed
  331. Whitwell JL, Tosakulwong N, Schwarz CG, Botha H, Senjem ML, Spychalla AJ, Ahlskog JE, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA. MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy. Mov Disord. 2019 Jan; 34 (1):105-113 Epub 2018 Nov 23
    View PubMed
  332. Sintini I, Martin PR, Graff-Radford J, Senjem ML, Schwarz CG, Machulda MM, Spychalla AJ, Drubach DA, Knopman DS, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell JL. Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease. Neuroimage Clin. 2019; 23:101823 Epub 2019 Apr 10
    View PubMed
  333. Neth BJ, Graff-Radford J, Mielke MM, Przybelski SA, Lesnick TG, Schwarz CG, Reid RI, Senjem ML, Lowe VJ, Machulda MM, Petersen RC, Jack CR Jr, Knopman DS, Vemuri P. Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging. Front Aging Neurosci. 2019; 11:355 Epub 2020 Jan 09
    View PubMed
  334. Battle MR, Pillay LC, Lowe VJ, Knopman D, Kemp B, Rowe CC, Dore V, Villemagne VL, Buckley CJ. Centiloid scaling for quantification of brain amyloid with [(18)F]flutemetamol using multiple processing methods. EJNMMI Res. 2018 Dec 5; 8 (1):107 Epub 2018 Dec 05
    View PubMed
  335. Jones DT, Townley RA, Graff-Radford J, Botha H, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Boeve BF. Amyloid- and tau-PET imaging in a familial prion kindred. Neurol Genet. 2018 Dec; 4 (6):e290 Epub 2018 Dec 03
    View PubMed
  336. Vassilaki M, Aakre JA, Kremers WK, Mielke MM, Geda YE, Machulda MM, Knopman DS, Coloma PM, Schauble B, Vemuri P, Lowe VJ, Jack CR Jr, Petersen RC, Roberts RO. Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia. J Am Geriatr Soc. 2018 Dec; 66 (12):2274-2281 Epub 2018 Nov 21
    View PubMed
  337. Vemuri P, Lesnick TG, Przybelski SA, Graff-Radford J, Reid RI, Lowe VJ, Zuk SM, Senjem ML, Schwarz CG, Gunter JL, Kantarci K, Machulda MM, Mielke MM, Petersen RC, Knopman DS, Jack CR Jr. Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging. Ann Neurol. 2018 Nov; 84 (5):705-716 Epub 2018 Oct 25
    View PubMed
  338. Utianski RL, Whitwell JL, Schwarz CG, Duffy JR, Botha H, Clark HM, Machulda MM, Senjem ML, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA. Tau uptake in agrammatic primary progressive aphasia with and without apraxia of speech. Eur J Neurol. 2018 Nov; 25 (11):1352-1357 Epub 2018 July 26
    View PubMed
  339. Lowe VJ, Lundt ES, Senjem ML, Schwarz CG, Min HK, Przybelski SA, Kantarci K, Knopman D, Petersen RC, Jack CR Jr. White Matter Reference Region in PET Studies of (11)C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-beta Deposition. J Nucl Med. 2018 Oct; 59 (10):1583-1589 Epub 2018 Apr 19
    View PubMed
  340. Lowe VJ, Kalari KR, Kandimalla KK. Your brain scan may be a reflection of your genes. Brain 2018 Sep 1; 141 (9):2539-2541
    View PubMed
  341. Utianski RL, Duffy JR, Clark HM, Strand EA, Botha H, Schwarz CG, Machulda MM, Senjem ML, Spychalla AJ, Jack CR Jr, Petersen RC, Lowe VJ, Whitwell JL, Josephs KA. Prosodic and phonetic subtypes of primary progressive apraxia of speech. Brain Lang. 2018 Sep; 184:54-65 Epub 2018 July 04
    View PubMed
  342. Zattoni F, Incerti E, Colicchia M, Castellucci P, Panareo S, Picchio M, Fallanca F, Briganti A, Moschini M, Gallina A, Karnes JR, Lowe V, Fanti S, Schiavina R, Rambaldi I, Ficarra V, Evangelista L. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study. Abdom Radiol (NY). 2018 Sep; 43 (9):2391-2399
    View PubMed
  343. Roberts RO, Aakre JA, Kremers WK, Vassilaki M, Knopman DS, Mielke MM, Alhurani R, Geda YE, Machulda MM, Coloma P, Schauble B, Lowe VJ, Jack CR Jr, Petersen RC. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting. JAMA Neurol. 2018 Aug 1; 75 (8):970-979
    View PubMed
  344. Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda MM, Senjem ML, Spychalla AJ, Vemuri P, Jones DT, Drubach DA, Knopman DS, Boeve BF, Ertekin-Taner N, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA. Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease. Alzheimers Dement. 2018 Aug; 14 (8):1005-1014 Epub 2018 Mar 30
    View PubMed
  345. Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ, Airey DC, Knopman DS, Roberts RO, Machulda MM, Jack CR Jr, Petersen RC, Dage JL. Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement. 2018 Aug; 14 (8):989-997 Epub 2018 Apr 05
    View PubMed
  346. Vera Aguilera J, Rao RD, Allred JB, Suman VJ, Windschitl HE, Kaur JS, Maples WJ, Lowe VJ, Creagan ET, Erickson LA, Markovic S. Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG-N0377, Alliance). Oncologist. 2018 Aug; 23 (8):887-e94 Epub 2018 Apr 17
    View PubMed
  347. Botha H, Duffy JR, Whitwell JL, Strand EA, Machulda MM, Spychalla AJ, Tosakulwong N, Senjem ML, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA. Non-right handed primary progressive apraxia of speech. J Neurol Sci. 2018 Jul 15; 390:246-254 Epub 2018 May 07
    View PubMed
  348. Carvalho DZ, St Louis EK, Knopman DS, Boeve BF, Lowe VJ, Roberts RO, Mielke MM, Przybelski SA, Machulda MM, Petersen RC, Jack CR Jr, Vemuri P. Association of Excessive Daytime Sleepiness With Longitudinal beta-Amyloid Accumulation in Elderly Persons Without Dementia. JAMA Neurol. 2018 Jun 1; 75 (6):672-680
    View PubMed
  349. Schwarz CG, Tosakulwong N, Senjem ML, Gunter JL, Therneau TM, Vemuri P, Lowe VJ, Jack CR Jr. Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values. Sci Rep. 2018 May 9; 8 (1):7421 Epub 2018 May 09
    View PubMed
  350. Jack CR Jr, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, Weigand SD, Therneau TM, Knopman DS, Gunter JL, Jones DT, Graff-Radford J, Kantarci K, Roberts RO, Mielke MM, Machulda MM, Petersen RC. Longitudinal tau PET in ageing and Alzheimer's disease. Brain. 2018 May 1; 141 (5):1517-1528
    View PubMed
  351. Ali F, Whitwell JL, Martin PR, Senjem ML, Knopman DS, Jack CR, Lowe VJ, Petersen RC, Boeve BF, Josephs KA. [(18)F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation. J Neurol. 2018 May; 265 (5):1079-1088 Epub 2018 Mar 01
    View PubMed
  352. Youland RS, Pafundi DH, Brinkmann DH, Lowe VJ, Morris JM, Kemp BJ, Hunt CH, Giannini C, Parney IF, Laack NN. Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas. J Neurooncol. 2018 May; 137 (3):583-591 Epub 2018 Jan 13
    View PubMed
  353. Swaminathan SK, Ahlschwede KM, Sarma V, Curran GL, Omtri RS, Decklever T, Lowe VJ, Poduslo JF, Kandimalla KK. Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain. J Cereb Blood Flow Metab. 2018 May; 38 (5):904-918 Epub 2017 June 01
    View PubMed
  354. Zeydan B, Lowe VJ, Schwarz CG, Przybelski SA, Tosakulwong N, Zuk SM, Senjem ML, Gunter JL, Roberts RO, Mielke MM, Benarroch EE, Rodriguez M, Machulda MM, Lesnick TG, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K, Kantarci OH. Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis. Mult Scler. 2018 May; 24 (6):739-749 Epub 2017 May 05
    View PubMed
  355. Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC, Jack CR Jr. Joint associations of beta-amyloidosis and cortical thickness with cognition. Neurobiol Aging. 2018 May; 65:121-131 Epub 2018 Feb 02
    View PubMed
  356. Kantarci K, Tosakulwong N, Lesnick TG, Zuk SM, Lowe VJ, Fields JA, Gunter JL, Senjem ML, Settell ML, Gleason CE, Shuster LT, Bailey KR, Dowling NM, Asthana S, Jack CR Jr, Rocca WA, Miller VM. Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial. Neurology. 2018 Apr 17; 90 (16):e1404-e1412 Epub 2018 Mar 21
    View PubMed
  357. Botha H, Mantyh WG, Murray ME, Knopman DS, Przybelski SA, Wiste HJ, Graff-Radford J, Josephs KA, Schwarz CG, Kremers WK, Boeve BF, Petersen RC, Machulda MM, Parisi JE, Dickson DW, Lowe V, Jack CR Jr, Jones DT. FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis. Brain. 2018 Apr 1; 141 (4):1201-1217
    View PubMed
  358. Kazda T, Pafundi DH, Kraling A, Bradley T, Lowe VJ, Brinkmann DH, Laack NN. Dosimetric impact of amino acid positron emission tomography imaging for target delineation in radiation treatment planning for high-grade gliomas. Phys Imaging Radiat Oncol. 2018 Apr; 6:94-100 Epub 2018 June 22
    View PubMed
  359. Botha H, Mantyh WG, Graff-Radford J, Machulda MM, Przybelski SA, Wiste HJ, Senjem ML, Parisi JE, Petersen RC, Murray ME, Boeve BF, Lowe VJ, Knopman DS, Jack CR Jr, Jones DT. Tau-negative amnestic dementia masquerading as Alzheimer disease dementia. Neurology. 2018 Mar 13; 90 (11):e940-e946 Epub 2018 Feb 07
    View PubMed
  360. Jones DT, Knopman DS, Graff-Radford J, Syrjanen JA, Senjem ML, Schwarz CG, Dheel C, Wszolek Z, Rademakers R, Kantarci K, Petersen RC, Jack CR Jr, Lowe VJ, Boeve BF. In vivo (18)F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms. Neurology. 2018 Mar 13; 90 (11):e947-e954 Epub 2018 Feb 09
    View PubMed
  361. Jung Y, Jordan LG 3rd, Lowe VJ, Kantarci K, Parisi JE, Dickson DW, Murray ME, Reichard RR, Ferman TJ, Jones DT, Graff-Radford J, Savica R, Machulda MM, Fields JA, Allen LA, Drubach DA, St Louis EK, Silber MH, Jack CR Jr, Knopman DS, Petersen RC, Boeve BF. Clinicopathological and 123I-FP-CIT SPECT correlations in patients with dementia. Ann Clin Transl Neurol. 2018 Mar; 5(3):376-381. Epub 2018 Jan 24.
    View PubMed
  362. Nehra A, Parker WP, Haloi R, Park SS, Mynderse LA, Lowe VJ, Davis BJ, Quevedo JF, Johnson GB, Kwon ED, Karnes RJ. Identification of recurrence sites following post-prostatectomy treatment for prostate cancer using c-11-choline positron emission tomography and multiparametric pelvic magnetic resonance imaging Journal Of Urology. 2018 Mar; 199 (3):726-33
  363. Josephs KA, Martin PR, Botha H, Schwarz CG, Duffy JR, Clark HM, Machulda MM, Graff-Radford J, Weigand SD, Senjem ML, Utianski RL, Drubach DA, Boeve BF, Jones DT, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Whitwell JL. [(18) F]AV-1451 tau-PET and primary progressive aphasia. Ann Neurol. 2018 Mar; 83 (3):599-611 Epub 2018 Mar 13
    View PubMed
  364. Whitwell JL, Ahlskog JE, Tosakulwong N, Senjem ML, Spychalla AJ, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy. Parkinsonism Relat Disord. 2018 Mar; 48:3-9 Epub 2017 Dec 13
    View PubMed
  365. Nehra A, Parker WP, Haloi R, Park SS, Mynderse LA, Lowe VJ, Davis BJ, Quevedo JF, Johnson GB, Kwon ED, Karnes RJ. Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using (11)C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance Imaging. J Urol. 2018 Mar; 199 (3):726-733 Epub 2017 Sept 12
    View PubMed
  366. Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda M, Senjem ML, Schwarz CG, Spychalla AJ, Jones DT, Drubach DA, Knopman DS, Boeve BF, Ertekin-Taner N, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA. [(18) F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease. Ann Neurol. 2018 Feb; 83 (2):248-257 Epub 2018 Feb 06
    View PubMed
  367. Krell-Roesch J, Lowe VJ, Neureiter J, Pink A, Roberts RO, Mielke MM, Vemuri P, Stokin GB, Christianson TJ, Jack CR, Knopman DS, Boeve BF, Kremers WK, Petersen RC, Geda YE. Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging. Int Psychogeriatr. 2018 Feb; 30 (2):245-251 Epub 2017 Dec 04
    View PubMed
  368. Utianski RL, Whitwell JL, Schwarz CG, Senjem ML, Tosakulwong N, Duffy JR, Clark HM, Machulda MM, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA. Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech. Cortex. 2018 Feb; 99:358-374 Epub 2018 Jan 02
    View PubMed
  369. Owens TE, Machulda MM, Duffy JR, Strand EA, Clark HM, Boland S, Martin PR, Lowe VJ, Jack CR, Whitwell JL, Josephs KA. Patterns of neuropsychological dysfunction and cortical volume changes in logopenic aphasia Journal Of Alzheimers Disease. 2018; 66 (3):1015-25
  370. Nedelska Z, Senjem ML, Przybelski SA, Lesnick TG, Lowe VJ, Boeve BF, Arani A, Vemuri P, Graff-Radford J, Ferman TJ, Jones DT, Savica R, Knopman DS, Petersen RC, Jack CR, Kantarci K. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET. Neuroimage Clin. 2018; 19:939-947 Epub 2018 June 19
    View PubMed
  371. Ramanan VK, Przybelski SA, Graff-Radford J, Castillo AM, Lowe VJ, Mielke MM, Roberts RO, Reid RI, Knopman DS, Jack CR, Petersen RC, Vemuri P. Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults. J Alzheimers Dis. 2018; 65 (4):1345-1352
    View PubMed
  372. Lowe VJ, Bruinsma TJ, Min HK, Lundt ES, Fang P, Senjem ML, Boeve BF, Josephs KA, Pandey MK, Murray ME, Kantarci K, Jones DT, Schwarz CG, Knopman DS, Petersen RC, Jack CR Jr. Elevated medial temporal lobe and pervasive brain tau-PET signal in normal participants. Alzheimers Dement (Amst). 2018; 10:210-216 Epub 2018 Feb 07
    View PubMed
  373. Johnson DR, Hunt CH, Nathan MA, Parisi JE, Boeve BF, Murray ME, Knopman DS, Jack CR Jr, Petersen RC, Lowe VJ, Johnson GB. Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors. J Neurooncol. 2018 Jan; 136 (2):373-378 Epub 2017 Nov 08
    View PubMed
  374. Robinson MM, Lowe VJ, Nair KS. Increased Brain Glucose Uptake After 12 Weeks of Aerobic High-Intensity Interval Training in Young and Older Adults. J Clin Endocrinol Metab. 2018 Jan 1; 103 (1):221-227
    View PubMed
  375. Evans JD, Jethwa KR, Ost P, Williams S, Kwon ED, Lowe VJ, Davis BJ. Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease. Pract Radiat Oncol. 2018 Jan - Feb; 8 (1):28-39 Epub 2017 July 20
    View PubMed
  376. Tetzloff KA, Duffy JR, Clark HM, Strand EA, Machulda MM, Schwarz CG, Senjem ML, Reid RI, Spychalla AJ, Tosakulwong N, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell JL. Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia. Brain. 2018 Jan 1; 141 (1):302-317
    View PubMed
  377. Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF, Josephs KA, Fang P, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, Machulda MM, Mielke MM, Roberts RO, Knopman DS, Petersen RC, Jack CR Jr. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. Brain. 2018 Jan 1; 141 (1):271-287
    View PubMed
  378. Bruinsma TJ, Sarma VV, Oh Y, Jang DP, Chang SY, Worrell GA, Lowe VJ, Jo HJ, Min HK. The Relationship Between Dopamine Neurotransmitter Dynamics and the Blood-Oxygen-Level-Dependent (BOLD) Signal: A Review of Pharmacological Functional Magnetic Resonance Imaging. Front Neurosci. 2018; 12:238 Epub 2018 Apr 10
    View PubMed
  379. Tetzloff KA, Graff-Radford J, Martin PR, Tosakulwong N, Machulda MM, Duffy JR, Clark HM, Senjem ML, Schwarz CG, Spychalla AJ, Drubach DA, Jack CR, Lowe VJ, Josephs KA, Whitwell JL. Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease. J Alzheimers Dis. 2018; 62(4):1713-1724.
    View PubMed
  380. Townley RA, Botha H, Graff-Radford J, Boeve BF, Petersen RC, Senjem ML, Knopman DS, Lowe V, Jack CR Jr, Jones DT. (18)F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus. Neuroimage Clin. 2018; 18:897-902 Epub 2018 Feb 28
    View PubMed
  381. Vassilaki M, Aakre JA, Syrjanen JA, Mielke MM, Geda YE, Kremers WK, Machulda MM, Alhurani RE, Staubo SC, Knopman DS, Petersen RC, Lowe VJ, Jack CR, Roberts RO. Mediterranean Diet, Its Components, and Amyloid Imaging Biomarkers. J Alzheimers Dis. 2018; 64 (1):281-290
    View PubMed
  382. Bruinsma TJ, Johnson DR, Fang P, Senjem M, Josephs KA, Whitwell JL, Boeve BF, Pandey MK, Kantarci K, Jones DT, Vemuri P, Murray M, Graff-Radford J, Schwarz CG, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ. Uptake of AV-1451 in meningiomas. Ann Nucl Med. 2017 Dec; 31 (10):736-743 Epub 2017 Sept 08
    View PubMed
  383. Botha H, Finch NA, Gavrilova RH, Machulda MM, Fields JA, Lowe VJ, Petersen RC, Jack CR Jr, Dheel CM, Gearhart DJ, Knopman DS, Rademakers R, Boeve BF. Novel GRN mutation presenting as an aphasic dementia and evolving into corticobasal syndrome. Neurol Genet. 2017 Dec; 3 (6):e201 Epub 2017 Dec 11
    View PubMed
  384. Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML, Botha H, Kantarci K, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr. Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum. Cortex. 2017 Dec; 97:143-159 Epub 2017 Oct 03
    View PubMed
  385. Pichler M, Vemuri P, Rabinstein AA, Aakre J, Flemming KD, Brown RD Jr, Kumar N, Kantarci K, Kremers W, Mielke MM, Knopman DS, Jack CR Jr, Petersen RC, Lowe V, Graff-Radford J. Prevalence and Natural History of Superficial Siderosis: A Population-Based Study. Stroke. 2017 Dec; 48 (12):3210-3214 Epub 2017 Oct 25
    View PubMed
  386. Dispenzieri A, Tong C, LaPlant B, Lacy MQ, Laumann K, Dingli D, Zhou Y, Federspiel MJ, Gertz MA, Hayman S, Buadi F, O'Connor M, Lowe VJ, Peng KW, Russell SJ. Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma. Leukemia. 2017 Dec; 31 (12):2791-2798 Epub 2017 Apr 25
    View PubMed
  387. Roberts RO, Knopman DS, Syrjanen JA, Aakre JA, Vassilaki M, Kremers WK, Mielke MM, Machulda MM, Graff-Radford J, Geda YE, Vemuri P, Lowe V, Jack CR Jr, Petersen RC. Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers. Neurology. 2017 Nov 14; 89 (20):2039-2048 Epub 2017 Oct 13
    View PubMed
  388. Zeydan B, Deelchand DK, Tosakulwong N, Lesnick TG, Kantarci OH, Machulda MM, Knopman DS, Lowe VJ, Jack CR Jr, Petersen RC, Oz G, Kantarci K. Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study. J Neuroimaging. 2017 Nov; 27 (6):630-636 Epub 2017 June 29
    View PubMed
  389. Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Lowe VJ, Graff-Radford J, Roberts RO, Mielke MM, Machulda MM, Petersen RC, Jack CR Jr. Age, vascular health, and Alzheimer disease biomarkers in an elderly sample. Ann Neurol. 2017 Nov; 82 (5):706-718 Epub 2017 Oct 26
    View PubMed
  390. Jiang H, Schmit NR, Koenen AR, Bansal A, Pandey MK, Glynn RB, Kemp BJ, Delaney KL, Dispenzieri A, Bakkum-Gamez JN, Peng KW, Russell SJ, Gunderson TM, Lowe VJ, DeGrado TR. Safety, pharmacokinetics, metabolism and radiation dosimetry of (18)F-tetrafluoroborate ((18)F-TFB) in healthy human subjects. EJNMMI Res. 2017 Oct 27; 7 (1):90
    View PubMed
  391. Nedelska Z, Przybelski SA, Lesnick TG, Schwarz CG, Lowe VJ, Machulda MM, Kremers WK, Mielke MM, Roberts RO, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K. (1)H-MRS metabolites and rate of beta-amyloid accumulation on serial PET in clinically normal adults. Neurology. 2017 Sep 26; 89 (13):1391-1399 Epub 2017 Aug 25
    View PubMed
  392. Leon-Ferre RA, Kottschade LA, Block MS, McWilliams RR, Dronca RS, Creagan ET, Allred JB, Lowe VJ, Markovic SN. Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma. Melanoma Res. 2017 Aug; 27 (4):335-341
    View PubMed
  393. Schwarz CG, Jones DT, Gunter JL, Lowe VJ, Vemuri P, Senjem ML, Petersen RC, Knopman DS, Jack CR Jr, Alzheimer's Disease Neuroimaging Initiative. Contributions of imprecision in PET-MRI rigid registration to imprecision in amyloid PET SUVR measurements. Hum Brain Mapp. 2017 Jul; 38 (7):3323-3336 Epub 2017 Apr 22
    View PubMed
  394. Xu M, Bradley EW, Weivoda MM, Hwang SM, Pirtskhalava T, Decklever T, Curran GL, Ogrodnik M, Jurk D, Johnson KO, Lowe V, Tchkonia T, Westendorf JJ, Kirkland JL. Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice. J Gerontol A Biol Sci Med Sci. 2017 Jun 1; 72 (6):780-785
    View PubMed
  395. Vemuri P, Knopman DS, Lesnick TG, Przybelski SA, Mielke MM, Graff-Radford J, Murray ME, Roberts RO, Vassilaki M, Lowe VJ, Machulda MM, Jones DT, Petersen RC, Jack CR Jr. Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals. JAMA Neurol. 2017 Jun 1; 74 (6):718-726
    View PubMed
  396. Vassilaki M, Christianson TJ, Mielke MM, Geda YE, Kremers WK, Machulda MM, Knopman DS, Petersen RC, Lowe VJ, Jack CR Jr, Roberts RO. Neuroimaging biomarkers and impaired olfaction in cognitively normal individuals. Ann Neurol. 2017 Jun; 81 (6):871-882 Epub 2017 June 09
    View PubMed
  397. Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Knopman DS, Lowe V, Vemuri P, Mielke MM, Roberts RO, Machulda MM, Senjem ML, Gunter JL, Rocca WA, Petersen RC. Age-specific and sex-specific prevalence of cerebral beta-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study. Lancet Neurol. 2017 Jun; 16 (6):435-444 Epub 2017 Apr 26
    View PubMed
  398. Josephs KA, Murray ME, Tosakulwong N, Whitwell JL, Knopman DS, Machulda MM, Weigand SD, Boeve BF, Kantarci K, Petrucelli L, Lowe VJ, Jack CR Jr, Petersen RC, Parisi JE, Dickson DW. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). Acta Neuropathol. 2017 May; 133 (5):705-715 Epub 2017 Feb 03
    View PubMed
  399. Whitwell JL, Graff-Radford J, Singh TD, Drubach DA, Senjem ML, Spychalla AJ, Tosakulwong N, Lowe VJ, Josephs KA. (18)F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies. J Nucl Med. 2017 Apr; 58 (4):632-638 Epub 2016 Sept 29
    View PubMed
  400. Parker WP, Davis BJ, Park SS, Olivier KR, Choo R, Nathan MA, Lowe VJ, Welch TJ, Evans JD, Harmsen WS, Zaid HB, Sobol I, Moreira DM, Haloi R, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes RJ, Kwon ED. Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease. Eur Urol. 2017 Mar; 71 (3):340-348 Epub 2016 Sept 03
    View PubMed
  401. Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Gunter JL, Senjem ML, Jones DT, Kantarci K, Machulda MM, Mielke MM, Roberts RO, Vemuri P, Reyes DA, Petersen RC. Defining imaging biomarker cut points for brain aging and Alzheimer's disease. Alzheimers Dement. 2017 Mar; 13 (3):205-216 Epub 2016 Sept 30
    View PubMed
  402. Parker WP, Evans JD, Stish BJ, Park SS, Olivier K, Choo R, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ, Davis BJ. Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography. Int J Radiat Oncol Biol Phys. 2017 Mar 1; 97 (3):526-535 Epub 2016 Nov 17
    View PubMed
  403. Whitwell JL, Lowe VJ, Tosakulwong N, Weigand SD, Senjem ML, Schwarz CG, Spychalla AJ, Petersen RC, Jack CR Jr, Josephs KA. [(18) F]AV-1451 tau positron emission tomography in progressive supranuclear palsy. Mov Disord. 2017 Jan; 32 (1):124-133 Epub 2016 Oct 27
    View PubMed
  404. Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, Spychalla AJ, Gunter JL, Fields JA, Graff-Radford J, Ferman TJ, Jones DT, Murray ME, Knopman DS, Jack CR Jr, Petersen RC. AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann Neurol. 2017 Jan; 81 (1):58-67 Epub 2016 Dec 19
    View PubMed
  405. Schwarz CG, Senjem ML, Gunter JL, Tosakulwong N, Weigand SD, Kemp BJ, Spychalla AJ, Vemuri P, Petersen RC, Lowe VJ, Jack CR Jr. Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE. Neuroimage. 2017 Jan 1; 144 (Pt A):113-127 Epub 2016 Aug 27
    View PubMed
  406. Sobol I, Zaid HB, Haloi R, Mynderse LA, Froemming AT, Lowe VJ, Davis BJ, Kwon ED, Karnes RJ. Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with (11)C-Choline Positron Emission Tomography and Multiparametric Magnetic Resonance Imaging. J Urol. 2017 Jan; 197 (1):129-134 Epub 2016 July 20
    View PubMed
  407. Machulda MM, Hagen CE, Wiste HJ, Mielke MM, Knopman DS, Roberts RO, Vemuri P, Lowe VJ, Jack CR Jr, Petersen RC. [Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status. Clin Neuropsychol. 2017 Jan; 31 (1):99-117 Epub 2016 Oct 11
    View PubMed
  408. Krishnan K, Machulda MM, Whitwell JL, Butts AM, Duffy JR, Strand EA, Senjem ML, Spychalla AJ, Jack CR, Lowe VJ, Josephs KA. Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity. J Alzheimers Dis. 2017; 55 (3):1019-1029
    View PubMed
  409. Sobol I, Zaid HB, Haloi R, Mynderse LA, Froemming AT, Lowe VJ, Davis BJ, Kwon ED, Karnes RJ. Contemporary mapping of post-prostatectomy prostate cancer relapse with c-11-choline positron emission tomography and multiparametric magnetic resonance imaging Journal Of Urology. 2017 Jan; 197(1):129-34. Epub 1900 Jan 01.
  410. Schwarz CG, Senjem ML, Gunter JL, Kemp BJ, Spychalla AJ, Vemuri P, Lowe VJ, Jack CR Jr, Senjem ML, Gunter JL, Tosakulwong N, Weigand SD, Petersen RC. Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE NeuroImage. 2017; 144:113-27.
  411. Lowe VJ, Lundt E, Knopman D, Senjem ML, Gunter JL, Schwarz CG, Kemp BJ, Jack CR Jr, Petersen RC. Comparison of [(18)F]Flutemetamol and [(11)C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals. Neuroimage Clin. 2017; 16:295-302 Epub 2017 Aug 14
    View PubMed
  412. Nagelschneider AA, Broski SM, Holland WP, Midthun DE, Sykes AM, Lowe VJ, Peller PJ, Johnson GB. The flip-flop fungus sign: an FDG PET/CT sign of benignity. Am J Nucl Med Mol Imaging. 2017; 7 (5):212-217 Epub 2017 Nov 01
    View PubMed
  413. Vemuri P, Lowe VJ, Knopman DS, Senjem ML, Kemp BJ, Schwarz CG, Przybelski SA, Machulda MM, Petersen RC, Jack CR Jr. Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition. Alzheimers Dement (Amst). 2017; 6:21-30 Epub 2016 Dec 21
    View PubMed
  414. Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, Spychalla AJ, Gunter JL, Fields JA, Graff-Radford J, Ferman TJ, Jones DT, Murray ME, Knopman DS, Jack CR Jr, Petersen RC. AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies Annals of Neurology. 2017 Jan; 81: (1)58-67.
  415. Wiepert DA, Lowe VJ, Knopman DS, Boeve BF, Graff-Radford J, Petersen RC, Jack CR Jr, Jones DT. A robust biomarker of large-scale network failure in Alzheimer's disease. Alzheimers Dement (Amst). 2017; 6:152-161 Epub 2017 Jan 25
    View PubMed
  416. Evangelista L, Zattoni F, Karnes RJ, Novara G, Lowe V. Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: a systematic review and meta-analysis. Nucl Med Commun. 2016 Dec; 37 (12):1223-1231
    View PubMed
  417. Labbé C, Heckman MG, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Murray ME, Allen M, Uitti RJ, Wszolek ZK, Smith GE, Kantarci K, Knopman DS, Lowe VJ, Jack CR Jr, Ertekin-Taner N, Hassan A, Savica R, Petersen RC, Parisi JE, Maraganore DM, Graff-Radford NR, Ferman TJ, Boeve BF, Dickson DW, Ross OA. MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies. Alzheimers Dement. 2016 Dec; 12(12):1297-1304. Epub 2016 Jun 07.
    View PubMed
  418. Zattoni F, Nehra A, Murphy CR, Rangel L, Mynderse L, Lowe V, Kwon E, Karnes RJ. Mid-term Outcomes Following Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Status Post-radical Prostatectomy. Eur Urol Focus. 2016 Dec; 2 (5):522-531 Epub 2016 Feb 10
    View PubMed
  419. McLaren RH, Mynderse LA, Davis BJ, Kwon ED, Lowe VJ, Nathan MA, Karnes R, Parker WP. The Utility of C11 Choline PET/CT in Post-prostatectomy Patients with Biochemical Recurrence: a Comparison to mpMRI. World Jnl of Urol.2016;().
  420. Shmidt E, Nehra V, Lowe V, Oxentenko AS. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study. BMC Gastroenterol. 2016 Oct 6; 16 (1):125 Epub 2016 Oct 06
    View PubMed
  421. Sarro L, Senjem ML, Lundt ES, Przybelski SA, Lesnick TG, Graff-Radford J, Boeve BF, Lowe VJ, Ferman TJ, Knopman DS, Comi G, Filippi M, Petersen RC, Jack CR Jr, Kantarci K. Amyloid-beta deposition and regional grey matter atrophy rates in dementia with Lewy bodies. Brain. 2016 Oct; 139 (Pt 10):2740-2750 Epub 2016 July 24
    View PubMed
  422. Knopman DS, Jack CR Jr, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC. Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum. Neurobiol Aging. 2016 Oct; 46:32-42 Epub 2016 June 16
    View PubMed
  423. Heckman MG, Soto-Ortolaza AI, Contreras MYS, Murray ME, Pedraza O, Diehl NN, Walton R, Labbé C, Lorenzo-Betancor O, Uitti RJ, van Gerpen J, Ertekin-Taner N, Smith GE, Kantarci K, Savica R, Jones DT, Graff-Radford J, Knopman DS, Lowe VJ, Jack CR Jr, Petersen RC, Parisi JE, Rademakers R, Wszolek ZK, Graff-Radford NR, Ferman TJ, Dickson DW, Boeve BF, Ross OA. LRRK2 variation and dementia with Lewy bodies. Parkinsonism Relat Disord. 2016 Oct; 31:98-103. Epub 2016 Jul 29.
    View PubMed
  424. Hodges K, Brewer SS, Labbé C, Soto-Ortolaza AI, Walton RL, Strongosky AJ, Uitti RJ, van Gerpen JA, Ertekin-Taner N, Kantarci K, Lowe VJ, Parisi JE, Savica R, Graff-Radford J, Jones DT, Knopman DS, Petersen RC, Murray ME, Graff-Radford NR, Ferman TJ, Dickson DW, Wszolek ZK, Boeve BF, Ross OA, Lorenzo-Betancor O. RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies. Neurobiol Aging. 2016 Sep; 45:107-108. Epub 2016 Mar 24.
    View PubMed
  425. Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC. Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia. Neurology. 2016 Aug 16; 87 (7):691-8 Epub 2016 July 15
    View PubMed
  426. Walton RL, Soto-Ortolaza AI, Murray ME, Lorenzo-Betancor O, Ogaki K, Heckman MG, Rayaprolu S, Rademakers R, Ertekin-Taner N, Uitti RJ, van Gerpen JA, Wszolek ZK, Smith GE, Kantarci K, Lowe VJ, Parisi JE, Jones DT, Savica R, Graff-Radford J, Knopman DS, Petersen RC, Graff-Radford NR, Ferman TJ, Dickson DW, Boeve BF, Ross OA, Labbé C. TREM2 p.R47H substitution is not associated with dementia with Lewy bodies. Neurol Genet. 2016 Aug; 2(4):e85. Epub 2016 Jul 14.
    View PubMed
  427. Krell-Roesch J, Ruider H, Lowe VJ, Stokin GB, Pink A, Roberts RO, Mielke MM, Knopman DS, Christianson TJ, Machulda MM, Jack CR, Petersen RC, Geda YE. FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging. J Alzheimers Dis. 2016 Jul 14; 53 (4):1609-16
    View PubMed
  428. Lowe VJ, Curran G, Fang P, Liesinger AM, Josephs KA, Parisi JE, Kantarci K, Boeve BF, Pandey MK, Bruinsma T, Knopman DS, Jones DT, Petrucelli L, Cook CN, Graff-Radford NR, Dickson DW, Petersen RC, Jack CR Jr, Murray ME. An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun. 2016 Jun 13; 4 (1):58 Epub 2016 June 13
    View PubMed
  429. Vassilaki M, Aakre JA, Mielke MM, Geda YE, Kremers WK, Alhurani RE, Machulda MM, Knopman DS, Petersen RC, Lowe VJ, Jack CR Jr, Roberts RO. Multimorbidity and neuroimaging biomarkers among cognitively normal persons. Neurology. 2016 May 31; 86 (22):2077-84 Epub 2016 Apr 13
    View PubMed
  430. Kantarci K, Lowe VJ, Lesnick TG, Tosakulwong N, Bailey KR, Fields JA, Shuster LT, Zuk SM, Senjem ML, Mielke MM, Gleason C, Jack CR, Rocca WA, Miller VM. Early Postmenopausal Transdermal 17beta-Estradiol Therapy and Amyloid-beta Deposition. J Alzheimers Dis. 2016 May 7; 53 (2):547-56
    View PubMed
  431. Raman MR, Schwarz CG, Murray ME, Lowe VJ, Dickson DW, Jack CR Jr, Kantarci K. An MRI-Based Atlas for Correlation of Imaging and Pathologic Findings in Alzheimer's Disease. J Neuroimaging. 2016 May; 26 (3):264-8 Epub 2016 Mar 28
    View PubMed
  432. Graff-Radford J, Madhavan M, Vemuri P, Rabinstein AA, Cha RH, Mielke MM, Kantarci K, Lowe V, Senjem ML, Gunter JL, Knopman DS, Petersen RC, Jack CR Jr, Roberts RO. Atrial fibrillation, cognitive impairment, and neuroimaging. Alzheimers Dement. 2016 Apr; 12 (4):391-8 Epub 2015 Oct 23
    View PubMed
  433. Tobin WO, Popescu BF, Lowe V, Pirko I, Parisi JE, Kantarci K, Fields JA, Bruns MB, Boeve BF, Lucchinetti CF. Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings. Mult Scler. 2016 Apr; 22 (5):698-704 Epub 2015 Oct 07
    View PubMed
  434. Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Machulda M, Lowe VJ, Mielke MM, Roberts RO, Gunter JL, Senjem ML, Geda YE, Rocca WA, Petersen RC, Jack CR Jr. Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study. Neurology. 2016 Mar 22; 86 (12):1128-35 Epub 2016 Feb 24
    View PubMed
  435. Mielke MM, Machulda MM, Hagen CE, Christianson TJ, Roberts RO, Knopman DS, Vemuri P, Lowe VJ, Kremers WK, Jack CR Jr, Petersen RC. Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort. Alzheimers Dement. 2016 Mar; 12 (3):281-91 Epub 2015 Nov 19
    View PubMed
  436. Jung Y, Whitwell JL, Duffy JR, Strand EA, Machulda MM, Senjem ML, Jack CR, Lowe VJ, Josephs KA. Regional beta-amyloid burden does not correlate with cognitive or language deficits in Alzheimer's disease presenting as aphasia. Eur J Neurol. 2016 Feb; 23 (2):313-9 Epub 2015 June 23
    View PubMed
  437. Whitwell JL, Weigand SD, Duffy JR, Strand EA, Machulda MM, Senjem ML, Gunter JL, Lowe VJ, Jack CR Jr, Josephs KA. Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech. Neuroimage Clin. 2016; 11:90-98 Epub 2016 Jan 20
    View PubMed
  438. Kalari KR, Thompson KJ, Nair AA, Tang X, Bockol MA, Jhawar N, Swaminathan SK, Lowe VJ, Kandimalla KK. BBBomics-Human Blood Brain Barrier Transcriptomics Hub. Front Neurosci. 2016; 10:71 Epub 2016 Mar 01
    View PubMed
  439. Petersen RC, Wiste HJ, Weigand SD, Rocca WA, Roberts RO, Mielke MM, Lowe VJ, Knopman DS, Pankratz VS, Machulda MM, Geda YE, Jack CR Jr. Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community. JAMA Neurol. 2016 Jan; 73 (1):85-92
    View PubMed
  440. Jack CR Jr, Therneau TM, Wiste HJ, Weigand SD, Knopman DS, Lowe VJ, Mielke MM, Vemuri P, Roberts RO, Machulda MM, Senjem ML, Gunter JL, Rocca WA, Petersen RC. Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study. Lancet Neurol. 2016 Jan; 15 (1):56-64 Epub 2015 Nov 18
    View PubMed
  441. Welle CL, Cullen EL, Peller PJ, Lowe VJ, Murphy RC, Johnson GB, Binkovitz LA. (1)(1)C-Choline PET/CT in Recurrent Prostate Cancer and Nonprostatic Neoplastic Processes. Radiographics. 2016 Jan-Feb; 36 (1):279-92
    View PubMed
  442. Madhavan A, Schwarz CG, Duffy JR, Strand EA, Machulda MM, Drubach DA, Kantarci K, Przybelski SA, Reid RI, Senjem ML, Gunter JL, Apostolova LG, Lowe VJ, Petersen RC, Jack CR, Josephs KA, Whitwell JL. Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study. J Alzheimers Dis. 2016; 49 (3):633-43
    View PubMed
  443. Camp JJ, Hanson DP, Lowe VJ, Kemp BJ, Senjem ML, Murray ME, Dickson DW, Parisi JE, Petersen RC, Robb RA, Holmes DR III. Quantitative characterization of brain beta-amyloid in 718 normal subjects using a joint PiB/FDG PET image histogram Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2016; 9785:97852V.
  444. DeGrado TR, Kemp BJ, Pandey MK, Jiang H, Gunderson TM, Linscheid LR, Woodwick AR, McConnell DM, Fletcher JG, Johnson GB, Petersen RC, Knopman DS, Lowe VJ. First PET Imaging Studies With 63Zn-Zinc Citrate in Healthy Human Participants and Patients With Alzheimer Disease. Mol Imaging. 2016; 15 Epub 2016 Dec 09
    View PubMed
  445. Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Mielke MM, Vemuri P, Lowe V, Senjem ML, Gunter JL, Reyes D, Machulda MM, Roberts R, Petersen RC. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings. Brain. 2015 Dec; 138 (Pt 12):3747-59 Epub 2015 Sept 30
    View PubMed
  446. Knopman DS, Jack CR Jr, Lundt ES, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC. Role of beta-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment. JAMA Neurol. 2015 Dec; 72 (12):1475-83
    View PubMed
  447. Flanagan EP, Kotsenas AL, Britton JW, McKeon A, Watson RE, Klein CJ, Boeve BF, Lowe V, Ahlskog JE, Shin C, Boes CJ, Crum BA, Laughlin RS, Pittock SJ. Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflamm. 2015 Dec; 2 (6):e161 Epub 2015 Oct 01
    View PubMed
  448. Mondal S, Roy D, Camacho-Pereira J, Khurana A, Chini E, Yang L, Baddour J, Stilles K, Padmabandu S, Leung S, Kalloger S, Gilks B, Lowe V, Dierks T, Hammond E, Dredge K, Nagrath D, Shridhar V. HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer. Oncotarget. 2015 Oct 20; 6 (32):33705-19
    View PubMed
  449. Botha H, Duffy JR, Whitwell JL, Strand EA, Machulda MM, Schwarz CG, Reid RI, Spychalla AJ, Senjem ML, Jones DT, Lowe V, Jack CR, Josephs KA. Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech. Cortex. 2015 Aug; 69:220-36 Epub 2015 May 27
    View PubMed
  450. Singh TD, Josephs KA, Machulda MM, Drubach DA, Apostolova LG, Lowe VJ, Whitwell JL. Clinical, FDG and amyloid PET imaging in posterior cortical atrophy. J Neurol. 2015 Jun; 262 (6):1483-92 Epub 2015 Apr 11
    View PubMed
  451. Vemuri P, Senjem ML, Gunter JL, Lundt ES, Tosakulwong N, Weigand SD, Borowski BJ, Bernstein MA, Zuk SM, Lowe VJ, Knopman DS, Petersen RC, Fox NC, Thompson PM, Weiner MW, Jack CR Jr, Alzheimer's Disease Neuroimaging Initiative. Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease. Neuroimage. 2015 Jun; 113:61-9. Epub 2015 Mar 20.
    View PubMed
  452. Nedelska Z, Schwarz CG, Boeve BF, Lowe VJ, Reid RI, Przybelski SA, Lesnick TG, Gunter JL, Senjem ML, Ferman TJ, Smith GE, Geda YE, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K. White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging. Neurobiol Aging. 2015 Jun; 36 (6):2010-7 Epub 2015 Mar 14
    View PubMed
  453. Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Vemuri P, Mielke MM, Lowe V, Senjem ML, Gunter JL, Machulda MM, Gregg BE, Pankratz VS, Rocca WA, Petersen RC. Age, Sex, and APOE epsilon4 Effects on Memory, Brain Structure, and beta-Amyloid Across the Adult Life Span. JAMA Neurol. 2015 May; 72 (5):511-9
    View PubMed
  454. Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, Rawal B, Parisi JE, Petersen RC, Kantarci K, Ross OA, Duara R, Knopman DS, Jack CR Jr, Dickson DW. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum. Brain. 2015 May; 138 (Pt 5):1370-81 Epub 2015 Mar 23
    View PubMed
  455. Whitwell JL, Duffy JR, Strand EA, Machulda MM, Senjem ML, Schwarz CG, Reid R, Baker MC, Perkerson RB, Lowe VJ, Rademakers R, Jack CR Jr, Josephs KA. Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia. Brain Lang. 2015 Mar; 142:45-53 Epub 2015 Feb 03
    View PubMed
  456. Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Preboske GM, Kantarci K, Raman MR, Machulda MM, Mielke MM, Lowe VJ, Senjem ML, Gunter JL, Rocca WA, Roberts RO, Petersen RC, Jack CR Jr. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain. 2015 Mar; 138 (Pt 3):761-71 Epub 2015 Jan 15
    View PubMed
  457. Evangelista L, Zattoni F, Rossi E, Karnes RJ, Lowe V. Early detection of prostate cancer relapse by biochemistry and diagnostic imaging. Q J Nucl Med Mol Imaging. 2015; 59(4):359-73.
    View PubMed
  458. Kemp BJ, Peterson WT, Uribe J, Williams JJ, Lowe VJ, Stearns CW. Performance measurements of a PET/CT system with prototype SiPM detectors 2015 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2015. 2015; 7582091.
  459. Whitwell JL, Kantarci K, Weigand SD, Lundt ES, Gunter JL, Duffy JR, Strand EA, Machulda MM, Spychalla AJ, Drubach DA, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA. Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type. J Alzheimers Dis. 2015; 45(4):1109-17.
    View PubMed
  460. Karnes RJ, Murphy CR, Bergstralh EJ, DiMonte G, Cheville JC, Lowe VJ, Mynderse LA, Kwon ED. Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography. J Urol. 2015 Jan; 193 (1):111-6 Epub 2014 Aug 20
    View PubMed
  461. Karantanis D, Kalkanis D, Czernin J, Herrmann K, Pomykala KL, Bogsrud TV, Subramaniam RM, Lowe VJ, Allen-Auerbach MS. Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physicians. J Nucl Med. 2014 Dec; 55 (12):1925-9 Epub 2014 Nov 07
    View PubMed
  462. Kantarci K, Schwarz CG, Reid RI, Przybelski SA, Lesnick TG, Zuk SM, Senjem ML, Gunter JL, Lowe V, Machulda MM, Knopman DS, Petersen RC, Jack CR Jr. White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration. JAMA Neurol. 2014 Dec; 71 (12):1547-54
    View PubMed
  463. Tobin WO, Strand EA, Clark HM, Lowe VJ, Robertson CE, Pittock SJ. NMDA receptor encephalitis causing reversible caudate changes on MRI and PET imaging. Neurol Clin Pract. 2014 Dec; 4 (6):470-473
    View PubMed
  464. Kottschade LA, Grotz TE, Dronca RS, Salomao DR, Pulido JS, Wasif N, Jakub JW, Bagaria SP, Kumar R, Kaur JS, Morita SY, Moran SL, Nguyen JT, Nguyen EC, Hand JL, Erickson LA, Brewer JD, Baum CL, Miller RC, Swanson DL, Lowe V, Markovic SN. Rare presentations of primary melanoma and special populations: a systematic review. Am J Clin Oncol. 2014 Dec; 37 (6):635-41
    View PubMed
  465. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Lowe VJ, Jack CR Jr, Whitwell JL. APOE epsilon4 influences beta-amyloid deposition in primary progressive aphasia and speech apraxia. Alzheimers Dement. 2014 Nov; 10 (6):630-6 Epub 2014 June 28
    View PubMed
  466. Mielke MM, Weigand SD, Wiste HJ, Vemuri P, Machulda MM, Knopman DS, Lowe V, Roberts RO, Kantarci K, Rocca WA, Jack CR Jr, Petersen RC. Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging. Alzheimers Dement. 2014 Nov; 10 (6):779-89 Epub 2014 Nov 15
    View PubMed
  467. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Gunter JL, Schwarz CG, Reid RI, Spychalla AJ, Lowe VJ, Jack CR Jr, Whitwell JL. The evolution of primary progressive apraxia of speech. Brain. 2014 Oct; 137 (Pt 10):2783-95 Epub 2014 Aug 11
    View PubMed
  468. Jack CR Jr, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Mielke MM, Lowe VJ, Senjem ML, Gunter JL, Preboske GM, Pankratz VS, Vemuri P, Petersen RC. Age-specific population frequencies of cerebral beta-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study. Lancet Neurol. 2014 Oct; 13 (10):997-1005 Epub 2014 Sept 04
    View PubMed
  469. Broski SM, Hunt CH, Johnson GB, Morreale RF, Lowe VJ, Peller PJ. Structural and functional imaging in parkinsonian syndromes. Radiographics. 2014 Sep-Oct; 34 (5):1273-92
    View PubMed
  470. Knopman DS, Jack CR Jr, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Neurobiol Aging. 2014 Sep; 35 (9):2096-106 Epub 2014 Mar 11
    View PubMed
  471. Graff-Radford J, Murray ME, Lowe VJ, Boeve BF, Ferman TJ, Przybelski SA, Lesnick TG, Senjem ML, Gunter JL, Smith GE, Knopman DS, Jack CR Jr, Dickson DW, Petersen RC, Kantarci K. Dementia with Lewy bodies: basis of cingulate island sign. Neurology. 2014 Aug 26; 83 (9):801-9 Epub 2014 July 23
    View PubMed
  472. DeGrado TR, Pandey MK, Byrne JF, Engelbrecht HP, Jiang H, Packard AB, Thomas KA, Jacobson MS, Curran GL, Lowe VJ. Preparation and preliminary evaluation of 63Zn-zinc citrate as a novel PET imaging biomarker for zinc. J Nucl Med. 2014 Aug; 55(8):1348-54. Epub 2014 Jul 21.
    View PubMed
  473. Agyare EK, Jaruszewski KM, Curran GL, Rosenberg JT, Grant SC, Lowe VJ, Ramakrishnan S, Paravastu AK, Poduslo JF, Kandimalla KK. Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits. J Control Release. 2014 Jul 10; 185:121-9 Epub 2014 Apr 13
    View PubMed
  474. Jung Y, Whitwell JL, Duffy JR, Strand EA, Machulda MM, Senjem ML, Lowe V, Jack CR Jr, Josephs KA. Amyloid burden correlates with cognitive decline in Alzheimer's disease presenting with aphasia. Eur J Neurol. 2014 Jul; 21 (7):1040-3 Epub 2013 Dec 16
    View PubMed
  475. Russell SJ, Federspiel MJ, Peng KW, Tong C, Dingli D, Morice WG, Lowe V, O'Connor MK, Kyle RA, Leung N, Buadi FK, Rajkumar SV, Gertz MA, Lacy MQ, Dispenzieri A. Remission of disseminated cancer after systemic oncolytic virotherapy. Mayo Clin Proc. 2014 Jul; 89 (7):926-33 Epub 2014 May 14
    View PubMed
  476. Lowe VJ, Weigand SD, Senjem ML, Vemuri P, Jordan L, Kantarci K, Boeve B, Jack CR Jr, Knopman D, Petersen RC. Association of hypometabolism and amyloid levels in aging, normal subjects. Neurology. 2014 Jun 3; 82 (22):1959-67 Epub 2014 May 02
    View PubMed
  477. Jack CR Jr, Wiste HJ, Knopman DS, Vemuri P, Mielke MM, Weigand SD, Senjem ML, Gunter JL, Lowe V, Gregg BE, Pankratz VS, Petersen RC. Rates of beta-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology. 2014 May 6; 82 (18):1605-12 Epub 2014 Apr 04
    View PubMed
  478. Roberts RO, Knopman DS, Cha RH, Mielke MM, Pankratz VS, Boeve BF, Kantarci K, Geda YE, Jack CR Jr, Petersen RC, Lowe VJ. Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation. J Nucl Med. 2014 May; 55 (5):759-64 Epub 2014 Mar 20
    View PubMed
  479. Zalewski N, Botha H, Whitwell J, Lowe V, Dickson D, Josephs KA. FDG-PET in Pathologically Confirmed 4R-Tauopathy Variants Neurology. 2014; 82(10):P5.251.
  480. Zalewski N, Botha H, Whitwell JL, Lowe V, Dickson DW, Josephs KA. FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants. J Neurol. 2014 Apr; 261(4):710-6. Epub 2014 Feb 04.
    View PubMed
  481. Baqir M, Lowe V, Yi ES, Ryu JH. 18F-FDG PET scanning in pulmonary amyloidosis. J Nucl Med. 2014 Apr; 55: (4)565-8.
    View PubMed
  482. Josephs KA, Duffy JR, Strand EA, Machulda MM, Vemuri P, Senjem ML, Perkerson RB, Baker MC, Lowe V, Jack CR Jr, Rademakers R, Whitwell JL. Progranulin-associated PiB-negative logopenic primary progressive aphasia. J Neurol. 2014 Mar; 261 (3):604-14 Epub 2014 Jan 22
    View PubMed
  483. Botha H, Whitwell JL, Madhaven A, Senjem ML, Lowe V, Josephs KA. The pimple sign of progressive supranuclear palsy syndrome. Parkinsonism Relat Disord. 2014 Feb; 20 (2):180-5 Epub 2013 Nov 04
    View PubMed
  484. Jaruszewski KM, Curran GL, Swaminathan SK, Rosenberg JT, Grant SC, Ramakrishnan S, Lowe VJ, Poduslo JF, Kandimalla KK. Multimodal nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain. Biomaterials. 2014 Feb; 35 (6):1967-76 Epub 2013 Dec 09
    View PubMed
  485. Mielke MM, Savica R, Wiste HJ, Weigand SD, Vemuri P, Knopman DS, Lowe VJ, Roberts RO, Machulda MM, Geda YE, Petersen RC, Jack CR Jr. Head trauma and in vivo measures of amyloid and neurodegeneration in a population-based study. Neurology. 2014 Jan 07; 82(1):70-6. Epub 2013 Dec 26.
    View PubMed
  486. Karantanis D, Kalkanis D, Allen-Auerbach MS, Herrmann K, Pomykala KL, Bogsrud TV, Lowe VJ, Czernin J. Oncologic PET/CT interpretation and reporting approaches: Survey in clinical practice. Nuklearmedizin. 2014; 53(2):19-25.
    View PubMed
  487. Sarkar G, Curran GL, Sarkaria JN, Lowe VJ, Jenkins RB. Peptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brain. PLoS One. 2014; 9 (5):e97655 Epub 2014 May 21
    View PubMed
  488. Camp JJ, Hanson DP, Holmes DR, Kemp BJ, Senjem ML, Murray ME, Dickson DW, Parisi JE, Petersen RC, Lowe VJ, Robb RA. Quantitative characterization of brain beta-amyloid using a joint PiB/FDG PET image histogram. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2014; 9035:90352A.
  489. Whitwell JL, Jack CR Jr, Duffy JR, Strand EA, Gunter JL, Senjem ML, Murphy MC, Kantarci K, Machulda MM, Lowe VJ, Josephs KA. Microbleeds in the logopenic variant of primary progressive aphasia. Alzheimers Dement. 2014 Jan; 10 (1):62-6 Epub 2013 Apr 03
    View PubMed
  490. Adeli A, Savica R, Lowe VJ, Vemuri P, Knopman DS, Dejesus-Hernandez M, Rademakers R, Fields JA, Crum BA, Jack CR, Petersen RC, Boeve BF. The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome. Neurocase. 2014; 20 (1):110-20 Epub 2012 Nov 30
    View PubMed
  491. Whitwell JL, Lowe VJ, Duffy JR, Strand EA, Machulda MM, Kantarci K, Wille SM, Senjem ML, Murphy MC, Gunter JL, Jack CR Jr, Josephs KA. Elevated occipital beta-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia. J Neurol Neurosurg Psychiatry. 2013 Dec; 84 (12):1357-64 Epub 2013 Aug 14
    View PubMed
  492. Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Lowe V, Vemuri P, Mielke MM, Jones DT, Senjem ML, Gunter JL, Gregg BE, Pankratz VS, Petersen RC. Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity. Neurology. 2013 Nov 12; 81 (20):1732-40 Epub 2013 Oct 16
    View PubMed
  493. Murray ME, Ferman TJ, Boeve BF, Przybelski SA, Lesnick TG, Liesinger AM, Senjem ML, Gunter JL, Preboske GM, Lowe VJ, Vemuri P, Dugger BN, Knopman DS, Smith GE, Parisi JE, Silber MH, Graff-Radford NR, Petersen RC, Jack CR Jr, Dickson DW, Kantarci K. MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies. Neurology. 2013 Nov 5; 81 (19):1681-9 Epub 2013 Oct 09
    View PubMed
  494. Flanagan EP, Hunt CH, Lowe V, Mandrekar J, Pittock SJ, O'Neill BP, Keegan BM. [(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy. Mayo Clin Proc. 2013 Nov; 88 (11):1204-12
    View PubMed
  495. Perez-Nievas BG, Stein TD, Tai HC, Dols-Icardo O, Scotton TC, Barroeta-Espar I, Fernandez-Carballo L, de Munain EL, Perez J, Marquie M, Serrano-Pozo A, Frosch MP, Lowe V, Parisi JE, Petersen RC, Ikonomovic MD, Lopez OL, Klunk W, Hyman BT, Gomez-Isla T. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Brain. 2013 Aug; 136(Pt 8):2510-26. Epub 2013 Jul 03.
    View PubMed
  496. Pafundi DH, Laack NN, Youland RS, Parney IF, Lowe VJ, Giannini C, Kemp BJ, Grams MP, Morris JM, Hoover JM, Hu LS, Sarkaria JN, Brinkmann DH. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study. Neuro Oncol. 2013 Aug; 15 (8):1058-67 Epub 2013 Mar 03
    View PubMed
  497. Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC. Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with beta-amyloidosis. JAMA Neurol. 2013 Aug; 70 (8):1030-8
    View PubMed
  498. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Lowe VJ, Jack CR Jr, Whitwell JL. Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA. Neurology. 2013 Jul 23; 81 (4):337-45 Epub 2013 June 26
    View PubMed
  499. Lowe VJ, Peller PJ, Weigand SD, Montoya Quintero C, Tosakulwong N, Vemuri P, Senjem ML, Jordan L, Jack CR Jr, Knopman D, Petersen RC. Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI. Neurology. 2013 Jun 4; 80 (23):2130-7 Epub 2013 May 03
    View PubMed
  500. Whitwell JL, Duffy JR, Strand EA, Xia R, Mandrekar J, Machulda MM, Senjem ML, Lowe VJ, Jack CR Jr, Josephs KA. Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: an MRI and FDG-PET study. Brain Lang. 2013 Jun; 125 (3):245-52 Epub 2013 Mar 28
    View PubMed
  501. Tabibian JH, Macura SI, O'Hara SP, Fidler JL, Glockner JF, Takahashi N, Lowe VJ, Kemp BJ, Mishra PK, Tietz PS, Splinter PL, Trussoni CE, LaRusso NF. Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography. Lab Invest. 2013 Jun; 93 (6):733-43 Epub 2013 Apr 15
    View PubMed
  502. Agyare EK, Leonard SR, Curran GL, Yu CC, Lowe VJ, Paravastu AK, Poduslo JF, Kandimalla KK. Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-beta proteins in the cerebral vasculature. Mol Pharm. 2013 May 6; 10(5):1557-65. Epub 2013 Mar 05.
    View PubMed
  503. Singh B, Stack BC Jr, Thacker S, Gaysinskiy V, Bartel T, Lowe V, Cool S, Entine G, Nagarkar V. A hand-held beta imaging probe for FDG. Ann Nucl Med. 2013 Apr; 27(3):203-8. Epub 2012 Dec 11.
    View PubMed
  504. Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC. Brain injury biomarkers are not dependent on beta-amyloid in normal elderly. Ann Neurol. 2013 Apr; 73 (4):472-80 Epub 2013 Feb 19
    View PubMed
  505. Mitchell CR, Lowe VJ, Rangel LJ, Hung JC, Kwon ED, Karnes RJ. Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment. J Urol. 2013 Apr; 189 (4):1308-13 Epub 2012 Oct 30
    View PubMed
  506. Jack CR Jr, Wiste HJ, Lesnick TG, Weigand SD, Knopman DS, Vemuri P, Pankratz VS, Senjem ML, Gunter JL, Mielke MM, Lowe VJ, Boeve BF, Petersen RC. Brain beta-amyloid load approaches a plateau. Neurology. 2013 Mar 5; 80 (10):890-6 Epub 2013 Feb 27
    View PubMed
  507. Youland RS, Kitange GJ, Peterson TE, Pafundi DH, Ramiscal JA, Pokorny JL, Giannini C, Laack NN, Parney IF, Lowe VJ, Brinkmann DH, Sarkaria JN. The role of LAT1 in (18)F-DOPA uptake in malignant gliomas. J Neurooncol. 2013 Jan; 111 (1):11-8 Epub 2012 Oct 20
    View PubMed
  508. Whitwell JL, Tosakulwong N, Weigand SD, Senjem ML, Lowe VJ, Gunter JL, Boeve BF, Knopman DS, Dickerson BC, Petersen RC, Jack CR Jr. Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects? Neuroimage Clin. 2013; 2:249-57 Epub 2013 Jan 24
    View PubMed
  509. Madhavan A, Whitwell JL, Weigand SD, Duffy JR, Strand EA, Machulda MM, Tosakulwong N, Senjem ML, Gunter JL, Lowe VJ, Petersen RC, Jack CR Jr, Josephs KA. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type. PLoS One. 2013; 8 (4):e62471 Epub 2013 Apr 23
    View PubMed
  510. Stack BC Jr, Ye J, Bartel TB, Shafirstein G, Chen C, Siegel E, Singh B, Thacker S, Lowe VJ, Nagarkar V. Orthotopic VX rabbit tongue cancer model with FDG-PET and histologic characterization. Head Neck. 2013; 35(8):1119-23.
    View PubMed
  511. Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Roberts RO, Lowe VJ, Kantarci K, Senjem ML, Gunter JL, Boeve BF, Petersen RC, Jack CR Jr. Effect of lifestyle activities on Alzheimer disease biomarkers and cognition. Ann Neurol. 2012 Nov; 72 (5):730-8
    View PubMed
  512. Mielke MM, Wiste HJ, Weigand SD, Knopman DS, Lowe VJ, Roberts RO, Geda YE, Swenson-Dravis DM, Boeve BF, Senjem ML, Vemuri P, Petersen RC, Jack CR Jr. Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology. 2012 Oct 9; 79 (15):1570-7 Epub 2012 Sept 12
    View PubMed
  513. Karantanis D, Kalkanis D, Allen-Auerbach M, Bogsrud TV, Subramaniam RM, Danielson A, Lowe VJ, Czernin J. Oncologic 18F-FDG PET/CT: referring physicians' point of view. J Nucl Med. 2012 Oct; 53(10):1499-505. Epub 2012 Aug 23.
    View PubMed
  514. Savica R, Adeli A, Vemuri P, Knopman DS, Dejesus-Hernandez M, Rademakers R, Fields JA, Whitwell J, Jack CR, Lowe V, Petersen RC, Boeve BF. Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72. Arch Neurol. 2012 Sep; 69 (9):1164-9
    View PubMed
  515. Kantarci K, Lowe VJ, Boeve BF, Weigand SD, Senjem ML, Przybelski SA, Dickson DW, Parisi JE, Knopman DS, Smith GE, Ferman TJ, Petersen RC, Jack CR Jr. Multimodality imaging characteristics of dementia with Lewy bodies. Neurobiol Aging. 2012 Sep; 33 (9):2091-105 Epub 2011 Oct 21
    View PubMed
  516. Graff-Radford J, Boeve BF, Pedraza O, Ferman TJ, Przybelski S, Lesnick TG, Vemuri P, Senjem ML, Smith GE, Knopman DS, Lowe V, Jack CR Jr, Petersen RC, Kantarci K. Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies. Brain. 2012 Aug; 135 (Pt 8):2470-7 Epub 2012 July 18
    View PubMed
  517. Lehman VT, Carter RE, Claassen DO, Murphy RC, Lowe V, Petersen RC, Peller PJ. Visual assessment versus quantitative three-dimensional stereotactic surface projection fluorodeoxyglucose positron emission tomography for detection of mild cognitive impairment and Alzheimer disease. Clin Nucl Med. 2012 Aug; 37: (8)721-6.
    View PubMed
  518. Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Lowe V, Kantarci K, Bernstein MA, Senjem ML, Gunter JL, Boeve BF, Trojanowski JQ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Knopman DS, Alzheimer's Disease Neuroimaging Initiative. Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch Neurol. 2012 Jul; 69 (7):856-67
    View PubMed
  519. Jack CR Jr, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Rocca WA, Boeve BF, Petersen RC. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol. 2012 Jun; 71 (6):765-75 Epub 2012 Apr 09
    View PubMed
  520. Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Boeve BF, Petersen RC. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. Neurology. 2012 May 15; 78 (20):1576-82 Epub 2012 May 02
    View PubMed
  521. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Master AV, Lowe VJ, Jack CR Jr, Whitwell JL. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain. 2012 May; 135 (Pt 5):1522-36 Epub 2012 Mar 01
    View PubMed
  522. Kantarci K, Yang C, Schneider JA, Senjem ML, Reyes DA, Lowe VJ, Barnes LL, Aggarwal NT, Bennett DA, Smith GE, Petersen RC, Jack CR Jr, Boeve BF. Antemortem amyloid imaging and beta-amyloid pathology in a case with dementia with Lewy bodies. Neurobiol Aging. 2012 May; 33 (5):878-85 Epub 2010 Oct 18
    View PubMed
  523. McDade E, Boeve BF, Burrus TM, Boot BP, Kantarci K, Fields J, Lowe VJ, Peller P, Knopman D, Baker M, Finch N, Rademakers R, Petersen R. Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin. Neurology. 2012 Apr 17; 78 (16):1245-9 Epub 2012 Apr 04
    View PubMed
  524. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker M, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Boot B, Kuntz KM, Gavrilova R, Reeves A, Whitwell J, Kantarci K, Jack CR Jr, Parisi JE, Lucas JA, Petersen RC, Rademakers R. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012 Mar; 135 (Pt 3):765-83
    View PubMed
  525. Kantarci K, Lowe V, Przybelski SA, Weigand SD, Senjem ML, Ivnik RJ, Preboske GM, Roberts R, Geda YE, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr. APOE modifies the association between Abeta load and cognition in cognitively normal older adults. Neurology. 2012 Jan 24; 78 (4):232-40 Epub 2011 Dec 21
    View PubMed
  526. Lingle WL, Negron V, Johnson GB, Nathan MA, Parasi JE, Johnson AJ, Hunt CH, Peller PJ, Broski SM, Fauq AH, Jack CR, Petersen RC, Klunk WE, Mathis CA, Lowe V. Adapting a pet imaging agent for correlative microscopy of meningiomas and other intracranial tumors Microscopy and Microanalysis. 2012; 18:178-9.
  527. Adelstein DJ, Ridge JA, Brizel DM, Holsinger FC, Haughey BH, O'Sullivan B, Genden EM, Beitler JJ, Weinstein GS, Quon H, Chepeha DB, Ferris RL, Weber RS, Movsas B, Waldron J, Lowe V, Ramsey S, Manola J, Yueh B, Carey TE, Bekelman JE, Konski AA, Moore E, Forastiere A, Schuller DE, Lynn J, Ullmann CD. Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia. Head Neck. 2012; 34(12):1681-703.
    View PubMed
  528. Kantarci K, Lowe V, Przybelski SA, Senjem ML, Weigand SD, Ivnik RJ, Roberts R, Geda YE, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr. Magnetic resonance spectroscopy, beta-amyloid load, and cognition in a population-based sample of cognitively normal older adults. Neurology. 2011 Sep 6; 77 (10):951-8 Epub 2011 Aug 24
    View PubMed
  529. Shahid KR, Amrami KK, Esther RJ, Lowe VJ, Spinner RJ. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1. J Surg Orthop Adv. 2011 Summer; 20: (2)132-5.
    View PubMed
  530. Bogsrud TV, Hay ID, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, Reading CC, Bjoro T, Lowe VJ. Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodies. Nucl Med Commun. 2011 Apr; 32: (4)245-51.
    View PubMed
  531. Claassen DO, Lowe VJ, Peller PJ, Petersen RC, Josephs KA. Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy. Parkinsonism Relat Disord. 2011 Mar; 17(3):160-5. Epub 2010 Dec 31.
    View PubMed
  532. Sarkar G, Curran GL, Mahlum E, Decklever T, Wengenack TM, Blahnik A, Hoesley B, Lowe VJ, Poduslo JF, Jenkins RB. A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brain. PLoS One. 2011; 6 (12):e28881 Epub 2011 Dec 21
    View PubMed
  533. Flanagan EP, McKeon A, Lennon VA, Boeve BF, Trenerry MR, Tan KM, Drubach DA, Josephs KA, Britton JW, Mandrekar JN, Lowe V, Parisi JE, Pittock SJ. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc. 2010 Oct; 85 (10):881-97
    View PubMed
  534. Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, Reading CC, Bjoro T, Hay ID, Lowe VJ. The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma. Mol Imaging Biol. 2010 Oct; 12(5):547-53. Epub 2009 Dec 01.
    View PubMed
  535. Kantarci K, Senjem ML, Lowe VJ, Wiste HJ, Weigand SD, Kemp BJ, Frank AR, Shiung MM, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr. Effects of age on the glucose metabolic changes in mild cognitive impairment. AJNR Am J Neuroradiol. 2010 Aug; 31 (7):1247-53 Epub 2010 Mar 18
    View PubMed
  536. Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E, Johnston PB, Wiseman GA. 18F-FDG PET and PET/CT in Burkitt's lymphoma. Eur J Radiol. 2010 Jul; 75(1):e68-73. Epub 2009 Aug 27.
    View PubMed
  537. Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E, Johnston PB, Wiseman GA. 18 F-FDG PET and PET/CT in Burkitt's lymphoma. Eur J Radiol. 2010; 75(1):e68-e73.
  538. Behzadi A, Ung Y, Lowe V, Deschamps C. The role of positron emission tomography in the management of non-small cell lung cancer. Can J Surg. 2009 Jun; 52(3):235-42.
    View PubMed
  539. Krajicek BJ, Ryu JH, Hartman TE, Lowe VJ, Vassallo R. Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis. Chest. 2009 Jun; 135: (6)1542-1549.
    View PubMed
  540. Lowe VJ, Kemp BJ, Jack CR Jr, Senjem M, Weigand S, Shiung M, Smith G, Knopman D, Boeve B, Mullan B, Petersen RC. Comparison of 18F-FDG and PiB PET in cognitive impairment. J Nucl Med. 2009 Jun; 50 (6):878-86 Epub 2009 May 14
    View PubMed
  541. Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC, Alzheimer's Disease Neuroimaging Initiative. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain. 2009 May; 132 (Pt 5):1355-65 Epub 2009 Mar 31
    View PubMed
  542. Kemp BJ, Hruska CB, McFarland AR, Lenox MW, Lowe VJ. NEMA NU 2-2007 performance measurements of the Siemens Inveon preclinical small animal PET system. Phys Med Biol. 2009 Apr 21; 54 (8):2359-76 Epub 2009 Mar 25
    View PubMed
  543. Yoon HH, Lowe VJ, Cassivi SD, Romero Y. The role of FDG-PET and staging laparoscopy in the management of patients with cancer of the esophagus or gastroesophageal junction. Gastroenterol Clin North Am. 2009 Mar; 38 (1):105-20, ix
    View PubMed
  544. Matteson EL, Lowe VJ, Prendergast FG, Crowson CS, Moder KG, Morgenstern DE, Messmann RA, Low PS. Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan. Clin Exp Rheumatol. 2009 Mar-Apr; 27 (2):253-9
    View PubMed
  545. Murphy R, Doerger KM, Nathan MA, Lowe VJ. Pretreatment with diphenoxylate hydrochloride/atropine sulfate (Lomotil) does not decrease physiologic bowel FDG activity on PET/CT scans of the abdomen and pelvis. Mol Imaging Biol. 2009 Mar-Apr; 11 (2):114-7 Epub 2008 Nov 27
    View PubMed
  546. Camp J, Simpson K, Bardsley MR, Popko LN, Young DL, Kemp BJ, Lowe V, Ordog T, Robb R. 3D registration of micro-PET-CT for measurable correlates of dyspeptic symptoms in mice. Proc SPIE Int Soc Opt Eng. 2009 Feb 27; 7262:72620Z
    View PubMed
  547. Kottschade LA, Suman VJ, Lowe V, Markovic SN. Positron emission tomography in early detection of relapse in high-risk melanoma patients: A retrospective review. Community Oncol. 2009; 6(8):344-7.
  548. Fortes DL, Allen MS, Lowe VJ, Shen KR, Wigle DA, Cassivi SD, Nichols FC, Deschamps C. The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules. Eur J Cardiothorac Surg. 2008 Dec; 34 (6):1223-7 Epub 2008 Oct 09
    View PubMed
  549. Patel RR, Subramaniam RM, Mandrekar JN, Hammack JE, Lowe VJ, Jett JR. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc. 2008 Aug; 83: (8)917-22.
    View PubMed
  550. Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, Reading CC, Hay ID, Lowe VJ. 18F-FDG PET in the management of patients with anaplastic thyroid carcinoma. Thyroid. 2008 Jul; 18(7):713-9.
    View PubMed
  551. Atkinson DM, Clarke MJ, Mladek AC, Carlson BL, Trump DP, Jacobson MS, Kemp BJ, Lowe VJ, Sarkaria JN. Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts. Head Neck. 2008 Jun; 30(6):790-9.
    View PubMed
  552. Galanis E, Carlson SK, Foster NR, Lowe V, Quevedo F, McWilliams RR, Grothey A, Jatoi A, Alberts SR, Rubin J. Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer. Mol Ther. 2008 May; 16 (5):979-84 Epub 2008 Mar 18
    View PubMed
  553. Karantanis D, Subramaniam RM, Peller PJ, Lowe VJ, Durski JM, Collins DA, Georgiou E, Ansell SM, Wiseman GA. The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma. Clin Lymphoma Myeloma. 2008 Apr; 8: (2)94-9.
    View PubMed
  554. Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain. 2008 Mar; 131 (Pt 3):665-80 Epub 2008 Feb 07
    View PubMed
  555. Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman RE, Wahl R, Paschold JC, Avrill N, Einhorn LH, Suh WW, Samson D, Delbekell D, Gorman M, Shields AF. Recommendations on the use of F-18-FDG PET in oncology. J Nucl Med. 2008 Mar; 49(3):480-508.
  556. Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman RE, Wahl R, Paschold JC, Avril N, Einhorn LH, Suh WW, Samson D, Delbeke D, Gorman M, Shields AF. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008 Mar; 49(3):480-508. Epub 2008 Feb 20.
    View PubMed
  557. Fletcher JW, Kymes SM, Gould M, Alazraki N, Coleman RE, Lowe VJ, Marn C, Segall G, Thet LA, Lee K. A comparison of the diagnostic accuracy of F-18-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med. 2008 Feb; 49(2):179-85.
  558. Fletcher JW, Kymes SM, Gould M, Alazraki N, Coleman RE, Lowe VJ, Marn C, Segall G, Thet LA, Lee K, VA SNAP Cooperative Studies Group. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med. 2008 Feb; 49(2):179-85. Epub 2008 Jan 16.
    View PubMed
  559. Shintani SA, Foote RL, Lowe VJ, Brown PD, Garces YI, Kasperbauer JL. Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008 Feb 1; 70(2):322-9. Epub 2007 Sep 24.
    View PubMed
  560. Fletcher JW, Djulbegovic B, Soares HP. Recommendations on the use of F18-FDG PET in Oncology. J Nucl Med. 2008; 49:480-508.
  561. Fletcher JW, Kymes SM, Gould M, Alazrake N, Coleman RE, Lowe VJ, et al. A Comparison of the Diagnostic Accuracy of F18 FDG PET PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med. 2008; 49:179-185.
  562. Karantanis D, O'eill BP, O'Neill BP, Subramaniam RM, Witte RJ, Mullan BP, Nathan MA, Lowe VJ, Peller PJ, Wiseman GA. 18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients. Nucl Med Commun. 2007 Nov; 28: (11)834-41.
    View PubMed
  563. Subramaniam RM, Lowe VJ. Squamous Cell Carcinoma: Restaging and Response to Therapy. PET Clin. 2007 Oct; 2: (4)481-7.
    View PubMed
  564. Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA, Peller PJ, Bahn RS, Lowe VJ. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med. 2007 Jun; 48 (6):896-901 Epub 2007 May 15
    View PubMed
  565. Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, Kasperbauer JL, Strome SE, Reading CC, Hay ID, Lowe VJ. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Commun. 2007 May; 28 (5):373-81
    View PubMed
  566. Daniels CE, Lowe VJ, Aubry MC, Allen MS, Jett JR. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Chest. 2007 Jan; 131: (1)255-60.
    View PubMed
  567. Kemp BJ, Kim C, Williams JJ, Ganin A, Lowe VJ, National Electrical Manufacturers Association (NEMA). NEMA NU 2-2001 performance measurements of an LYSO-based PET/CT system in 2D and 3D acquisition modes. J Nucl Med. 2006 Dec; 47(12):1960-7.
    View PubMed
  568. Karakelides H, Lowe VJ, Erickson D. Visual vignette. Endocr Pract. 2006 Nov-Dec; 12 (6):699
    View PubMed
  569. Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. AJR Am J Roentgenol. 2006 Nov; 187 (5):1361-7
    View PubMed
  570. Carlson SK, Classic KL, Hadac EM, Bender CE, Kemp BJ, Lowe VJ, Hoskin TL, Russell SJ. In vivo quantitation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography. Mol Imaging Biol. 2006 Nov-Dec; 8 (6):324-32
    View PubMed
  571. Bogsrud TV, Lowe VJ. Normal variants and pitfalls in whole-body PET imaging with 18F FDG. Appl Radiol. 2006; 35(6):16-30.
  572. Bogsrud TV, Karantanis D, Lowe VJ. Normal uptake of F-18 FDG in the sublingual gland. Clin Nucl Med. 2006 Jan; 31 (1):50
    View PubMed
  573. Dingli D, Kemp BJ, O'Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol. 2006 Jan-Feb; 8 (1):16-23
    View PubMed
  574. Lowe VJ, Booya F, Fletcher JG, Nathan M, Jensen E, Mullan B, Rohren E, Wiersema MJ, Vazquez-Sequeiros E, Murray JA, Allen MS, Levy MJ, Clain JE. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol. 2005 Nov-Dec; 7 (6):422-30
    View PubMed
  575. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Nathan MA, Lowe VJ. Lung cancer screening experience: a retrospective review of PET in 22 non-small cell lung carcinomas detected on screening chest CT in a high-risk population. AJR Am J Roentgenol. 2005 Jul; 185 (1):126-31
    View PubMed
  576. Matteson EL, Choi HK, Poe DS, Wise C, Lowe VJ, McDonald TJ, Rahman MU. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study. Arthritis Rheum. 2005 Jun 15; 53 (3):337-42
    View PubMed
  577. Rohren EM, Lowe VJ. Update in PET imaging of nonsmall cell lung cancer. Semin Nucl Med. 2004 Apr; 34 (2):134-53
    View PubMed
  578. Thompson RH, Hartman RP, Lowe VJ, Kawashima A, Leibovich BC. Applications of positron emission tomography imaging, intraoperative ultrasonography, magnetic resonance imaging, and angiography in the evaluation of renal masses. Curr Urol Rep. 2004 Feb; 5 (1):30-4
    View PubMed
  579. Fosko SW, Hu WM, Cook TF, Lowe VJ. Positron emission tomography for basal cell carcinoma of the head and neck. Arch Dermatol. 2003 Sep; 139(9):1141-6.
    View PubMed
  580. Lowe VJ, Mullan BP, Hay ID, McIver B, Kasperbauer JL. 18F-FDG PET of patients with Hurthle cell carcinoma. J Nucl Med. 2003 Sep; 44: (9)1402-6.
    View PubMed
  581. Mazlumzadeh M, Lowe VJ, Mullan BP, Fabry DA, McDonald TJ, Matteson EL. The utility of positron emission tomography in the evaluation of autoimmune hearing loss. Otol Neurotol. 2003 Mar; 24 (2):201-4
    View PubMed
  582. Hamblen SM, Lowe VJ. Clinical 18F-FDG oncology patient preparation techniques. J Nucl Med Technol. 2003 Mar; 31: (1)3-7; quiz 8-10.
    View PubMed
  583. Lowe VJ. Positron emission tomography scanning in lung cancer. Respir Care Clin N Am. 2003 Mar; 9 (1):119-36
    View PubMed
  584. Hardeman SH, Collins B, Lowe VJ, Solomon H, Stack BC Jr. Cholangiocarcinoma metastatic to the neck: first report of a case. Ear Nose Throat J. 2002 Nov; 81(11):776-8.
    View PubMed
  585. Forstrom LA, Dunn WL, Mullan BP, Hung JC, Lowe VJ, Thorson LM. Biodistribution and dosimetry of [(18)F]fluorodeoxyglucose labelled leukocytes in normal human subjects. Nucl Med Commun. 2002 Aug; 23 (8):721-5
    View PubMed
  586. Lowe VJ, Stack BC Jr. Esophageal cancer and head and neck cancer. Semin Roentgenol. 2002 Apr; 37 (2):140-50
    View PubMed
  587. Hollenbeak CS, Lowe VJ, Stack BC. The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck. Cancer. 2001 Nov 1; 92(9):2341-8.
    View PubMed
  588. Kokoska MS, Olson G, Kelemen PR, Fosko S, Dunphy F, Lowe VJ, Stack BC. The use of lymphoscintigraphy and PET in the management of head and neck melanoma. Otolaryngol Head Neck Surg. 2001 Sep; 125(3):213-20.
    View PubMed
  589. Lowe VJ, Stack BC. PET's role in head and neck cancer. Nuclear Medicine Annual. 2001; 1-21.
  590. Forstrom LA, Mullan BP, Hung JC, Lowe VJ, Thorson LM. 18F-FDG labelling of human leukocytes. Nucl Med Commun. 2000 Jul; 21 (7):691-4
    View PubMed
  591. Lowe VJ, Boyd JH, Dunphy FR, Kim H, Dunleavy T, Collins BT, Martin D, Stack BC Jr, Hollenbeak C, Fletcher JW. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol. 2000 Feb; 18(3):651-8.
    View PubMed
  592. Stack BC, Lowe VJ, Hardeman S. Radioguided surgical advancements for head and neck oncology. Southn Med J. 2000; 93:360-3.
  593. Lowe VJ, Kim H, Boyd JH, Eisenbeis JF, Dunphy FR, Fletcher JW. Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging. Radiology. 1999 Sep; 212(3):799-802.
    View PubMed
  594. Collins BT, Lowe VJ, Dunphy FR. Correlation of CT-guided fine-needle aspiration biopsy of the liver with fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of metastatic hepatic abnormalities. Diagn Cytopathol. 1999 Jul; 21(1):39-42.
    View PubMed
  595. Watson MR, Welsh-Bohmer KA, Hoffman JM, Lowe VJ, Rubin DC. The neural basis of naming impairments in Alzheimer's disease revealed through positron emission tomography. Arch Clin Neuropsychol. 1999; 14:347-57.
    View PubMed
  596. Goodsell BH, Lowe VJ, Stack BC. Melanoma of the head and neck: two cases evaluated with PET imaging and lymphoscintigraphy. International Online Journal of Otorhinolaryngology - Head and Neck Surgery. 1999; 2(1):.
  597. Collins BT, Gardner LJ, Verma AK, Lowe VJ, Dunphy FR, Boyd JH. Correlation of fine needle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of locally recurrent and metastatic head and neck neoplasia. Acta Cytol. 1998 Nov-Dec; 42(6):1325-9.
    View PubMed
  598. Lowe VJ, Naunheim KS. Positron emission tomography in lung cancer. Ann Thorac Surg. 1998 Jun; 65(6):1821-9.
    View PubMed
  599. Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, Karis J, Hubner K, Delbeke D, Heiberg EV, Patz EF, Coleman RE. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998 Mar; 16(3):1075-84.
    View PubMed
  600. Lowe VJ, Hebert ME, Anscher MS, Coleman RE. Chest wall FDG accumulation in serial FDG-PET images in patients being treated for bronchogenic carcinoma with radiation. Clin Positron Imaging. 1998; 1:185-91.
    View PubMed
  601. Lowe VJ, Naunheim K. The current role of positron emission tomography in thoracic oncology. Thorax. 1998; 53:703-712.
    View PubMed
  602. Lowe VJ. PET imaging in head and neck cancer. International Online Journal of Otorhinolaryngology - Head and Neck Surgery. 1998; 1(2):.
  603. Lowe VJ. Parathyroid imaging with technetium-99m-sestamibi. International Online Journal of Otorhinolaryngology - Head and Neck Surgery. 1998; 1(5):.
  604. Lowe VJ, Dunphy FR, Varvares M, Kim H, Wittry M, Dunphy CH, Dunleavy T, McDonough E, Minster J, Fletcher JW, Boyd JH. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head & Neck. 1997 Dec; 19(8):666-74.
    View PubMed
  605. Keogan MT, Lowe VJ, Baker ME, McDermott VG, Lyerly HK, Coleman RE. Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging. Abdom Imaging. 1997 May-Jun; 22(3):332-7.
    View PubMed
  606. Lowe VJ, Duhaylongsod FG, Patz EF, Delong DM, Hoffman JM, Wolfe WG, Coleman RE. Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology. 1997 Feb; 202(2):435-9.
    View PubMed
  607. Hebert ME, Lowe VJ, Hoffman JM, Patz EF, Anscher MS. Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings. Am J Clin Oncol. 1996 Aug; 19(4):416-21.
    View PubMed
  608. Lowe VJ, Bullard AG, Coleman RE. Ventilation/perfusion lung scan probability category distributions in university and community hospitals. Clin Nucl Med. 1995 Dec; 20(12):1079-83.
    View PubMed
  609. Patz EF Jr, Lowe VJ, Goodman PC, Herndon J. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. Chest. 1995 Dec; 108(6):1617-21.
    View PubMed
  610. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg. 1995 Nov; 60(5):1348-52.
    View PubMed
  611. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). Journal of Thoracic & Cardiovascular Surgery. 1995 Jul; 110(1):130-9; discussion 139-40.
    View PubMed
  612. Lowe VJ, DeLong DM, Hoffman JM, Coleman RE. Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. J Nucl Med. 1995 May; 36(5):883-7.
    View PubMed
  613. Lowe VJ, Hoffman JM, DeLong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med. 1994 Nov; 35(11):1771-6.
    View PubMed
  614. Lowe VJ, Hoffman JM, Hanson MW, Paine S, Massey EW, Jordan LK, Gray L, Moon RE, Coleman RE. Cerebral imaging of decompression injury patients with 18-F-2-fluoro-2-deoxyglucose positron emission tomography. Undersea & Hyperbaric Medicine. 1994 Jun; 21(2):103-13.
    View PubMed
  615. Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology. 1994 May; 191(2):379-82.
    View PubMed
  616. Lowe VJ, Greer KL, Hanson MW, Jaszczak RJ, Coleman RE. Cardiac phantom evaluation of simultaneously acquired dual-isotope rest thallium-201/stress technetium-99m SPECT images. J Nucl Med. 1993 Nov; 34(11):1998-2006.
    View PubMed
  617. Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Burrowes P, Coleman RE, Goodman PC. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology. 1993 Aug; 188(2):487-90.
    View PubMed
PST-20219857